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SUMMARY
Bunyamwera virus is the prototype of both the 
Bunyavirus genus and the Bunyaviridae family, which 
comprises more than 300 viruses. The virus possesses a 
negative stranded RNA genome of three segments designated 
Large (L), Middle (M) and Small (S). The M segment codes 
for the two virion glycoproteins, G1 and G2, and a non- 
structural polyprotein, termed NSm. The mature gene 
products are derived from a polyprotein precursor which is 
probably cotranslationally cleaved as it has not been 
detected in virus-infected cells. Genetic studies have 
indicated that the M segment gene products are involved in 
many of important biological attributes of the virus, 
including determinants of virulence, neutralisation and 
haemagglutination. The M segment RNA of bunyaviruses has a 
different gene organisation from those of Phlebovirus genus 
in having NSm in the middle of the precursor, whereas some 
members of the Phlebovirus genus have NSm at the beginning 
of the precursor. The Uukuniemi group of phleboviruses and 
members of the Hantavirus genus have no NSm. A common 
feature among members of the Bunyaviridae is maturation at 
the smooth surfaced membranes of the Golgi complex. The 
glycoproteins encoded by the M segment RNA are thought to be 
the main determinants of this feature. It was therefore of 
interest to express the Bunyamwera virus M RNA segment in 
order to study the biogenesis of the glycoproteins and NSm, 
and with the long-term view of studying and targetting of 
these proteins to the Golgi.
The overall aims of this work were to express the M RNA 
segment of Bunyamwera virus from a cloned cDNA; to determine 
the cellular residence of NSm; and to investigate the 
transport of the proteins from the endoplasmic reticulum to 
the Golgi complex. No immunological reagents specific for 
NSm were available, and two approaches were utilized in the 
production of specific antisera to NSm. One involved 
synthesis of fusion proteins with 3-galactosidase using the
pUEX3 vector system, and the second synthesis of branching 
peptides to selected sequences of NSm. Rabbits were
immunized separately with these immunogens and the antisera 
characterised by enzyme-linked immunosorbent assays and 
radioimmunoprecipitations. Antisera to fusion proteins 
failed to recognise NSm in immunoprecipitations. However, 
immune sera raised against the branching peptides recognised 
NSm specifically in Bunyamwera virus-infected cells by
radioimmunoprecipitation.
The antipeptide sera were used in indirect
immunofluorescence experiments to determine that NSm 
localized to the Golgi complex in virus-infected cells; this 
was confirmed by dual staining with rhodamine conjugated 
wheat germ agglutinin which predominantly stains the Golgi 
complex.
For in vitro translation of mRNA synthesized from 
Bunyamwera virus cDNA, the full length cDNA was cloned in 
the pT7T3 transcription vector under the control of the T3 
RNA promoter. Full length and various truncated transcripts 
were made using T3 RNA polymerase. Attempts to express the 
transcripts in vitro were unsuccessful in both rabbit 
reticulocyte lysate and in wheat germ cell free translation 
systems. However, a transcript representing nucleotides 
1352 to 4001 of the M segment mRNA, with an internal
in-frame AUG at nucleotides 1430-1432, was translated
in vitro in the rabbit reticulocyte lysate system to yield a 
90K protein which was immunoprecipitated by antivirus serum. 
These experiments suggested that sequences at the 5' end of 
the M segment mRNA inhibited translation in vitro.
Since translation in vitro appeared to be unsuitable in 
the study of the biogenesis of the M RNA gene products, 
attempts were made to express the proteins using recombinant 
vaccinia viruses. The cDNA was cloned in the vaccinia virus 
transfer vector vTF7-5 under control of the T7 promoter. 
Recombinant viruses were obtained, as demonstrated by dot
blot and Southern blot analyses, and one designated 
recBUN M. In cells dually infected with recBUN M and 
vTF7-3, a recombinant vaccinia virus, which expresses T7 RNA 
polymerase, Gl, G2 and NSm were synthesised. These proteins 
were demonstrated to be antigenically authentic by 
immunoprecipitation reactions with anti-BUN serum, which 
recognises both Gl and G2, and the antipeptide
serum to NSm.
Plasmids containing full length M segment cDNA and 
fragments representing Gl (nucleotides 1352-4458), G2 
(nucleotides 1-941) and NSm (nucleotides 963-1466) under the 
control of the bacteriophage T7 RNA promoter were made. The 
genes were transiently expressed by transfecting plasmid DNA 
into cells infected with vTF7-3. The Gl glycoprotein was 
detected in cells transfected with pT7T318UBUNM and was 
precipitated with virus antiserum. Cells transfected with 
PT7T318U/G1 also synthesised G l , which co-migrated with Gl 
made by the virus, and was also immunoprecipitated by 
antivirion serum. The G2 glycoprotein was synthesised in 
cells transfected with pTF7-5/G2 and detected by 
immunofluorescence with anti-virion serum. NSm was also 
synthesised and detected by immunofluorescence using 
branched antipeptide sera to NSm. Studies on glycosylation 
of Gl using tunicamycin (an inhibitor of glycosylation) 
revealed that the glycoprotein was properly glycosylated 
when synthesised in dual vaccinia virus infected cells, and 
also when transiently expressed.
Immunofluorescence studies of cells dually infected 
with the recombinant vaccinia virus demonstrated that G l , G2 
and NSm localised to the Golgi complex. When transiently 
expressed individually, G2 and NSm were localised to the 
Golgi complex. Gl on its own however remained in the 
endoplasmic reticulum. When G2 was co-expressed with Gl, 
both transported to the Golgi complex. Some Gl was 
expressed on the cell surface, but no G2 was detectable on 
the surface.
This is the first report about the expression of the 
middle RNA genome segment for any member of the Bunyavirus 
genus, and provides the basis for study of the very actively 
researched area of intracellular protein transport.
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M molar
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nt nucleotides
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rpm revolutions per minute
RT room temperature
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Virus Abbreviations
BUN Bunyamwera
DUG Dugbe
GER Germiston
HTN Hantaan
LAC La Crosse
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NE nephropathia epidemica
PH Prospect Hill
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RVF Rift Valley Fever
SR Sapporo rat
SSF Sicilian sandfly fever
SSH snowshoe hare
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VSV vesicular stomatitis v
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1INTRODUCTION
BUNYAVIRIDAE
Taxonomy and classification
Bunyaviruses belong to the family Bunyaviridae, and 
form the largest and most diverse grouping of arthropod- 
borne viruses. They also form the largest family of RNA 
viruses and include about 350 distinguishable viral 
serotypes, subtypes and varieties (Bishop, 1990; Gonzalez- 
Scarano and Nathanson, 1990; Schmaljohn and Patterson, 1990; 
Elliott, 1990; Bouloy, 1991). The number of confirmed or 
putative members of the family Bunyaviridae continues to 
increase (Pringle, 1991). The assignment of viruses to the 
family was made primarily because of their structural 
features, including a trisegmented genome of negative 
polarity and a similar protein-coding pattern within each 
genome segment. Many viruses of the family are transmitted 
by arthropods and can replicate in both vertebrates and 
invertebrates (Bouloy, 1991). However, it has recently been 
demonstrated that members of the family do not exclusively 
infect and replicate in invertebrates and vertebrates but 
can infect and grow in plants, as exemplified by the tomato 
spotted wilt virus, TSW (Milne and Francki, 1984; de Haan 
et al, 1989, 1990).
Currently five genera within the family have been 
defined. They are;
Bunyavirus genus - Prototype: Bunyamwera (BUN) virus 
Phlebovirus genus - Prototype: Sandfly fever Sicilian (SFS)
virus
Nairovirus genus - Prototype: Crimean-Congo haemorrhagic
fever (CCHF) virus 
Hantavirus genus - Prototype: Hantaan (HTN) virus 
Tospovirus genus - Prototype: Tomato spotted wilt (TSW)
virus
2The distinctive features of the viruses in the family
Bunyaviridae as defined by Bishop and Shope (1979) and
Pringle (1991) are the following:
1 Tripartite structure of the genome and the negative
sense of the linear single-stranded virion RNA.
2 Subdivision of the family predominantly on the basis of 
coding strategy into five distinct genera which embrace
subgeneric groupings of viruses with varying degrees of
serological relationships.
3 Ambisense encoding of a putative non-structural protein
gene in the S genome segment in viruses of the
Phlebovirus and Tospovirus genera. This was also 
observed in the former Uukuvirus genus which now has
been amalgamated with the Phlebovirus genus to become 
the Phlebovirus genus.
4 Enveloped pleiomorphic particles with four virus-
specified proteins: the putative polymerase protein (L),
cysteine rich precursor derived envelope glycoproteins
(Gl and G2, plus G3 in the Nairovirus genus), and the
nucleoprotein (N).
5 Three circular nucleocapsids, comprising in viruses of 
the Bunyavirus genus about 2100 molecules of N and 25 
molecules of L per particle, all enveloped by a lipid 
envelope containing approximately 600 molecules of
glycoproteins Gl and G2.
6 Absence of a matrix protein.
7 Maturation by budding from membranes of the Golgi
apparatus.
38 Close association with specific vertebrate hosts and 
specific arthropod vectors, with the exception of the 
tospoviruses, which are transmitted by thrips, and the 
hantaviruses which do not seem to be arthropod-borne.
9 Temporal separation of internal and envelope protein 
synthesis.
10 Priming of mRNA synthesis by a cap transfer mechanism 
analogous to that of influenza virus, except that it 
occurs in the cytoplasm, and absence of 
3 ‘-polyadenylation of mRNA.
11 Insensitivity to actinomycin-D and alpha-amanitin, and 
variable dependence on the presence of an intact 
functional nucleus.
12 Limitation of gene exchange to reassortment of genome 
subunits between closely related viruses within 
serogroups.
Classification and serological relationships
Serological tests have been the main instruments used 
to study antigenic variance and relatedness of the more than 
300 members of the Bunyaviridae family (Karabatsos, 1985). 
Classification of these viruses into genera and serogroups 
has most commonly been established by use of complement 
fixation, haemagglutination inhibition, indirect
immunofluorescent antibody and various forms of
neutralization tests in mice and cell cultures (Hunt and 
Calisher, 1979; Bishop, 1985a).
A member of a given serogroup is neutralized by 
homologous antisera and with varying degrees by heterologous 
antisera specific to other members of the serogroup. 
Usually members of one serogroup are not neutralized by 
antisera raised against members of another serogroup
4(Bishop, 1985a) . Viruses within a given serogroup that are 
easily distinguished by serological tests are referred to as 
types. Those that are only slightly different by standard 
serological assays are subtypes and those that show very 
slight but significant, repeatable cross-reactions are 
varieties or, if hardly distinguishable, strains (Calisher, 
1983; Shope, 1985). Haemagglutination and neutralization 
assays detect epitopes on the viral glycoproteins whereas 
complement fixation antibodies are directed to the 
nucleocapsid proteins (Shope, 1985; Bishop, and Beaty, 
1988). Complement fixation assays have been used to place 
viruses into serogroups while haemagglutination and 
neutralization tests have been used to divide members of the 
serogroups further into types and subtypes. This 
observation does not hold for members of the Phlebovirus 
genus because of the lesser conservation of the N protein 
than the glycoproteins Gl and G2 (Shope, 1985; Pifat et al, 
1988) and probably Tospovirus genus (Law and Moyer, 1990).
The separation of viruses into dfferent genera by use 
of immunological techniques has also been supported by the 
more powerful genome sequence comparisons (Clerx-van-Haaster 
et al, 1982; Eshita and Bishop, 1984; Ihara et al, 1985; 
Collett et al, 1985; Lees et al, 1986; Schmaljohn et al, 
1987; Ronnholm and Pettersson, 1987; Grady et al, 1987; 
Kakach et al, 1988; Pardigon et al, 1988; Simons, 1990). 
Such sequence comparisons, replication strategies and 
protein homologies of the N and NS of phleboviruses and 
uukuviruses showed genetic relatedness and led to the merger 
of the previously different genera (Simons et al, 1990). It 
is also hoped that use of monoclonal antibodies will greatly 
help in sorting out the many inconsistencies and errors 
based on conventional serology (Kingsford, 1991).
Classification of viruses in the Bunyaviridae family 
has been no small matter considering the number of viruses 
involved. Classification into genera seems reasonable for 
the most part but, when it comes to determining serogroups,
5complexes, virus species, subtypes, variants, varieties and 
strains, it is very difficult in many instances to know 
whether the term used to describe a given isolate is indeed 
correct (Calisher et al, 1988c, Calisher, 1988). The 
current classification of members and candidate members of 
the family Bunyaviridae is listed below (Francki et al, 
1991) . Possible members of the family have been considered 
on the basis of morphologic (electron microscopy) studies 
(Beaty and Calisher, 1991).
Unassigned viruses: For these viruses, apart from data from 
electron microscopy, no studies have been reported on the 
structure and replication of the viruses and no serologic 
relationship has been demonstrated between these candidate 
members and any of the recognised members of the family 
(Bishop, 1990) .
The list of members of the family Bunyaviridae, as 
reported by the International Committee on Taxonomy of 
Viruses, 1991, is as follows:
Bunyavirus genus
ANOPHELES A GROUP: Anopheles A, Las Maloyas, Lukuni,
Tacaiuma, Trombetas, Virgin River, CoAr3624, CoArl071, 
CoAr3627, ColAn57389, SpAr2317, H32580.
ANOPHELES B GROUP: Anopheles B, Boraceia.
BAKAU GROUP: Bakau, Ketapang, Nola, Tanjong Rabok, Telok 
Forest.
BUNYAMWERA GROUP: Anhembi, Batai, Birao, Bozo, Bunyamwera, 
Cache Valley, Fort Sherman, Germiston, Guaroa, Iaco, 
Ilesha, Kairi, Lokern, Macaua, Maguari, Main Drain, 
Mboke, Ngari, Northway, Playas, Santa Rosa, Shokwe, 
Sororoca, Taiassui, Tansaw, Tlacotalpan, Tucunduba, 
Wyeomyia, Xingu, AG83-1746, BeAr328208, CbaAr426.
BWAMBA GROUP: Bwamba, Pongola.
6C GROUP: Apeu, Bruconha, Caraparu, Gumbo Limbo, Itaqui,
Madrid, Marituba, Murutucu, Nepuyo, Oriboca, Ossa, 
Restan, Vinces, 63U11.
CALIFORNIA GROUP: California encephalitis, Inkoo, Jamestown 
Canyon, Keystone, La Crosse, Melao, San Angelo, Serra do 
Navio, snowshoe hare, South River, Tahyna, trivittatus, 
AG83-497.
CAPIM GROUP: Acara, Benevides, Benfica, Bushbush, Capim,
Guajara, Juan Diaz, Moriche, GU71u344, GU71u350.
GAMBOA GROUP: Alajuela, Brus Laguna, Gamboa, Pueblo Viejo, 
San Juan, 75V-2621, 78V-2441, 75V-2374.
GUAMA GROUP: Ananindeua, Bertioga, Bimiti, Cananeia, Catu, 
Guama, Guaratuba, Itimirim, Mahogany Hammock, Mirim, 
Moju, Timboteua.
KOONGOL GROUP: Koongol, Wongal.
MINATITLAN GROUP: Minatitlan, Palestina.
NYANDO GROUP: Nyando, Eret-147.
OLIFANTSVLEI GROUP: Bobia, Botambi, Olifantsvei, Oubi,
Dabakala.
PATOIS GROUP: Abras, Babahoyo, Estero Real, Pahayokee,
Patois, Shark River, Zegla.
SIMBU GROUP: Aino, Akabane, Buttonwillow, Douglas, Facey's 
Paddock, Ingwavuma, Inini, Kaikalur, Manzanilla, Mermet, 
Oropouche, Para, Peaton, Sabo, Sango, Sathuperi, 
Shamonda, Shuni, Simbu, Thimiri, Tinaroo, Utinga, Utive, 
YABA-7.
TETE GROUP: Bahig, Batama, Matruh, Tete, Tsuruse.
TURLOCK GROUP: Lednice, Turlock, Umbre, Yaba-1.
UNGROUPED VIRUSES: Kaeng Khoi, Leanyer, Mojui dos Campos, 
Termeil.
Hantavirus genus
HANTAAN GROUP: Hantaan, Leaky, Seoul, Prospect Hill,
Puumala, Thottapalayam.
7Nairovirus genus
CRIMEAN-CONGO HAEMORRHAGIC FEVER GROUP: Crimean-Congo
haemorrhagic fever, Hazara, Khasan.
DERA GHAZI KHAN GROUP: Abu Hammad, Abu Mina, Dera Ghazi
Khan, Kao Shuan, Pathum Thani, Pretoria.
HUGHES GROUP: Farallon, Fraser Point, Great Saltee, Hughes, 
Puffin Island, Punta Salinas, Raza, Sapphire II, Soldado 
Zirqa.
NAIROBI SHEEP DISEASE GROUP: Dugbe, Nairobi sheep disease.
QALYUB GROUP: Bandia, Omo, Qalyub.
SAKHALIN GROUP: Avalon, Clo Mor, Kachemak Bay, Paramushir, 
Sakhalin, Taggert, Tillmook.
THIAFORA GROUP: Evre, Thiafora.
Phlebovirus genus
SANDFLY FEVER GROUP: Sandfly fever Naples complex,
Karimabad, Sandfly fever Naples, Tehran, Toscana; Bajaru 
complex: Bujaru, Munguba; Candiru complex: Alenquer,
Candiru, Itaituba, Nique, Oriximina, Turuna; Chillibre 
complex: Cacao, Chillibre; Frijoles complex: Frijoles, 
Joa; Punta Toro complex: Buenaventura, Punta Toro; Rift
Valley fever complex: Belterra, Icoaraci, Rift Valley
fever; Salehebad complex: Arbia, Salehabad; No complex
assigned: Aguacate, Anhanga, Arboledas, Arumowot,
Caimito, Chagres, Corfou, Gabek Forest, Gordil, 
Itaporanga, Odrenisrou, Pacui, Rio Grande, Saint-Floris, 
Sandfly fever Sicillian, Urucuri.
UUKUNIEMI GROUP: Grand Arbaud, Manawa, Murre, Oceanside,
Ponteves, Precarious Point, St. Abbs Head, Uukuniemi, 
Zialiv, Terpeniya, EgAnl825-61, Fin V-707, RML 105355.
Other possible members of the family Bunyaviridae
BHANJA GROUP: Bhanja, Forecariah, Kismayo.
KAISODI GROUP: Kaisodi, Lanjan, Silverwater.
MAPPUTTA GROUP: Gan Gan, Mapputta, Maprik, Trubanaman.
8OKALO GROUP:? Okola, Tanga.
RESISTENCIA GROUP: Antequera, barranqueras, Resistencia. 
UPOLU GROUP: Aransas Bay, Upolu.
YOGUE GROUP: Yogue, Kasokero.
UNGROUPED VIRUSES: Bangui, Batken, Belem, Belmont, Bobaya,
Caddo Canyon, Chim, Enseada, Issyk-Kul (Keterah),
Kowanyama, Lone Star, Pacora, Razdan, Salanga, Santarem, 
Sunday Canyon, Tai, Tamdy, Tataguine, Wanowrie,
Witwatersrand, Yacaaba.
9VIRUS PARTICLE 
Morphology
Viruses of the family Bunyaviridae show similar 
morphological features (Horzinek, 1975; Murphy et al, 1968, 
1973; Pettersson and Von Bonsdorff, 1987). Classical 
negative staining showed particle pleiomorphism (Obijeski 
et al, 1976a) . However, recent technology involving use of 
electron cryomicroscopy showed uniform spherical shapes for 
La Crosse virus ranging from 75 nm to 115 nm in diameter 
(Talmon et al, 1987). This method also preserved structural 
details of the virion in its native state and revealed 
10 nm-long regular spikes and a 4 nm-thick bilayer 
structure.
Composition
The chemical composition for members of the 
Bunyaviridae has not been determined except for a member of 
the Phlebovirus genus, Uukuniemi virus (UUK). UUK particles 
were found to consist of 7% carbohydrate, 33% lipid, 58% 
protein and 2% RNA (Pettersson, 1975).
The virion particles of the family are composed of 
nucleocapsids containing three different RNA species, 
designated Large (L), Middle (M) and Small (S), in 
association with the nucleocapsid protein (N) and the virion 
polymerase (L). The nucloecapsids are packaged inside a 
lipid envelope during budding which occurs at the internal 
cellular membranes of the Golgi apparatus (Lyons and Heyduk, 
1973; Murphy et al, 1973; Kuisroanen et al, 1982; Smith and 
Pifat, 1982; Booth et al, 1991). In addition, all 
Bunyaviridae have two glycoproteins designated G1 and G2 
except in some nairoviruses which may have three 
glycoproteins (Foulke et al, 1981; Watret and Elliott, 
1985). For some nairoviruses a G1 protein has not been
10
detected and the G2 has only been detected for members of
the Qalyub and CCHF serogroups (Clerx et al, 1981; Booth 
et al, 1991).
Sedimentation coefficients and buoyant densities
Sedimentation coefficients (Sso,w) for various members 
of the family have been reported: BUN (Kascsak and Lyons,
1977), CCHF (Donets and Chumakov, 1975), RVF (Poison and
Levitt, 1963), UUK (Pettersson et al, 1971), TSW (Joubert 
et al, 1974) . The reported sedimentation coefficient values 
range from 350S to 500S (Francki et al, 1991).
Buoyant densities range from 1.17 to 1.19g/cm3 and such 
buoyant densities were shown for BUN (Kascsak and Lyons, 
1977), California encephalitis virus (Goldman et al, 1977; 
White, 1975), CCHF (Chumakov and Donets, 1975), UUK (von 
Bonsdorff and Pettersson, 1975). The average buoyant 
density in caesium chloride is 1.2g/cm3 (Obijeski and 
Murphy, 1977).
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GENOME STRUCTURE AND ORGANISATION 
Sizes of the genome RNA segments
Sizes of the genomic RNA segments were determined from 
the electrophoretic mobilities of the RNA in agarose or 
polyacrylamide gels or for some segments, by nucleotide 
sequence determinations of cloned cDNA (Elliott et al, 
1991). The pattern of RNA segment size is distinctive for 
bunyaviruses, nairoviruses, and tospoviruses. There is less 
difference between the pattern of RNAs of hantaviruses and 
phleboviruses. The sizes of RNA segments for each genus of 
the Bunyaviridae are presented in Table 1.1.
The 3* and 5* RNA sequences
When observed under the electron microscope, the 
nucleocapsids of members of Bunyaviridae were seen to form 
circular structures (Pettersson and von Bonsdorff, 1975; 
Sarnso et al, 1975; Obijeski et al, 1976b). This 
observation is explained by the complementarity of the 3' 
and the 5' termini of the RNA segments which accounts for 
the formation of circular and/or panhandle forms of the RNAs 
seen by the electron microscope (Bouloy et al, 1973, 1974; 
Sarnso et al, 1976; Hewlett et al, 1977; Pardigon et al,
1982). The terminal 11 bases of the three BUN RNAs are 
conserved and complementary except for positions 9 and -9 
and the following 20 or so bases show segment specific 
complementarity (Elliott, 1990). These are shown in 
Fig 1.1. The mismatch at positions 9 and -9 is found in all 
bunyavirus RNAs sequenced. However, this mismatch has not 
been observed in the complementary sequence termini of the 
phlebovirus M and S segments nor the hantavirus M and S 
segments, although a mismatch in positions 12 and -12 was 
repoted for Hantan virus M in the terminal 18 complementary 
nucleotides (Yoo and Kang, 1987a).
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Figure 1.1 Complementary sequences and possible base-paired 
structures between the 3' and 5' termini of Bunyamwera virus 
genomic RNA segments.
The terminal 11 nucleotides are conserved in all genome 
segments; shaded regions represent nucleotides which are 
conserved on a segment specific basis in all available 
sequenced bunyavirus RNA segments.
(From Elliott, 1990)
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It has been suggested that the conserved terminal 
sequences of the RNAs are important for encapsidation by the 
N protein as the genomic (-) and full-length viral 
complementary (+) RNA are encapsidated, whereas viral mRNA, 
which has 5 '-terminal extensions and is shorter at the 3' 
end, is not (Raju and Kolakofsky, 1986b). However, the same 
authors found a small amount of mRNA-like transcripts late 
in infection that were encapsidated and full-length (+) 
molecules with 5' extensions that were not encapsidated. 
They concluded that nucleocapsid recognition sequences were 
at the 5' end of the RNA. Raju and Kolakofsky (1989) also 
showed that full-length (-) and (+) strands are base-paired 
in the viral nucleocapsid and they emphasised the importance 
of unmatched and mismatched bases within the double-stranded 
regions of RNA for recognition by proteins (reviewed in 
Wickens and Dahlberg, 1987).
The consensus 3' and 5 ’ terminal nucleotide sequences 
of the Bunyaviridae genome RNA segments are shown in 
Table 1.2.
Bunyavirus genus
The complete genome sequence of BUN, the prototype of 
the family Bunyaviridae, has been determined (Lees et al, 
1986; Elliott, 1989a, b ) . This is the only member of the 
Bunyavirus genus whose complete sequence has been reported 
(Elliott et al, 1991) . The genome comprises 12294 
nucleotides.
The BUN L RNA segment is 6875 nucleotides long and has 
a base composition of 66.7% A+U residues; this is richer in 
A+U residues than the M (61.0%) or the S (58.2%) segments. 
Only limited sequence information is available for the L RNA 
segments of other bunyaviruses. Some sequences from the 
L RNA segment of snowshoe hare virus (SSH) and La Crosse
Table 1.2 Terminal nucleotide sequences of the L, M and S genome segments of 
representative members of the Bunyaviridae
Gene
Genus Virus Segment 3' terminus® 5' terminusb
Bunyavirus La Crosse S 3' UCAUCACAUGAGGUG 5 ’ AGUAGUGUGCUCCAC
M 3' UCAUCACAUGAUGGU 5* AGUAGUGUGCIJACCA
L 3 ’ UCAUCACAUGAGGAU
Hantavirus Hantaan S 3' AUCAUCAUCUGAGGG 5' UAGUAGUAUGCUCCC
M 3 ’ AUCAUCAUCUGAGGC 5' UAGUAGUAGACACCG
L 3 1 AUCAUCAUCUGAGGG
Nairovirus Qalyub S
M
L
3'
3'
3'
AGAGAUUCUGCCUGC
AGAGAUUCUUUAUGA
AGAGAUUCUUUAAUU
Phlebovirus Rift Valley Fever S 3 1 UGUGUUUCGG
M 3' UGUGUUUCUGCCACGU 5' ACACAAAGACCGGUG
L 3' UGUGUUUCUG
Uukuvirus Uukuniemi S 3' UGUGUUUCUGGAGGUU
M 3* UGUGUUUCUGCCGAUU 5 ’ ACACAAAGACGGCUA
L 3' UGUGUUUCUGGAGUUG
a 3' terminal sequences were obtained by direct sequencing of virion RNAs or by 
analysis of cDNA clones. Sequences identical on all three genome segments are 
underlined.
b 5' terminal sequences were determined by sequence analysis of cDNA.
(From Schmaljohn and Patterson, 1990)
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virus (LAC) (Clerx-van Haaster et al, 1982a; Hacker et al,
1990) have been reported. Comparison of the sequences shows 
about 40% homology with the BUN L RNA.
Complete nucleotide sequences of four bunyavirus M 
segments are available from viruses of two serogroups? the 
Bunyamwera serogroup and the California serogroup 
(Table 1.3). The segments are similar in size (4458-4534 
bases, base composition 61.0-63.2% A+U) and an economy in 
the use of RNA to encode protein (Elliott et al, 1991).
Nucleotide sequence homology is greater between the M 
segments of viruses of the same serogroup (e.g. SSH virus 
and LAC virus 79%; Grady et al, 1987) than between viruses 
in different serogroups (e.g. SSH virus and BUN virus, 55%, 
Lees et al, 1986) .
Sequences of the S segment of six members of the
Bunyavirus genus have been reported, representing the 
Bunyamwera, California and Simbu serogroups (Table 1.4).
The sizes range from 850 to 984 nucleotides in length with a 
base composition of 55.9-59.9% A+U residues.
Hantavirus genus
The Hantavirus genus was included into the family 
Bunyaviridae as a result of the analysis of the virus RNA 
which showed similarities with other members of the family 
(Schmaljohn and Dalrymple, 1983). Nucleotide sequences have 
been reported for the M and/or the S genome segments of four 
serologically distinct hantaviruses: Hantaan (HTN) virus,
Sapporo rat (SR-II) virus, nephropathia epidemica (NE) virus 
(Hallnas strain), and Prospect Hill (PH) virus. L segment 
sequences of HTN, NE and Seoul viruses have also been 
reported.
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In common with other members of the Bunyaviridae 
family, the L, M and S segments show consensus sequences at 
the 3' termini which are distinct from viruses of the other 
four genera (Schmaljohn and Dalrymple, 1983, 1984;
Schmaljohn et al, 1985). Complementary 5' terminal
sequences were identified by analyses of cDNA copies of
viral genomes (Schmaljohn et al, 1986a, 1987b; Giebel et al, 
1989; Stohwasser et al, 1990; Arikawa et al, 1990; 
Parrington and Kang, 1990), and this allows noncovalent
circularization of the individual genome segments forming
stable, base-paired, panhandle structures.
Nairovirus genus
The L RNA segment of members of the Nairovirus genus is 
much larger (almost twice the size) than L RNAs of other
genera. Some estimates of the size of the M segment
indicate that this is also larger in the Nairovirus genus 
than in other genera (Clerx and Bishop, 1981; Clerx et al, 
1981; Watret and Elliott, 1985; Ward et al, 1990).
Ward et al (1990) reported the sequence of the S
segment of Dugbe virus. The segment is 1712 nucleotides
long and has a base composition of 30.6% A, 20.1%C, 23.4% G 
and 25.9% U. Sixteen of the 17 terminal nucleotides at the 
3' and 5' ends are complementary. No homologies were found
with other S RNA segments of the other genera in
Bunyaviridae.
Phlebovirus genus
Molecular genetic analysis of phleboviruses and
uukuviruses revealed ancestral relationship and led to the 
unification of the previously separate genera (Elliott 
et al, 1991; Francki et al, 1991). The nucleotide sequence 
for the L RNA segment has been determined for RVF (Muller 
et al, 1991) and UUK (Elliott et al, 1992). Sequences for 
the M segment are available for Punta Toro (PT), RVF and UUK
15
viruses (Ihara et al, 1985b; Collett et al, 1985; Rounholm 
and Pettersson, 1987). Sequence analyses of the S segment 
have also been reported for PT, SFS and UUK (Ihara et al, 
1984; Marriott et al, 1989; Simons et al, 1990).
Tospovirus genus
The genome of TSW, the prototype of the genus, consists
of three linear RNA molecules of 2916 nucleotides for S RNA,
about 5000 nucleotides for M RNA and 8897 nucleotides for 
the L RNA. Analysis of the terminal sequences of TSW RNA 
showed some difference from those of all members of the 
Bunyaviridae. Strikingly the termini of the TSW RNAs showed 
considerable sequence homology to that of RNA segment 3 of 
Thogoto virus and segment 2 of Dhori virus, which are 
members of the Orthomyxoviridae (de Haan, 1991, PhD Thesis). 
This may reflect ancentral relationships between TSW and 
some members of the Orthomyxoviridae. The 3' end sequence
is conserved and complementary to the 5' end (de Haan et al,
1989).
GENE EXPRESSION STRATEGIES
The coding properties of the genome segments for
different genera of members of the Bunyaviridae family are 
quite similar, despite the differences in relative sizes of 
the corresponding subunits. Generally, the coding
assignments of the different segments are;
1 The L RNA segment codes for the L protein.
2 The M RNA segment codes for two glycoproteins, G1 and G2,
in the form of a precursor polypeptide which is then 
cleaved cotranslationally to give mature polypeptides.
3 The S RNA segment encodes the nucleocapsid protein N.
16
The L, M and S RNA segments of bunyaviruses and 
hantaviruses are of negative polarity, i.e. the viral genome 
segments have to be transcribed into positive sense mRNA for 
protein synthesis. However, the S RNA segments of 
phleboviruses and tospoviruses resemble the S RNA segment of
arenaviruses, i.e. a linear single-stranded structure of
covalently-linked negative- and positive-sense molecules 
from which separate mRNAs are made. This kind of arrangment 
is referred to as being ambisense.
The L segment
The bunyavirus L RNA codes for the L protein (Elliott, 
1989b; Endres et al, 1989). There is a single AUG-initiated 
open reading frame in the BUN L segment viral complementary 
RNA flanked by 5' and 3' noncoding regions of 50 and 108 
bases respectively. The open reading frame (ORF) contains 
2239 codons. There is a short ORF of 63 codons which is 
present in the negative-sense strand, but no gene product 
has been identified for it (Elliott, 1989b).
Sequence analysis of the cDNA of the L RNA segment of
HTN (Schmaljohn, 1990) showed a similar coding strategy to
that of the L segment of BUN described above. The sequence 
analysis of the RVF phlebovirus shows a single long ORF 
coding for 2149 amino acids (243.6 Kd) in the viral- 
complementary sequence. The 5' and 3' non-coding regions in 
the viral-complementary RNA sequences are 18 and 141 
nucleotides in length, respectively. There is the potential 
for a short gene product (3.5 Kd) coded in the 5' region of 
the viral RNA sequence, suggesting that the L RNA, like the 
RVF S RNA, may have an ambisense coding strategy. This 
remains to be confirmed by identification of a gene product 
(Muller et al, 1992). No sequence reports have been made 
for the L segment of nairoviruses but it is assumed that 
similar strategies are employed. The L RNA segment of TSW, 
has been determined (de Haar ^ ^ t  al, 1991) and an ORF 
starting with an AUG c o d o n ^ 34 and extending to an UAA
17
stopcodon at position 8659. The non-coding regions of the 
complementary RNA are 33 bases at the 5' end and 235 bases 
at the 3' end. A representation of the coding strategy of 
the L segment is shown in Fig 1.2.
The M segment
Bunyavirus cjenus
Four M RNA segments of members of the bunyavirus genus
have been sequenced for SSH, LAC, GER and BUN. All have a
single ORF of 1433-1441 amino acids which represents a 
polypeptide precursor to the two virion glycoproteins, G1 
(Mr 108,000-120,000) and G2 (Mr 29,000-41,000), and a 
nonstructural protein NSm (Mr 15,000-18,000; Gentsch and 
Bishop, 1979; Fuller and Bishop, 1982; Elliott, 1985). The 
putative precursor has not been detected in virus infected 
cells (Pennington et al, 1977; Lees et al, 1986). It has 
not been possible to translate mRNA derived from the M RNA 
segment in vitro (Abraham and Pattnaik, 1983; Elliott, 1985) 
although it has been possible to express phlebovirus 
glycoproteins using similar conditions. No reports have 
been made about the expression of bunyavirus M segment from 
cloned cDNAs in both prokaryotic and eukaryotic systems.
Phlebovirus genus
The most extensively studied M RNA segments of the
phlebovirus genus are those of the RVF and UUK. The M
segment of RVF has 3,885 nucleotides with a coding potential 
of 133kd in the main ORF of the cRNA (Battles and Dalrymple, 
1988; Collett et al, 1985). The M segment mRNA of RVF has a 
3' terminal truncation of about 100 nucleotides as compared 
to the genomic RNA. There is also an extension beyond the 
5' genomic end by 12-14 nucleotides of heterogeneous 
sequence. Amino-terminal sequence analysis of purified G1 
and G2 with respect to cRNA showed a coding potential of 
about 17kd between the first AUG translation initiation
Figure 1.2 Coding strategies of Bunyaviridae genomes.
Thin lines: the genomic RNAs; arrows: mRNAs, : 5'
: 3' end; solid boxes: gene products (not to scale).
end;
(From Elliott et al, 1991).
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codon and the amino terminus of G2 (Collett, 1985, 1986). 
This region, referred to as preglycoprotein or nonstructural 
M (NSm), has five in-frame AUG codons which come before G2. 
In vitro translation of an RNA transcript of cDNA containing 
the five initiation codons gave rise to a polypeptide of 
133 Kd which, when translated in the presence of microsomal 
membranes, yielded four proteins. Apart from the two 
glycoproteins, G1 and G2, two other polypeptides of 78 Kd 
and 14 Kd were observed. Alteration of the initiation 
codons and expression in vaccinia virus systems indicated 
involvement of independent initiation at each of the first 
and second AUG codons yielding primary translation products 
which are co-translationally processed (Kakach et al, 1989). 
Initiation at the first AUG of the ORF yielded the 78 Kd 
protein representing a fusion between the preglycoprotein 
region and the G2 glycoprotein coding sequences, and the 
78 Kd protein probably represents the unprocessed 
polyprotein of NSm and G2 (Kakach et al, 1988; Suzich and 
Collett, 1988). Translation from the second in-frame AUG, 
which is 37 amino acids downstream from the first, yielded 
the 14 Kd protein which consists only of the preglycoprotein 
sequences. There is a common glycosylation site at position 
285 which is not utilized in the 14 Kd protein but is used 
in the 78 Kd protein (Kakach et al, 1989). G1 appears to be 
produced by internal initiation downstream of the 
preglycoprotein region (Suzich et al, 1990).
The terminal complementary 3' and 5' sequences of the M 
segments of UUK are identical for 10-15 nucleotides to those 
of RVF (Collett et al, 1985; Parker and Hewlett, 1981).
Although the former Uukuvirus genus is now included in the 
Phlebovirus genus, sequence analysis of UUK M segment 
revealed a coding strategy different from that of other 
phleboviruses. There are common features like encoding G1 
and G2 proteins and cotranslational cleavage of a 
polyprotein precursor (Ronnholm and Pettersson, 1987; 
Ulmanen et al, 1981). However, the uukuviruses do not have 
a preglycoprotein coding region and there is only one
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initiation AUG codon which is 17 amino acids upstream of the
amino terminus of Gl. The G1 of UUK appears similar to the
RVF 78kd protein.
Hantavirus genus
The M genome segment of HTN consists of 3,616 
nucleotides and has a continuous ORF in the cRNA that 
encodes Gl and G2. The M segment does not appear to encode
NSm. There is a 17 amino acid leader sequence between the
first AUG codon and the amino terminus of Gl. A second 
in-frame AUG codon which is located nine amino acids 
upstream of the amino terminus of Gl apparently is not used 
for initiation. This was demonstrated by removing the first 
initiation codon and expressing the cDNA in vaccinia or 
baculovirus systems (Schmaljohn et al, 1989). There is a 
region of 34 amino acids between Gl and G2 and 19 of these 
showed characteristics that constitute a signal sequence for 
G2 (Schmaljohn et al, 1987b).
Nairovirus genus
There is currently no information concerning the M 
segment coding strategy of nairoviruses. The M RNA of 
different nairoviruses range from 4,400 to 6,300 bases 
(Clerx and Bishop, 1981? Clerx et al, 1981; Watret and 
Elliott, 1985b). Analysis of nairovirus glycoproteins show 
molecular size estimates of Mr 72,000-84,000 for Gl and 
Mr 30,000-45,000 for G2 (Clerx and Bishop, 1981; Clerx 
et al, 1981; Cash, 1985; Watret and Elliott, 1985b). Three 
virion glycoproteins have been observed for Hazara virus 
with Mr of 84,000, 45,000 and 30,000 (Foulke et al, 1981). 
Reports have been made about non-structural glycoprotein 
precursors which were shown to be related to the structural 
glycoproteins by pulse-chase experiments (Clerx and Bishop, 
1981? Cash, 1985; Watret and Elliott, 1985b). Details about 
the cleavage events or interrelationships between the 
identified proteins are not available.
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Tospovirus genus
The expression strategies of the M RNA segments of 
representative viruses is shown in Fig 1.2.
The S segment
Bunyavirus genus
The S RNA segment for members of the Bunyavirus genus 
encode two proteins, the nucleocapsid N protein (Mr 19,GOO- 
26,000) and a nonstructural protein, NSs (Mr 10,000-12,000). 
These proteins are encoded in overlapping reading frames, 
i.e. proteins are synthesised from the same nucleotide 
sequences but in different reading frames (Gentsch and 
Bishop, 1978; Cash et al, 1979; Bishop et al, 1982; Fuller 
and Bishop, 1982; Akashi and Bishop, 1983; Cabradilla et al, 
1983; Fuller et al, 1983; Akashi et al, 1984; Bouloy et al, 
1984; Elliott, 1985; Gerbaud et al, 1987b; Elliott and 
McGregor, 1989). Only one S segment mRNA species has been 
described for bunyaviruses SSH, LAC and GER (Bouloy et al, 
1984; Eshita et al, 1985; Patterson and Kolakofsky, 1984) 
and it appears therefore that the N and NSs proteins are 
made from the same mRNA species, the result of alternative 
initiation of translation (Bishop et al, 1983b; Elliott and 
McGregor, 1989). The S segments of GER and MAG bunyaviruses 
contain an additional ORF downstream of, and in the same 
frame as, NSs (Gerbaud et al, 1987b; Elliott and McGregor,
1989). The product of this third ORF has been translated 
in vitro from cloned cDNA but the protein has not been 
observed in vivo (Elliott and McGregor, 1989).
Phlebovirus genus
The coding strategy of the S segments of phleboviruses 
is different from those of bunyaviruses, nairoviruses and 
hantaviruses but appear to be similar to tospoviruses.
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Cloning and sequence analysis and cell-free translation 
studies have revealed the existence of two ORFs for PT 
(Ihara et al, 1984), SFS (Marriott et al, 1989), Toscana, 
RVF (Giorgi et al, 1991) and UUK (Simons et al, 1990). One 
ORF is present in the viral complementary sense RNA and 
codes for the N protein; the other ORF is present in the 
virion sense RNA and codes for the NSs protein. This 
strategy of encoding two proteins from non-overlapping 
regions of virion-sense and anti-virion-sense RNA is 
referred to as ambisense and had been identified previously 
in the S segment of arenaviruses (Bishop, 1986). The N and 
NSs proteins are encoded by two subgenomic mRNAs of opposite 
polarity.
Hantavirus genus
Members of the Hantavirus genus apparently do not 
encode any NSs polypeptide. There is only one continuous 
ORF in the HTN S cRNA that encodes N. The N protein is 
translated from a virus complementary-sense messenger RNA 
which is indistinguishable in size from genomic length S RNA 
(Schmaljohn et al, 1986a, 1987a). The HTN N protein, which 
is 48-kD, is much larger than those of bunyaviruses and 
phleboviruses.
Nairovirus crenus
The nucleotide sequence of the S RNA segment of Dugbe 
(DUG) virus has been determined (Ward et al, 1990). The
S RNA of DUG virus is 1712 nucleotides in length and
contains one large ORF of 1326 nucleotides. The ORF is 
flanked by 3' and 5* non-coding regions of 49 and 337 
nucleotides, respectively. The identity of the protein 
encoded by the ORF was demonstrated when monoclonal
antibodies to the DUG virus N protein precipitated a fusion 
protein of p-galactosidase and the DUG virus ORF. The
S segment of DUG virus mRNA was found to be essentially 
full-length, and similar to /jtutt of hantaviruses
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(Schmaljohn et al, 1986). No evidence was found for the 
overlapping reading frame coding strategy of bunyaviruses 
and the ambisense coding strategy of phleboviruses.
Tospovirus genus
De Haan et al (1990) reported the nucleotide sequence 
of the S RNA segment of TSW. The RNA is 2916 nucleotides 
long and analysis of the genome revealed two major reading 
frames. The ORF on the viral RNA strand starts with an AUG 
codon at position 88 and ends at a UAA stop codon at 
position 1481, which is capable of coding for a protein of 
465 amino acids. The ORF on the cRNA strand starts with an 
AUG codon at position 2763 and ends at the UGA codon at 
position 1989 (numbered from the 5' end of the viral 
strand). It encodes a protein of 259 amino acids. In vitro 
translation of this second ORF from a cloned cDNA showed 
that it was the nucleocapsid protein, N, as it co-migrated 
with authentic N viral protein and reacted with antiserum 
raised against purified nucleocapsids. Two subgenomic mRNAs 
were detected by northern blots. It was deduced that TSW 
S RNA segment had an ambisense arrangement (de Haan et al,
1990) .
The coding strategies of the S genome segments of the 
family Bunyaviridae are shown in Fig 1.2.
VIRAL PROTEINS AND FUNCTION
Most of the viruses of the Bunyaviridae family are 
composed of four structural proteins designated L, N, Gl and 
G2. The L and N proteins are associated with RNA, forming 
nucleocapsids. Gl and G2 are located at the surface and 
form spikes observable in the electron microscope. Apart 
from their structural proteins, bunyaviruses and some 
phleboviruses have two nonstructural proteins, designated 
NSm and NSs; uukuviruses of the Phlebovirus genus express 
one nonstructural protein, NSs. These nonstructural
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proteins have not been reported for members of the other 
genera (Bouloy, 1991). Proteins encoded by the Bunyaviridae 
are shown in Table 1.5.
The L protein
The L protein is thought to be the virion-associated 
transcriptase. In the Bunyavirus genus transcriptase 
activity has been detected in detergent disrupted 
preparations of Lumbo (Bouloy and Hannoun, 1976), LAC 
(Patterson et al, 1984), GER (Gerbaud et al, 1987a). 
Schmaljohn and Dalrymple (1983) found RNA-dependent RNA 
polymerase activity associated with purified HTN virions. 
Jin and Elliott (1991) demonstrated the polymerase activity 
of the L protein by synthesizing BUN RNA using the L protein 
made by recombinant vaccinia virus. There have yet to be 
similar reports on the polymerase activity of the other 
genera.
The M segment proteins
The middle RNA segment codes for two glycoproteins, Gl 
and G2, and, depending on the genus, a nonstructural 
protein, NSm. Apart from their structural role the 
glycoproteins show biological functions including 
neutralising epitopes, an acid pH-dependent fusion activity, 
and are involved in attachment to cellular receptors. They 
are also responsible for the induction of immune responses 
resulting in the production of haemagglutinating and 
neutralizing antibodies. The glycoproteins have been shown 
to be the main determinants of virulence in mice (Shope 
et al, 1981; Gonzalez-Scarano et al, 1985a? Janssen et al, 
1986; Endres et al, 1990) and for infection of mosquitoes 
(Beaty et al, 1981, 1982; Sundin et al, 1987).
Neutralising epitopes have been mapped to only Gl of 
the bunyaviruses (Gonzalez-Scarano et al, 1982; Kingsford 
et al, 1983; Kingsford and Boucquey, 1990; Grady et al,
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1983) whereas they have been found in both G1 and G2 of RVF 
(Keegan and Collett, 1986; Battles and Dalyrymple, 1988), PT 
(Pifat and Smith, 1987; Pifat et al, 1988) and HTN 
(Yamanishi et al, 1984; Dantas et al, 1986; Arikawa et al, 
1989) . The ability of the glycoprotein to induce immunity 
and protection has been reported for the G2 of RVF (Collett 
et al, 1987; Dalrymple et al, 1989; Schmaljohn et al, 1989) 
and for both G1 and G2 of HTN (Pensiero et al, 1988; 
Schmaljohn et al, 1990).
Acid-dependent fusion activity has been demonstrated in 
LAC and HTN virions. This activity is thought to be 
important in the attachment of virions to cells in the early 
stages of infection. For LAC bunyavirus it has been 
suggested that the G2 glycoprotein is actually responsible 
for cell fusion (Pobjecky et al, 1989) although it is G1 
that has been observed to undergo a conformational change at 
the pH of fusion (Gonzalez-Scarano, 1985; Gonzalez-Scarano 
et al, 1985b). Protease treatment of LAC caused a dramatic 
effect on the ability of the virus to attach to and infect 
vertebrate and invertebrate cells. Treatment of LAC with 
protease decreased the ability to attach to and infect 
vertebrate cells by 77%, while attachment to mosquito cells 
increased to as much as 306% (Ludwig et al, 1989). The same 
authors observed that treatment with protease was a 
prerequisite for detectable attachment of virus to mosquito 
midguts, suggesting that protease treatment of LAC may play 
an important role in attachment to, and subsequent infection 
of, mosquito midguts in nature. On the basis of their 
observation, Ludwig et al (1989) proposed a model for 
infection of mosquitoes by LAC. Earlier work had suggested 
that for vertebrates G1 is the glycoprotein responsible for 
attachment to cells, either by fusion or through 
interactions with specific virus receptor proteins 
(Kingsford and Hill, 1981; Janssen et al, 1984; Gonzalez- 
Scarano et al, 1984; Gonzalez-Scarano, 1985). Thus, Ludwig 
et al (1989) hypothesise that when LAC enters the mosquito 
midgut after feeding on vertebrate hosts, the virus would be
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unable to bind directly to epithelial cells because G1 
receptor proteins may not be present. The binding of virus 
to midgut occurs after mosquito secretory proteases cleave 
the G1 protein, exposing regions on G2 which allow virus to 
fuse to cells or attach to specific receptor proteins. This 
was based on the fact that proteases are present in mosquito 
midguts immediately following a blood meal.
Glvcosvlation
The envelope glycoproteins of all members of the family 
Bunyaviridae analysed to date possess N-linked 
oligosaccharide side chains (Cash et al, 1980; Pesonen 
et al, 1982; Schmaljohn et al, 1986). Glycosylation is 
initiated by en bloc transfer of preformed oligosaccharide 
chains from an oligosaccharide pyrophosphryldolichol 
intermediate to an asparagine residue in the amino acid 
sequence, Asn-X-Ser/Thr, in the newly synthesized 
polypeptide chain (Hubbard and Ivatt, 1981; Klenk and Rott, 
1980). Sugar residues are then modified by enzymes in the 
endoplasmic reticulum (ER) and the Golgi complex as the 
glycoproteins translocate through these organelles (Kornfeld 
and Kornfeld, 1985).
Modification of oligosaccharide in the ER and Golgi complex
High mannose type oligosaccharide side chains, which 
are the primary sugar residues attached in the ER, are 
specifically cleaved to remove glucose and some mannose by 
endoglycosidase H. After removal of their residues, the 
side chains are converted to complex sugar chains by 
attachment of the peripheral sugars in the Golgi complex and 
the resulting mature forms of sugar become resistant to 
endoglycosidase H. This phenomenon can be used to study the 
transport of membrane glycoproteins between the ER and the 
Golgi complex. Kuismanen (1984) showed that the G1 and G2 
glycoproteins of UUK acquired endoglycosidase H resistance 
with a half-life of 45 min and 90-150 min, respectively.
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Similar times were observed for PT (Chen et al, 1991; 
Matsuoka et al, 1988) and the G1 glycoprotein of LAC (Madoff 
and Lenard, 1982). However, the G glycoprotein of vesicular 
stomatitis virus (VSV) and the influenza virus 
haemagglutinin (HA) acquired endo H resistance much more 
rapidly, in about 15-20 min after synthesis (Copeland et al, 
1988; Dorns et al, 1987; Strous and Lodish, 1980). From 
this, it appears that the bunyavirus glycoproteins 
translocate rather slowly.
AMINO ACID SEQUENCES AND GENE ORDER OF THE M  SEGMENT 
PROTEINS
Bunyavirus genus
The amino acid sequences of four bunyaviruses M 
segments (BUN, GER, LAC and SSH) have been determined and 
analysis of the amino acid sequences derived from the coding 
nucleotide sequences of the four segments reveal a notable 
conservation of cysteine residues (Elliott, 1990) and are 
shown in Fig 1.3.
The gene order of the bunyavirus M segment was 
determined by Fazakerley et al (1988) using direct amino 
acid sequence analysis and specific peptide antibodies as 
5' G2-NSm-Gl 3' in the viral complementary RNA. The 
following points can be observed when data on SSH are used 
and extrapolated to BUN, GER and LAC. There is a putative 
signal sequence of 13 to 21 residues at the amino terminus 
of the precursor. The G2 proteins show an overall amino 
acid homology of about 66%. The positions of N-linked 
glycosylation sites As-Xxx-Ser/Thr are strictly conserved. 
Cleavage at the carboxy terminus of G2 occurs after a 
conserved arginine residue. NSm shows about 50% 
conservation of residues. Prediction of the amino terminus 
of G1 by alignment with SSH is not clear because of low 
sequence homology in this area but appears to occur after a 
conserved alanine residue. The G1 proteins exhibit the
Figure 1.3 Alignment of the glycoprotein precursors of SSH, 
LAC, BUN and GER viruses.
The amino and carboxy termini of G2 and amino terminus of 
G1 , as determined for SSH (Fazakerley et al, 1988) are 
indicated. The exact boundaries of NSm are not known. 
N-linked glycosylation sites conserved in all four proteins 
are indicated by • and in two proteins (serogroup
conserved) © or Q  . There is a potential glycosylation
site at position 89 in GER which is not conserved.
(From Elliott, 1990).
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Lac.Gp DIIkeElsVYRKetEEVtnvelClTF sdkTYCTnlNpVtP iITD1FEvQFKTVETySLPrIVAVqNHeik iGQINDLGvYskgCGNVQKvNgtVyGnGvP 
Bun.Gp DVIRpEtkVYRKavDEVvi1tvCiTYpghTFCTeiNaIePkITEe i ElQFKTVDTkt LPyIVAVnNHklysGQINDLGtFgqmCGNVQKtNssI lGtGtP 
Ger.Gp DVIRtEtkVYRKanEEtvmltvCiTYpghTFCTdvNahePkITDeLElQFKTIDi kSLPnlVAVtNHklytGQINDLGtFgqmCGNVQKtNtshtGaGtP 
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Ger.Gp PLnNFFGnYlnmFLyilgglIlLFlalYILMPmCa rLRDeLkrnEr1hqmEMKkR*
Consensus PFKN-FGSY--IFY--II-11-L--I IYIL-P-C-KLRD-L E--Y--EMK-R-
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lowest homology (about 40%) and similarity is more enhanced 
in the carboxy half than the amino half of the molecule. 
There is one strictly-conserved N-glycosylation site whereas 
a second site is conserved between viruses of the same 
serogroup (Elliott, 1990). The G1 protein is susceptible to 
trypsin digestion (Kingsford and Hill, 1983; Gonzalez- 
Scarano, 1985). Fazakerley et al (1988) determined the 
major trypsin site by limited trypsin digestion of the G1 of 
SSH coupled with amino-terminus sequencing of the fragment 
from the trypsin digestion. The trypsin sensitive site is 
also conserved.
Hydropathy profiles of BUN. GEM, SSH and LAC M proteins
The hydropathy profiles of the M segment proteins of 
the four viruses are very similar (Elliott, 1990) and are 
shown in Fig 1.4.
The G2 protein has a rather long hydrophobic sequence
(residues 187 to 245) followed by a charged stop-transfer
sequence. The orientation of G2 in relation to the membrane
has not been determined (Elliott, 1990). The G1 protein has
more characteristics of a typical membrane glycoprotein than
G2. There is a carboxy-terminal transmembrane and anchor 
(this evidence together _ .
sequence and^witn the data from trypsin digestion orientate
G1 with its amino terminus external to the membrane
(Fazakerley et al, 1988). Neither the function nor the
intracellular location of NSm aft known; examination of the
amino acid sequence and hydropathy profile suggest that it
is a membrane bound protein. Information from the amino
acid homologies, gene order and hydropathy profiles
demonstrate the evolutionary relatedness of the glycoprotein
species of viruses from the two serogroups of the
bunyavirus, i.e. the Bunyamwera serogroup and the California
serogroup and antigenic differences that differentiate
individual viruses may be located in external (least
Figure 1.4 Hydropathy profiles of (a) SSH, (b) LAC, (c) BUN 
and (d) GER virus glycoprotein precursors.
The boundaries of G2, NSm and G1 are indicated. H 
designates the hydrophobic domain in G2, suggested to be 
involved in fusion.
(From Elliott, 1990).
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homologous) amino half of G 1 . The proposed topology of the 
bunyavirus M segment proteins in relation to membranes is 
illustrated in Fig 1.5.
The Hantavirus genus
The G1 and G2 proteins of hantaviruses are similar to 
those of other members of the Bunyaviridae family in being 
both glycosylated and rich in cysteine residues. Amino acid 
sequences have been determined for three members of the 
genus (HTN, NE and SR-11) for both G1 and G2. Hydropathy 
plots of the predicted amino acids of HTN, NE and SR-11 are 
almost superimposable, even if the overall amino acid 
sequence homologies of only 43% for G1 and 55% for G2 exist 
among the three viruses. When differences due to 
conservative substitutions are taken into account the amino 
acid sequence homologies show 58% and 71% for G1 and G2, 
respectively (Arikawa et al, 1990). Deduced amino acid 
sequences encoded in the SR-11 virus M segment ORF are more 
closely related to those of HTN virus (78% identical) than 
those of NE virus (53% identical). These amino acid
sequence homologies reflect the closer serological 
relationship of HTN and SR-11 viruses compared to HTN and NE 
viruses (Schmaljohn et al, 1985) . Two isolates from 
patients with Korean haemorrhagic fever showed homologies in
excess of 98% with HTN, indicating the indistinguishable
serological characteristics of those isolates (Schmaljohn 
et al, 1988).
The amino-terminal residues of G1 for both HTN and 
SR-11 is leucine. The amino-terminal residues for G2 were 
found to be serine and alanine for HTN and SR-11,
respectively.
There are five asparagine-linked glycosylation sites in 
the G1 proteins of SR-11 and HTN viruses. The first four 
sites are conserved. Three of the four glycosylation sites 
are also maintained in the NE G1 protein.
Figure 1.5 Gene organisation of M genome segments of 
bunyaviruses and proposed topology of their protein 
products.
The ORF for the precursor protein is shown with hydrophobic 
regions (—■ ) and known amino termini ( T* ) and carboxy 
termini ( *1 ) of G1 and G2 glycoproteins. The predicted 
transmembrane topology of proteins based on the 
hydrophobicity profiles is also shown. Arrows: polypeptide 
cleavage sites.
(From Matsuoka et al, 1991).
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Hydropathy profiles of hantavirus M segment proteins
The hydropathy plots of the predicted amino acids
within the middle segment ORFs of HTN, NE and SR-11 viruses 
are nearly superimposible (Elliott et al, 1991) and are
shown in Fig 1.6.
The Phlebovirus genus
Amino acid sequence comparisons of three members of the 
Phlebovirus genus have been made for PT, RVF and UUK. The 
proteins are rich in cysteine residues (5-7%) and of these 
70% are conserved among the three viruses (Ihara et al, 
1985b; Ronnholm and Pettersson, 1987). This was suggestive 
of the important role the cysteine residues played in the
structure of the protein and also indicated the close
relatedness of the viruses. This observation contributed 
towards the data that necessitated the inclusion of the 
former Uukuvirus genus into the Phlebovirus genus.
Within the unique ORF present in the viral 
complementary-sense RNA, which codes for a polypeptide 
precursor, the gene order for RVF has been determined as 
NSm-G2-Gl, for PT NSm-Gl-G2 and G1-G2 for UUK. The 
uukuvirus group lacks the nonstructural protein found in the 
phlebovirus group within the genus. The difference in the 
gene order of PT and RVF merely reflects the relative size 
difference between the two glycoproteins as measured on 
polypeptide gels, with G2 being the faster migrating.
Hydropathy plots of PT, RVF and UUK
Hydropathy plots of the three viruses, i.e. PT, RVF and 
UUK, are strikingly similar. Preceeding each glycoprotein 
is a stretch of 17-20 hydrophobic amino acids that may 
represent a signal or membrane insertion sequence. There is 
an additional hydrophobic region near the carboxy-terminal
Figure 1.6 Hydropathy plots of the M segment ORFs of
hantaviruses.
The hydropathic profiles of the deduced amino acids of the M 
segment ORFs of HTN, SR-11, and NE viruses are displayed. 
Where protein sequence information is available, vertical 
lines are added to represent the position of the amino 
terminus of the indicated proteins. In all cases, the
mature glycoprotein coding sequences are preceeded by a 
hydrophobic signal sequence (black box). Similarly, at or 
near the carboxy terminus of the first glycoprotein,
possible hydrophobic transmembrane anchor sequences are 
identified (shaded boxes). Asterisks represent potential 
asparagine-linked glycosylation sites.
(From Elliott et al, 1991).
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end of both G1 and G2 which may represent transmembrane 
anchor sequences. The profiles are different from those of 
the bunyaviruses but the carboxy hydrophobic end of G2 (PT), 
G1 (RVF) and G2 UUK are similar to the G1 of the 
bunyaviruses (Fig 1.7).
There is a single site for N-linked glycan attachment 
in RVF G2 and four sites in PT G1 and UUK Gl. The second 
glycoprotein has four sites for each virus.
Nairovirus M segment proteins
In the absence of sequence data, not much is known 
about the M segment proteins of nairoviruses but it is 
presumed that they will have common features with other 
members of the Bunyaviridae family, like richness in 
cysteine residues and glycosylation sites.
Tospovirus M proteins
The M RNA segment of TMW has not been sequenced but it 
is presumed it encodes the 78K and 58K proteins which are 
glycosylated and represent the Gl and G2 glycoproteins, 
respectively (Mohamed et al, 1973) .
The S segment proteins
The bunyavirus S segment encodes the N protein (Mr 19K 
to 26K) and a nonstructural protein NSs (Mr 10K to 12K). 
The nucleotide sequences of six bunyavirus S segments have 
been determined and range in size from 850 to 984 bases. 
The six segments which represent three serogroups in the 
Bunyavirus genus have 40% sequence similarity overall, 
whereas the N proteins from the same serogroup show 80% 
similarity (Elliott, 1989a). Some regions of the N protein 
are strictly conserved between all six sequences. The 
conserved regions may be important in binding to the viral 
RNA, although homology to RNA binding proteins (Chen et al,
Figure 1.7 Hydropathy plots of the M segment ORFs of
phleboviruses.
The hydropathic profile of the amino acid sequence of the M
segment ORF of PT, RVF, and UUK viruses are displayed.
Vertical lines represent the position of the amino terminus 
of the indicated proteins. Pre-G is the protein coding 
region preceeding that of the first envelope glycoprotein. 
In all cases, the mature glycoprotein coding sequences are 
preceeded by a hydrophobic signal sequence (black box). 
Similarly, towards the carboxy end of the first glycoprotein 
and at the end of the second, there appear hydrophobic 
putative transmembrane anchor sequences (shaded boxes).
Asterisks demonstrate potential asparagine-linked
glycosylation sites.
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1989; Query et al, 1989) is not obvious. They may also be 
important in eliciting complement-fixing antibodies since 
the N is the complement fixing antigen. The N protein 
synthesised in large amounts, e.g. via baculovirus 
expression systems, will be invaluable for diagnostic use 
for specifying a genus, since complement fixation cross­
reactivity does not occur beyond a genus.
In the Hantavirus genus, the N protein is about 48.IK 
predicted Mr. It seems that no nonstructural protein is 
synthesised or coded for in this genus.
The N protein is an important cross-reactive antigen in 
immunoprecipitation reactions between different antigenic 
groups (Sheshberadaran et al, 1988) which probably reflects 
areas of sequence conservation on the S segment detected by 
cross-hybridisation studies (Schmaljohn et al, 1987b).
The nairovirus N protein is similar in size to that of 
hantavirus (Mr. 48K to 52K). It is the major viral protein 
detected in infected cells (David-West, 1974; Clerx and 
Bishop, 1981; Clerx et al, 1981; Foulke et al, 1981; Cash, 
1985; Watret and Elliott, 1985b; Watret et al, 1985).
In the Phlebovirus genus the S RNA codes for two 
proteins, N and N S s ,  of predicted Mr of 24-30K and 29-31K, 
respectively. The NSs protein has not been observed in 
cells infected with some members of the genus. The NSs 
could be seen in cells infected with RVF, KAR and SSF but 
not in cells infected with PT. The intracellular location 
of this protein also varied as NSs of RVF was observed in 
the nuclei of infected cells (Struthers and Swanepoel, 1982) 
whereas NSs of KAR remained entirely in the cytoplasm (Smith 
and Pifat, 1982). NSs of PT has been found to be 
specifically associated with nucleocapsids (Overton et al,
1987) .
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BIOLOGY AND EPIDEMIOLOGY 
Disease
Most of the more than 300 members of the family 
Bunyaviridae rarely infect humans or domestic animals 
(Gonzalez-Scarano and Nathanson, 1990). However, there are 
members in the family of considerable medical and economic 
importance. The full pathogenic importance of the viruses 
may not be fully appreciated, especially in the so-called 
third world countries, where diagnostic technologies are 
less advanced and in some cases non-existent. Inappropriate 
diagnosis often places infections caused by members of the 
Bunyaviridae and other arboviruses under the 'great 
umbrella' of malaria and are often treated as such (Downs, 
1975; Shope, 1985). RVF, California encephalitis virus, 
CCHF and HTN are important human pathogens. TSWV, which 
infects up to 400 species from 50 different plant families, 
both monocotyledons and dicotyledons, cause an enormous 
economical loss due to its wide geographical distribution. 
Selected Bunyaviruses that cause disease in humans or 
domestic animals are shown in Table 1.6.
Transmission and perpetuation
The ecological patterns of different bunyaviruses are 
quite diverse between different genera (Gonzalez-Scarano and 
Nathanson, 1990). Bunyaviruses, nairoviruses and
phleboviruses are transmitted between vertebrate hosts by a 
wide variety of haematophageous vectors, including culicine 
and anopheline mosquitoes, argasid and ixodid ticks, biting 
midges and sandflies. Virus genera are typically
associated with a given vector taxon (Beaty and Calisher, 
1991); bunyaviruses are principally transmitted by 
mosquitoes, nairoviruses and the uukuvirus group of 
phleboviruses by ticks and the phlebovirus group of 
phleboviruses by sandflies. Tospoviruses are transmitted by 
thrips and hantaviruses, which are maintained by persistent
Table 1.6 Selected bunyaviruses that cause disease in humans or domestic animals
Genus,
serogroup
Virus Host Disease Frequency
Bunyavirus
California La Crosse Human Encephalitis Endemic
Snowshoe hare Human Encephalitis Rare
California encephalitis Human Encephalitis Rare
Jamestown Canyon Human Encephalitis Sporadic
Tahyna Human Influenzalike Endemic
Simbu Oropouche Human Acute fever Epidemic
Akabane Ungulates Fetal malformations Endemic
Phlebovirus
RVF RVF Sheep Hepatitis Epidemic
Human Influenzalike Epidemic
Sandfly Sandfly fever
fever Naples Human Acute fever Endemic
Sicilian Human Acute fever Endemic
Hantavirus
Hantaan Hantaan Human HFRS Endemic
Seoul Human HFRS Endemic
Puumala Human Renal syndrome Endemic
Nairovirus
NSD NSD Sheep Hepatitis Endemic
CCHF CCHF Human Hemorrhagic fever Sporadic
Ref: F. Gonzalez-Scarano et al , 1991.
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infection in rodents, by aerosolised excreta of rodents. 
Reservoir host for members of the Bunyaviridae are mainly 
mammals and birds.
Geographic distribution
The Bunyaviridae are found worldwide. Restriction of a 
virus to a vertebrate-vector pairing with defined geographic 
distribution may lead to natural isolation and therefore 
genetic stability in divergent evolution (Calisher and 
Karabatsos, 1988). For example, no Bunyamwera serogroup 
virus has been isolated in Australia whereas Batai virus, 
which is maintained in birds, has been isolated in Asia and 
Europe - probably because of migrating birds.
Vertebrate host-virus interactions
Reservoir hosts are usually not untowardly affected by 
arboviral infection, probably because they have evolved a 
relative benign host-parasite relationship over time. In 
contrast, tangential hosts may experience considerable 
morbidity and mortality when infected with the virus (Beaty 
and Calisher, 1991). Nosocomial infections have been 
observed with CCHF, RVF and HTN viruses.
Vector-virus interactions
Like other arboviruses, bunyaviruses are transmitted 
either biologically or mechanically by vectors. Biological 
transmission involves ingestion of the virus by the vector 
after feeding on a viraemic vertebrate host. After the 
vector becomes infected the virus replicates in the tissues 
and organs. The virus may then be transmitted when the 
vector seeks another blood meal. This occurs after an 
extrinsic period, i.e. the period between after digestion 
and when the vector is competent to transmit the virus.
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In mechanical transmission, the vectors do not need to 
become infected by the virus but the virus is carried on the 
mouth parts. For transmission to occur the vector must feed 
upon a host in time before the virus becomes inactivated.
In both cases the process by which the virus enters a 
vector and exits is quite complex and involves multiple 
infection and dissemination barriers (Hardy, 1988; Kramer 
et alt 1981; Beaty and Bishop, 1988). The usual sequence of 
events in the extrinsic incubation period modulated by 
temperature (Turell, 1989) is: (a) infection of vector
midgut cells, (b) replication in these cells, (c) escape 
into the haemolymph, and (d) dissemination to an infection 
of epidemiologically significant target organs. Infection 
of salivary glands permits transmission to vertebrates and 
infection of ovaries permits transovarial transmission to 
progeny.
It is the accepted view that arbovirus infection is not 
detrimental to natural vectors in contrast to vertebrate 
hosts, where sometimes dramatic effects occur. However, it 
has been shown that some effect associated with arboviral 
infection of vectors takes place (Beaty et al, 1980; 
Grimstad et al, 1980; Weaver et al, 1988).
PROTEIN TARGETTING
Overview
It is a generally accepted view that proteins which are 
not retained at their site of synthesis have signals that 
direct their intracellular transport, their folding and 
interaction with other cell components once they reach their 
destination. These signals may be divided into four groups:
1 Routing sicinals operate at the earliest stages of protein 
targetting and direct the specific interaction between 
targetted polypeptides and the surface of the first membrane
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with which they come into contact. Routing signals may be 
located in any part of the polypeptide and they need not be 
cleaved off during the early stages of translocation. If 
they are proteolytically processed, then the initial form of 
the polypeptide is the precursor and the processed 
polypeptide is the mature form.
2 Sorting signals direct proteins into different branches 
of a targetting pathway or redirect them once they have 
reached their initial destination.
3 Retention signals prevent proteins from passing along the 
entire length of targetting pathway or from being released 
from organelles to which they have been targetted.
4 Membrane topology - stop transfer signals involve routing 
signals which are not cleaved off and remain embedded in the 
membrane. These are then referred to as membrane anchor 
sequences. Those that halt the translocation of the 
polypeptide through the membrane are termed stop transfer 
signals.
Bunyavirus protein transport
One of the characteristics of the members of the 
Bunyaviridae family is that they mature by budding at 
smooth-surfaced membranes close to the nucleus (Lyons and 
Heyduk, 1973; von Bonsdorff et al, 1970). Kuismanen et al 
(1982) showed by immunological cytochemical and 
immunoelectron microscopic techniques that this region 
corresponds to the Golgi complex. Budding at the Golgi 
membranes was also observed by Murphy et al (1973) by direct 
electron microscopy.
Bunyavirus glycoproteins accumulate at the membranes of 
the Golgi apparatus before virus assembly and it has been 
suggested that the glycoproteins serve to direct other 
structural components to the site of maturation (Matsuoka
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et al, 1991). Bunyavirus glycoproteins expressed from 
cloned cDNAs are retained in the Golgi complex and behave 
like resident proteins of the Golgi complex. Studies with
recombinant glycoproteins also revealed that the
glycoproteins are targetted to the Golgi complex in the
absence of other viral components, structural or
nonstructural (Matsuoka et al, 1988; Pensiero et al, 1988; 
Wasmoen et al, 1988).
The location and funtional roles of other protein
products of the M segment are not clear.
Possible mechanisms for intracellular transport and
localization
Some proteins remain in the ER while others are
exported to the Golgi complex, most of which are
subsequently distributed to various organelles. Two
mechanisms have been demonstrated for retention in the ER. 
Resident ER proteins like disulphide isomerase contain the 
same carboxy terminal tetrapeptide sequence Lys-Asp-Glu-Leu 
(KDEL). Removal of the KDEL sequence resulted in the 
protein being secreted and addition of the sequence to 
secretory proteins caused them to accumulate in the ER
(Munro and Pelham, 1987; Pelham, 1988). Another mechanism 
to control the exit of proteins from the ER has been 
described as possession of transport competency - this 
involves correct folding and assembly of proteins.
Mutations introduced into viral glycoproteins were reported 
to block or slow export of proteins from the ER (Rose and 
Dorns, 1988).
It has also been observed that for some proteins
including influenza HA and VSV G protein, assembly into 
oligomers is required for transport from the ER (Copeland 
et al, 1986; Dorns et al, 1988; Gething et al, 1986; Hurtley 
and Helenius, 1989; Kreis and Lodish, 1986). Failure to 
assemble into an oligomer resulted in ER retention, without
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the requirement for a specific signal. In virions, the Gl
and G2 glycoproteins of UUK exist as heterodimers (Persson 
et al, 1989). Protein products from recombinant vaccinia 
viruses containing only either Gl or G2 coding sequence of 
PT failed to exit the ER (Chen et al, 1991). The same was
observed for HTN glycoproteins (Ruusala et al, 1992).
The question of whether the glycoproteins of
bunyaviruses contain a Golgi retention signal is unclear, 
and if they had a retention signal, is it present on both Gl 
and G2 or just on one of them? Are extra sequences such as 
the NSm coding sequence involved in retention of
glycoproteins in the Golgi? The requirement of an NSm 
protein in Golgi retention was ruled out for phlebovirus: 
recombinant vaccinia viruses with truncated 5' ends, hence 
lacking NSm, were synthesised, processed and transported to 
the Golgi complex and stably retained in the Golgi membranes 
(Matsuoka et al, 1988; Wasmoen et al, 1988).
VIRUS REPLICATION CYCLE
The main stages of replication are as follows: 
Attachment and entry
The early events in the infection process of members of 
the Bunyaviridae are not well understood (Schmaljohn and 
Patterson, 1991), but, in common with other enveloped 
viruses, one or both of the integral viral glycoproteins 
mediate attachment to host-cell receptors. Obijeski et al 
(1976b) showed that when LAC was treated with proteolytic 
enzymes, the virus particles became 'spikeless' and this 
resulted in a five-log reduction in infectivity as compared 
to the untreated virions. Using polyclonal and monoclonal 
antibodies to block infection or haemagglutinating activity 
and with limited digestion with bromelain or pronase which 
degrade part of G l , it has been concluded that Gl is the 
more actively involved glycoprotein in binding to host cells
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(Gonzalez-Scarano et al, 1982; Grady et al, 1983; Kingsford 
and Hill, 1981; Kingsford et al, 1983). However, 
neutralising and haemagglutination inhibition sites have 
been found on both the G1 and G2 proteins of HTN (Arikawa
et al, 1989; Dantas et al, 1986).
Fusion, which is pH-dependent, is thought to be part of 
the early events in the infection process, especially at the 
point of translocation of RNA and proteins into the host
cell cytoplasm. Marsh and Helenius (1980) described entry
of Semliki Forest virus into cells by endocytosis via coated 
vesicles. These endosomes were shown by Tycko and Maxfied 
(1982) to be acidified and acidification triggered release 
of the nucleocapsid into the cell cytoplasm. A similar 
series of events was observed for RVF in which viral 
particles appeared to enter cells in phagocytic vacuoles by 
electron microscopy (Ellis et al, 1988). It is assumed the
same events occur for other members of the family
Bunyaviridae.
Genome replication
In negative strand viruses, the change from primary 
transcription to replication needs a switch from mRNA 
synthesis to synthesis of full-length cRNA templates and 
then vRNA. These steps are schematically illustrated in 
Fig 1.8 using S RNA as an example.
The events involved in making the switch from mRNA 
synthesis to synthesis of full length cRNA templates and 
vRNA are not understood. However, ^some signal to suppress
the termination signal responsible for generation . of
truncated mRNA and also to prevent the addition of capped 
and methylated structures to the 5' termini of the cRNAs 
(Schmaljohn and Patterson (1991) . It is known that 
continuous protein synthesis is necessary for replication of 
the genome as translational inhibitors such as cycloheximide 
interfere with this process. The actual protein that may be
Genome 
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Figure 1.8. Bunyavirus S RNA coding, transcription
and replication strategies, from Bishop D.H.L.,1990.
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important in the switch from mRNA synthesis to replication 
is not known but a candidate could be nonstructural protein 
NSs, in those viruses which encode it.
Viral assembly and release
Although assembly of the bunyaviruses occurs by budding 
at the smooth membrane vesicles of the Golgi apparatus 
(Murphy et al, 1973; Kuismanen et al, 1982; Ellis et al,
1988) , reports of budding at the plasma membrane and 
possibly the ER have been made. When RVF was grown in 
primary hepatocyte cultures, growth kinetics were comparable 
to those seen in other permissive cell lines but maturation 
was associated with budding at cellular surface membranes in 
addition to the Golgi and ER membranes (Anderson and Smith 
(1987). Maturation at the plasma membrane was also reported 
by Madoff and Lenard (1982) for LAC in BHK 21 cells.
The actual mechanisms of budding are not understood but 
it has been suggested that budding involves a transmembrane 
interaction between membrane glycoproteins and other 
components of the virus in the cytoplasm, followed by 
pinching off from the membrane surface (Lenard and Compans, 
1974) . The importance of the glycoproteins in the process 
of maturation has been demonstated by use of glycoproteins 
expressed via vaccinia virus or baculovirus. The G1 and G2 
of HTN, RVF and PT viruses translocated to the Golgi in the 
absence of other viral glycoproteins (Pensiero et al, 1988; 
Matsuoka et al, 1988; Wasmoen et al, 1988). Studies on ts 
mutants of UUK defective in virus maturation also showed 
that G1 and G2 are localized in the Golgi even if virion 
maturation failed to occur (Gahmberg, 1984; Gamberg et al, 
1986a). Smith and Pifat (1982) suggested that 
transmembranal recognition between the viral glycoproteins 
and the nucleoproteins induced budding.
Budding is followed by the virions acquiring their 
lipid bilayer from the host cell membranes as most other
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host cell membrane proteins are excluded from the viral 
particles. The viral particles are transported in vesicles 
to the plasma membrane where fusion of the vesicles and the 
cellular plasma membrane occurs and the release of the viral 
particles takes place, presumably by normal exocytosis.
Effects of viral replication on host cells
The c.p.e. observed in cultured cells infected with 
members of the family Bunyaviridae vary considerably, 
depending on the virus and the type of host cell. Viruses 
of all genera except the Hantavirus genus alternatively 
replicate in vertebrates and arthropods. The viruses are
cytolytic for their vertebrate hosts but not their
invertebrate hosts (James and Millican, 1986; Lyons and
Heyduck, 1973). In infections of mammals, there appears to 
be both organ and cell tropism. For example, bunyaviruses 
like LAC appear to be neurotropic (Parsonson and MacPhee, 
1985) whereas the RVF phlebovirus is primarily hepatotropic 
(Anderson and Smith, 1987; Anderson et al, 1987; Easterday, 
1965; Peters et al, 1988). The HTN hantavirus replicates 
and remains persistent in rodent lungs (Lee et al, 1981). 
The mechanism for this apparent tropism is not well 
understood but Sundin et al (1987) working with LAC variant 
and revertant viruses suggested that the specificity resided 
in the G1 glycoprotein and probably at the level of 
attachment to host cells.
Bunyaviruses and phleboviruses have been shown to cause 
a reduction in host-cell protein synthesis which increases 
with progression of infection (Pennington et al, 1977, for 
BUN; Madoff and Lenard, 1982, for LAC; Parker et al, 1984, 
for RVFV). Similar reduction in host-cell protein synthesis 
has not been observed in UUK infected cells (Pettersson, 
1974; Ulmanen et al, 1981), nor in Dugbe nairovirus infected 
cells (Cash, 1985). Some host protein synthesis reduction 
was, however, observed when Xenopus laevis cell line was 
infected with Clo Mor, a Scottish nairovirus and St Abb's
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Head phlebovirus (Watret et al, 1985). On the other hand, 
hantaviruses have not been demonstrated to cause reduction 
in host protein synthesis (L H Elliott et al, 1984; 
Schmaljohn and Dalrymple, 1984), but often establish 
persistent, non-cytolytic infections in susceptible 
mammalian host cells. This observation is consistent with 
the documented non-pathogenic persistence in their natural 
rodent hosts (Lee et al, 1981).
GENETICS OF BUNYAVIRIDAE
Evolution of Bunvaviridae
The plethora of viruses and the multiplicity of 
serogroups that comprise the family Bunyaviridae suggest 
that viruses in this family have considerable evolutionary 
potential (Beaty and Calisher, 1991). This evolutionary 
potential will result in viruses with altered virulence and 
other characteristics like new viral phenotypes capable of 
infecting new vector species. New viruses of potentially 
significant epidemiologic consequences may also result 
(Beaty et al, 1988). Natural host vectors provide many 
opportunities for the evolution of the Bunyaviridae by 
intramolecular changes in the viral genome, such as point 
mutations, sequence deletions, inversions, etc (genetic 
drift) and RNA segment reassortment (genetic shift).
Genetic drift
Most of the life cycle of bunyaviruses, nairoviruses 
and phleboviruses occurs in the vector host. If 
transovarial transmission occurs, viruses may persist 
through generations of infected arthropods without being 
transmitted to the vertebrate host. As with other negative- 
strand RNA viruses, such conditions will enhance nucleotide 
sequence deletions, inversions and point mutations (Holland 
et al, 1982). This was explained in part by the absence of 
proof-reading exonucleases and the high error rate of RNA
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polymerases (Holland et al, 1982). For members of
Bunyaviridae, it has been shown that no two isolates of LAC 
recovered from nature had identical genome segments, as
demonstrated by oligonucleotide fingerprints (Bishop and
Beaty, 1988). This was true for LAC isolates obtained at 
the same place at the same time, the same place at different 
times, and different places at different times. Low-passage 
SSH virus isolates from mosquitoes exhibited different 
fingerprints (Beaty and Calisher, 1991) . In contrast, SSH 
and LAC viruses derived from the original prototype and 
maintained by lytic passage in different laboratories for 
many years had identical oligonucleotide fingerprints (Beaty 
and Calisher, 1991). Genetic stability has also been
demonstrated during long-term persistent infections of 
vectors with some bunyaviruses in the laboratory (Bilsel 
et al, 1988; Baldridge et al, 1989). This involved 
passaging of plaque purified viruses transovarially for two 
generations in vectors and horizontally to mice during each 
generation. Examination of oligonucleotide fingerprints at 
each stage showed them to be identical. This state of 
affairs indicated that genetic instability occurs more 
frequently in nature.
Genetic shift
The segmented genome of the Bunyaviridae provides the 
chance for virus evolution to occur through RNA segment 
reassortment during dual infection of cells. High frequency 
reassortment of members of the family have been documented 
to occur in vitro, in vivo and in nature. In the laboratory 
reassortment has been shown to be restricted to viruses 
within a genus, and even within a genus reassortment was 
confined or only possible among some closely related members 
within serogroups (Gentsch and Bishop, 1976; Gentsch et al, 
1977b, 1979; Ozden and Hannoun, 1980; Iroegbu and Pringle, 
1981; Rozhon et al, 1981; Pringle et al, 1984; Pringle and 
Iroegbu, 1982; R M Elliott et al, 1984; Janssen et al, 1986; 
Bishop, 1988). Klimas et al (1981) showed by genotypic
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analysis of natural isolates of LAC that RNA segment
reassortment occured between topotypes of LAC and Shark 
River and that Pahayokee virus may be a reassortment of LAC 
and Shark River viruses (Bishop and Shope, 1979). Shope 
(1985) analysed seven group C viruses from the Utinga Forest 
in Brazil. These viruses segregated into three groups by HI 
and NT tests which assay for the gene products of the M RNA 
segment. However, the viruses segregated into three
alternative groups by CF tests, which assay mainly the gene 
products of the S RNA segment. This suggested that 
reassortment of RNA segments was occuring between the
group C viruses. For example, two of the group C virus,
Caraparu and Itaqui, share vector and vertebrate hosts and 
are identical by CF tests, but differ in their HI and NT, 
i.e. one cannot induce HI or NT antibodies to the other in 
the vertebrate host. This meant that their M RNA segment 
gene products differ.
Although reassortment is typically restricted to 
viruses from a given serogroup, suggesting the serogroups 
consg.tute gene pools that are evolving divergently,
serologic relationships have been observed between different 
groups. Whitman and Shope (1962) found serologic 
relationship between Guaroa virus and the California group 
viruses by NT test and to the Bunyamwera group viruses by 
CF.
High frequency reassortment of members of the
Bunyaviridae occurs in vitro in vertebrate cell cultures but 
has not been detected in vivo in vertebrates (Bishop and 
Beaty, 1988) . Lack of reassortment may be due to the 
ephemeral nature of infection in reservoir hosts, the
relatively low-level viraemia, and the production of 
antibody, all of which limit the chance that two viruses 
infect the same cell (Beaty and Calisher, 1991). High- 
frequency reassortment has not been demonstrated in vectors. 
There appears to be only a small window of time for dual 
oral infection to occur in arthropod vectors. Within two to
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three days after ingestion of one virus, mosquitoes become 
resistant to superinfection with a second closely related 
virus (Beaty et al, 1985; Sundin and Beaty, 1988). However, 
some mosquitoes may preclude this interference when the 
defensive behaviour of the host interrupts the mosquito 
during engorgement. The vector will engorge on an 
alternative host (Beaty et al, 1988). The ability to 
engorge from two hosts raises the potential for infection by 
different viruses and could permit dual infection and 
subsequent segment reassortment.
Temperature-sensitive mutants
Some 200 temperature sensitive mutants have been 
isolated from 11 viruses in the family Bunyaviridae. Ten of 
these viruses belong to two serogroups, California and 
Bunyamwera of the Bunyavirus genus. The other one belongs 
to the uukuvirus group of the Phlebovirus genus (Pringle, 
1991). The majority of these mutants were generated by 
chemical mutagenesis using either 5-fluorouracil, 
5-azacytidine or N-methyl-N'-nitrosoguanidine (Gentsch 
et al, 1977b, 1979; Bishop, 1979; Ozden et al, 1978, 1980; 
Iroegbu and Pringle, 1981; Pringle and Iroegbu, 1982; 
Gahmberg, 1984). A significant feature of these mutants has 
been the recovery of mutants assignable to two reassortment 
groups rather than the three expected from the tripartite 
structure of the genome. Maguari virus of the Bunyamwera 
serogroup is the exception. One mutant of the 46 ts mutants 
isolated from mutagenized wild type Maguari virus, mutant 
tsMAG23(III), recombined with all members of panels of 
mutants representing reassortment groups I and II and two 
putative double I+II mutants, thus identifying the third 
reassortment group (Pringle and Iroegbu, 1982). Unlike 
group I and II mutants, tsMAG23(III showed marked host cell 
dependence as evidenced by at least 100-fold less plaque- 
forming ability on BS-C-1 cells and 1,000-fold lower yields, 
compared to wild type.
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Temperature-sensitive mutants have been important tools 
in the investigation of gene function, definition of genetic 
basis of virulence and the delineation of the extent of 
reassortment and the limits of gene exchange.
At the moment assignments of the group I, II and III 
lesions are mapped to lesions in the S RNA, M RNA and L RNA, 
respectively. This is true for the Bunyamwera serogroup in 
the Bunyavirus genus but not the California serogroup in the 
same genus, where apparently no N gene mutations and many L 
gene mutations have been observed (Pringle, 1991).
INTERFERENCE AND PERSISTENT INFECTION
Defective interfering particles
Most animal viruses can establish persistent 
infections. One of the mechanisms of initiation and 
regulation of persistent infections involves defective- 
interfering (DI) particles: a class of animal virus mutants 
that share a number of common properties. These are the 
inability to propagate in the absence of a helper virus 
(defectiveness), the ability to be complemented by helper 
virus and therefore multiply in the presence of helper 
virus, the ability to decrease the yield of the wild type 
virus (interference), and the ability to increase their 
proportion of the yield from cells co-infected with wild- 
type virus (enrichment) (Huang and Baltimore, 1977).
The defectiveness of DI particles indicates that they 
have a lesion in some essential gene which appears to be a 
deletion, but there exist possibilities for point mutations 
or gene rearrangements. Interference by DI particles is 
specific against the standard virus from which a particular 
DI particle arose or a serologically closely-related virus. 
The ability of host cells to support interference by DI 
particles varies but host functions that control these 
variations are not known (Huang and Baltimore, 1977).
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DI particles of negative-strand viruses
For most of the negative-strand RNA viruses, DI 
particles appear to be identical to the standard virus in 
their protein composition and overall morphological 
characteristics. Most of the information has come from 
vesicular stomatitis virus and Sendai virus. By use of 
velocity sedimentation and hybridisation, it was shown that 
the DI RNA of VSV and Sendai virus was a deleted form of the 
standard RNA (Huang and Wagner, 1966a; Brown et al, 1967; 
Schaffer et al, 1968; Kingsbury et al, 1970). It was also 
shown, by , RNA-RNA annealing, that a given DI particle 
contains a specific portion of the standard virus genome and 
not random pieces encapsidated into mature DI particles 
(Schincariol and Howatson, 1972; Stamminger and Lazzarini, 
1974). Hybridisation studies of DI genomes from purified 
VSV Dl-particles with mRNA fractions obtained from VSV- 
infected extracts and with mRNA synthesised in vitro 
(Leamson and Reichmann, 1974; Stamminger and Lazzarini, 
1974; Schnitzlein and Reichmann, 1976; Adler and Banerjee, 
1976; Roy and Bishop, 1972) showed that DI RNAs originated 
from the 5' end of the standard virus genome. However, a DI 
particle isolate of VSV (Indianastrain) was reported to have 
a deletion in the 3' end and exhibited other unique 
characteristics like heterotypic interference with VSV New 
Jersey strain (Prevec and Kang, 1970; Schnitzlein and 
Reichmann, 1976). Additional evidence showed that some DI 
particles had internal genome deletions with the intact 3' 
and 5' termini of standard VSV (Perrault and Semler, 1979). 
DI particles from VSV could sometimes contain (-) strands 
(Roy and Bishop, 1972; Stamminger and Lazzarini, 1974) and 
sometimes unlinked (+) and (-) strands (Roy et al, 1973; 
Leamson and Reichmann, 1974; Reichmann et al, 1974; 
Schnitzlein and Reichmann, 1976; Perrault and Leavitt, 
1977b).
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The RNA from influenza DI particles differed from those 
described for VSV and Sendai virus. It seemed that the DI 
particles lost, partially or completely, the largest segment 
of viral RNA (Duesberg, 1968; Choppin and Pons, 1970). 
However, other data suggested that influenza virus did not 
always lose a particular segment (Bean and Simpson, 1976; 
Nayak et al, 1978) but there appeared to be a relative 
reduction of one or more of the four largest viral RNA 
segments.
In the Bunyaviridae family, the existence of DI 
particles and their role in persistent infections has not 
been directly demonstrated. The difficulty to characterise 
such mutants may be due to the frequent inability to recover 
subunit RNA in equimolar amounts from purified virus 
(Elliott, 1990). Kascsak and Lyons (1978) reported 
generation of particles which interfered with homologous 
virus when BUN was passaged at high multiplicity in BHK 
cells and these particles were shown to contain the S 
segment-sized RNA. Elliott and Wilkie (1986) reported that 
particles which contained only the S segment sequences were 
shed from Aedes albopictus cells persistently infected with 
BUN and these particles also interfered with growth of 
standard virus. Later Cunningham and Szilagyi (1987) 
demonstrated that the interfering particles for GER grown in 
BHK cells had defects in the L-segment. More recently, 
Scallan and Elliott (1992) demonstrated that defective RNAs 
from persistently infected C6/36 cells (Igarashi, 1978) with 
BUN had subgenomic (defective) components that originated 
from the L RNA segment by northern blotting. Patel and 
Elliott (1992) characterised five BUN variants that produced 
small plaques on BHK and mouse L cells. They showed that 
progeny of these variants reduced the titre of standard 
coinfected virus by several hundred-fold. Analysis of 
cloned cDNA to the RNA of these particles revealed internal 
deletions in the L segment ranging from 72% to 77% of the 
L RNA segment. The 5'- and 3 '-terminal sequences were
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retained (Patel and Elliott, 1992). The same authors could 
readily generate defective L and M segments in mouse L cells 
but not in BHK-21 cells.
Persistent infection
Apart from the suggested involvement of defective 
interfering particles in the establishment and maintenance 
of persistent infections in cells, other factors including 
interferon, mutations in the standard virus and inherent 
resistence of the cell to a particular virus may have a role 
(Huang and Baltimore, 1970) . Traditionally, persistent 
viral infections have been categorised into two groups. One 
in which the infectious virus is present and can be 
recovered biologically has been referred to as chronic. 
Infectious chronic viral infections are exemplified by 
hepatitis B virus in humans (Marion and Robinson, 1983) and 
lympocytic choriomeningitis virus (LCMV) in mice (Buchmeier 
et al, 1980; Lehmann-Grube et al, 1983). The other group of 
persistent infections involve those in which the genome is 
present but infectious virus is not produced except during 
intermittent episodes of reactivation and are referred to as 
latent infections. The best known in this group are the 
herpesviruses (Roizman and Sears, 1987; Stevens, 1989). 
This kind of classification is not fool-proof as it is 
becoming apparent that the site of infection may be the 
determinant of whether a given type of virus will be in a 
latent or chronic productive state. This was demonstrated 
by hepatitis B virus which was known to produce chronic 
infections in hepatocytes but could also cause latent 
infection in lymphocytes (Korba et al, 1988).
Although the actual mechanisms involved in the 
initiation and maintenance of persistent infections are not 
well understood, a necessary prerequisite appears to be an 
inhibition of the rate of virus multiplication in the early 
stages of infection, i.e. the virus should not be overtly 
cytolytic and must be able to regulate its lytic potential
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(Ahmed and Stevens, 1990). This is not a problem for
viruses that cause non-lytic productive infections, for 
example the areanviruses which survive m  nature as lifelong
chronic infections of their rodent hosts (Howard, 1986;
Lehmann-Grube, 1984; Rawls et al, 1981). Lytic viruses can 
get around this problem by regulating their gene expression, 
i.e. by restricted expression of virus proteins or by 
generation of viral variants that are less cytolytic or
interfere with growth of the wild type virus (Ahmed and 
Stevens, 1990).
Another important component of viral continuance 
involves evasion of immunologic surveillance. This may 
happen by changes in the structure or expression of the 
surface viral glycoproteins by which the viruses can avoid 
recognition by humoural antibodies or by changes in any 
viral protein, structural or non-structural, which may be 
targets for T-cell recognition. Antigenic variation is 
another effective means of escape from neutralising 
antibodies. This is exemplified by the antigenic shift and 
drift amoung influenza viruses (Palese and Young, 1982; 
Webster et al, 1982) which although does not establish 
persistent infections in individuals, contibutes to the 
persistence of the virus in the population.
Members of the Bunyaviridae, in common with other 
arboviruses, do not cause serious disease in their 
invertebrate hosts. Instead, a non-cytocidal, self-limiting 
infection that leads to persistent infection ensues. The 
existence of persistent infections in vertebrate hosts 
probably occurs although not widely documented. Persistent 
infections have been established in mosquito cell lines with 
BUN, LAC and Marituba bunyaviruses and Toscana phlebovirus. 
The mosquito cells showed no differences in their metabolic 
activities from the uninfected ones and continued to shed 
infectious virus (Newton et al, 1981; Nicoletti and Verani, 
1985; Carvalho et al, 1986; Elliott and Wilkie, 1986; 
Rossier et al, 1988; Scallan and Elliott, 1992). Apart from
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establishment of persistent infections in mosquito cells, 
reports have been made of establishment of persistent 
infections for Dugbe virus in pig kidney cells (David-West 
and Porterfield, 1974) and Toscana virus in Vero cells 
(Verani et al, 1984).
When BUN (Newton et al, 1981; Elliott and Wilkie, 1986) 
and LAC (Rossier et al, 1988) were examined under identical 
conditions in BHK and C6/36 cells it was clearly observed 
that macromolecules accumulated more slowly in mosquito than 
in mammalian cells. It was also demonstrated that infection 
in mosquito cells still remained asymptomatic even when the 
intracellular concentration of viral products reached the 
same levels as those in mammalian cell infection. Except 
for the L mRNA, which remained close to or below the level 
of detection in mosquito cells, other viral RNAs accumulated 
linearly until about 24 hours post infection then decreased 
slowly over the following several days (Rossier et al,
1988). Scallan and Elliott (1992) reported that viral L, M 
and S RNAs were detectable up to 72 hours post infection. 
In BHK cells they observed more L and M segment RNA relative 
to the S segment RNA, whereas in mosquito cells there 
appeared to be more S segment RNA than L and M segment RNAs. 
There was also marked inhibition of host protein synthesis 
in BHK cells compared to the mosquito cells.
Bunvavirus RNA synthesis
Like other negative strand RNA viruses, replication of 
the BUN genome requires that the infecting genome be first 
transcribed into mRNA by the virion-associated 
transcriptase. Most studies on RNA synthesis for members of 
the Bunyaviridae family have concerned transcription 
processes leading to the synthesis of mRNA. Little is known 
about the synthesis of genomic or antigenomic RNA molecules 
(Bouloy, 1991). The negative strand genome is the template 
for both mRNA and antigenome (the replicative intermediates) 
synthesis. Events leading to the synthesis of mRNA and
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which do not require concurrent protein synthesis are termed 
primary transcription, whereas secondary transcription 
occurs after the primary mRNA is translated, and genome 
replication is accompanied by amplification of mRNA 
transcription (Elliott, 1990).
mRNA molecules
For the bunyaviruses (Bishop et al, 1983b; Patterson 
and Kolakofsky, 1984? Bouloy et al, 1984, 1990; Eshita
et al, 1985? Cunningham and Szilagyi, 1987; Gerbaud et al, 
1987a), phleboviruses (Ihara et al, 1985a; Collett, 1986; 
Emery and Bishop, 19867; Marriot et al, 1989) and 
hantaviruses (Schmaljohn et al, 1987a) which have been 
studied, all mRNAs are subgenomic, do not contain a poly A 
tail at their 3' ends (as demonstrated by their inability to 
bind to oligo dT-cellulose), have 10- to 18-base 
heterogenous non-virus coded extensions at the 5' ends and 
are capped.
These non-viral sequences have been implicated as 
initiation primers in transcription and similarities have 
been drawn with influenza viruses, i.e. they utilize 
cellular sequences in a 'cap-snatch' mechanism to prime mRNA 
synthesis (Krug et al, 1987). Purified LAC virions were 
shown to have polymerase activity which was stimulated by 
oligonucleotides of the A(n)G series and cap structures 
(mGppp A ) . Primer extension studies of the polymerase 
products showed that the oligonucleotides were acting as 
primers. Addition of natural mRNAs, for example alfafa 
mosaic virus RNA 4, also stimulated polymerase activity 
(Patterson et al, 1984). That the intracellular mRNAs of 
LAC are indeed capped was demonstrated by Hacker et al 
(1990) using specific selection by anti-cap antibodies. The 
difference in initiation between bunyaviruses and influenza 
virus appears to be their site of action. Bunyavirus mRNAs 
are synthesised in the cytoplasm, whereas those of influenza 
virus are synthesised in the nucleus (Kolakofsky and Hacker,
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1991) . This has been demonstrated by the observation that 
transcription of influenza virus is inhibited by 
actinomycin D and a-amanitin, whereas bunyavirus 
transcription is not affected by these drugs.
The suggested mechanism for bunyavirus mRNA initiation 
(Kolakofsky and Hacker, 1991) would be:
1 The viral polymerase, presumably attached to the 3' end 
of the genome template, binds to the cap group of a host 
mRNA, either directly or via a host cell cap-binding 
protein.
2 The polymerase cleaves this chain 10-18 nucleotides 
downstream of the cap, depending on the particular 
sequence of the host mRNA, leaving a 3' hydroxyl group on 
the capped fragment.
3 The 3' base of the fragment is then aligned on the 3' 
base of the template (this need not be by base pairing; 
Bouloy, 1990) and utilised as a primer for viral mRNA 
synthesis).
The 3' ends of mRNA do not extend to the end of their 
templates. The mRNAs are about 60 to 100 nucleotides 
shorter than full length transcripts. This is important 
because it makes the formation of circular and panhandle 
structures via the complementary terminal sequences 
difficult: such structures may interfere with translation. 
When the template sequences corresponding to the 3' ends of 
six mRNAs were mapped by nuclease digestion, two different 
but related consensus sequences were identified. The LAC S 
(Patterson and Kolakofsky, 1984) and L (Hacker et al, 1990) 
and GER M mRNAs (Bouloy et al, 1990) all ended within the 
sequence 3' GUUUUU 5'. The SSH (Ihara et al, 1985) and RVF 
(Collett, 1986) mRNAs ended within the sequence 3' ACCCC 5'. 
It has been suggested that these consensus sequences 
probably are signals for mRNA termination. The mRNAs are
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not polyadenylated, but could form stem-loop structures just 
upstream of their 3' ends. These stem-loop structures may 
substitute for the poly (A) tail in conferring mRNA 
stability (Kolakofsky and Hacker, 1991).
In the S segments of phleboviruses (Ihara et al, 1984; 
Simons et al, 1990) and tospoviruses (de Haan et al, 1990) 
which are ambisense, two subgenomic mRNAs of opposite 
polarity are transcribed (Elliott et al, 1991). The N mRNA 
is transcribed from the 3' end of the genome, and the NSm 
mRNA from the 3' end of the antigenome. The open reading 
frames of these transcripts do not overlap but are separated 
by an intergenic region which, except for S>$F (Marri ott 
et al, 1989), has the potential to form a strong stem-loop 
structure. It is assumed that stem-loop structures also 
form within the nucleocapsids and probably play a role in 
terminating the mRNAs.
Transcriptional requirement for full length mRNA synthesis
In all negative-strand RNA virus infected cells, 
addition of drugs which inhibit protein synthesis, such as 
cycloheximide and puromycin, also blocks genome replication, 
and has been shown for members of Bunyaviridae family 
(Patterson and Kolakofsky, 1984) . A difference between 
other negative-strand viruses and the Bunyaviridae is that 
inhibition of protein synthesis also stops mRNA synthesis in 
many mammalian cell types. This was observed in BHK cells 
for BUN (Abraham and Pattnaik; and Abraham, 1983), LAC (Raju 
and Kolakofsky, 1986), GER (Gerbaud et al, 1987). 
Contradictory results, i.e. lack of translational 
requirement, were reported for SSH (Vezza et al, 1979; 
Eshita et al, 1985). Resolution of this issue has not been 
helped by observations in Kolakofsky's laboratory which 
indicated that SSH has the same translational requirement as 
LAC, at least in their line of BHK cells (unpublished data, 
cited in Kolakofsky and Hacker, 1991). Earlier, Gerbaud 
et al (1987a) reported that full-length S transcripts of GER
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could be obtained in an in vitro transcription system,
although the synthesis of transcripts was inhibited in cell 
culture by anisomycin or cycloheximide. It was also 
reported that there was hardly any translational requirement 
for LAC mRNA synthesis in C6/36 mosquito cells (Raju et al,
1989) . It seems that the translational requirement is cell
type dependent.
Detergent disrupted bunyavirus preparations can 
synthesize RNA in vitro, as reported by Bouloy and Hannoun 
(1976), Gerbaud et al (1987), Patterson et al (1984), Ranki 
and Patterson (1975) and Schmaljohn and Dalrymple (1983),
which is paradoxical for translational requirement. 
However, detailed examination of LAC transcripts made
in vitro showed that almost all of the S RNAs were found to 
have terminated prematurely at nucleotide 175; addition of 
protein synthesis inhibitors did not change the situation. 
Full-length S mRNA, terminating at nucleotide 8 8 6, could be
obtained only when rabbit reticulocyte lysate, active in
translation, was added to the transcription mixture. 
Examination of the sequence at position 175 and the mature 
mRNA termination site at position 886 suggested that the
sequenceS'YAAAAAT(A)GCAG3 1 is involved in transcription 
termination (Raju and Kolakofsky, 1987).
It was concluded that addition of cycloheximide to the 
coupled transcription/translation system had no effect on 
mRNA transcripts and the effect of rabbit reticulocyte 
lysates in elongation of the chain was to prevent the 
polymerase from terminating prematurely. Bellocq and 
Kolakofsky (1987) showed that the polymerase could be 
induced to read through the termination site at 
nucleotide 886 even in the absence of ongoing protein 
synthesis. This was done by progressively replacing the 
guanosines of the nascent chain with inosine. It was 
revealed during these studies that position 175 was only the 
first and probably the strongest of several sites where the 
polymerase would terminate prematurely in the absence of
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translation. When the uridines were replaced with bromo- 
uridine, an opposite effect was obtained, i.e. there was no 
premature termination of the chain and this suggested that 
premature termination was due to base pairing of the nascent 
chain and the template and that concurrent translation of 
the nascent chain was required to break these interactions.
In the presence of concomitant protein synthesis, ribosomes 
moving along the nascent mRNA behind the polymerase prevent 
the mRNA from hybridising to its template and hence the 
polymerase reads through (Bellocq and Kolakofsky, 1987; 
Kolakofsky et al, 1987). This theory, however, does not 
explain the in vitro full-length S mRNA synthesis of GER in
the absence of active rabbit reticulocyte lysates, reported
by Gerbaud et al (1987).
For the ambisense S RNA of phlebovirus, four types of S 
segment-specific RNA were identified in cells infected with 
PT; these were genomic RNA, full length viral complementary 
RNA, N mRNA and NSs mRNA. In the presence of protein 
inhibitors only newly synthesised N mRNA was detected, and 
could be translated in vitro to yield the N protein (Ihara 
et al, 1985a). This result showed that NSs mRNA requires
the onset of RNA replication to yield the full length viral 
complementary RNA which then acts as a template for NSs mRNA 
synthesis. Also, the synthesis of NSs is regulated 
independently to that of N mRNA, showing that the NSs 
protein is not involved in the early stages of viral 
complementary RNA synthesis (Bishop, 1986).
There appears to be no ongoing protein synthesis 
requirement for mRNA synthesis in virus infected mosquito
cells, as the case is for BHK cells. To examine whether the 
difference is due to a host protein or a host modification 
of a viral component, reconstitution experiments were 
carried out. Addition of uninfected mosquito cell extracts 
of BHK genomes in an in vitro system had no effect but j 
addition of uninfected BHK extracts to mosquito cell genomes 
both stimulated mRNA initiation and recreated the
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translational requirement for efficient read-through of 
nucleotide 175 (Raju et al, 1989). This suggested that the 
translational requirement was due to a factor(s) present in
BHK, but not in C6/36, cells. When, during the same
<(4v» tftd
experiments, BHK/genomes of LAC were washed by pelleting 
through sucrose cushions, the translational requirement was 
abolished and the polymerase was able to read through 
nucleotide 175. The translational requirement therefore
seems to be due to a host component.
AIMS OF THE PROJECT
1 To express BUN M RNA from a cloned cDNA.
2 To clone and express individual gene products of BUN
RNA.
3 To characterise the translocation of the G1 and 
glycoproteins and NSm.
4 To determine the cellular localization of NSm.
Experiments done after completion of this thesis by Dr R.M. Elliott 
showed that BUN G2 aggregates on heating (see Figures 6.1 and 6.2), 
thus explaining the failure to detect G2 during the course of my work.
This does not invalidate any of the experiments or conclusions reported here.
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MATERIALS AND METHODS
MATERIALS
Cells
BHK-21, clone 13 (BHK-cl3)
BHK-cl3 is a continuous cell line derived from baby 
hamster kidneys (MacPherson and Stoker, 1962). The cells 
were supplied by the Cytology Unit, Institute of Virology, 
Glasgow and maintained in the Glasgow modification of
Eagle's Minimum Essential Medium (Stoker and MacPherson, 
1961), supplemented with new born calf serum (10%),
tryptose phosphate broth (10%), L-glutamine (5mM),
penicillin (lOOU/ml) and streptomycin (lOOpg/ml).
CV-1 cells
CV-1 monkey kidney cells were grown in Dulbecco's 
modified Eagle's medium (DMEM) containing 5% foetal calf 
serum, lOOU/ml penicillin and lOOyg/ml streptomycin.
TK~ 143 cells
TK" 143, human thymidine kinase deficient (TK~) cells 
(Rhim et al, 1975) were maintained in DMEM, supplemented 
with 5% foetal calf serum and 25pg/ml 5-bromodeoxyuridine.
HeLa T4* cells
HeLa T44 cells were obtained from the MRC AIDS
Directed Reagent Project, repository reference number:
ADP019. The cells were maintained in DMEM, supplemented 
with 10% foetal calf serum, lOOU/ml penicillin and 100yg/ml 
streptomycin. HeLa T44 cells contain the CD4 gene and 
support infection by HIV and induction of syncytia (Maddon 
et al, 1986) . The cells are relatively resistant to the 
cytopathic effects of vaccinia virus (Matsuoka et al, 
1988).
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Viruses
Bunyamwera virus, obtained originally as a suckling 
mouse brain homogenate from Dr N Karobatsos, Vector-borne 
Diseases Laboratory, Centers for Disease Control, Fort 
Collins, Colorado, USA, was cloned by three sequential 
plaque isolations from single plaques on BSC-1 (African 
Green Monkey Kidney) cell monolayers by Dr C R Pringle, 
formerly of the Institute of Virology, Glasgow (Watret 
et al, 1985).
Vaccinia virus, WR strain, was obtained from 
Dr A Patel of the Institute of Virology, Glasgow and the 
recombinant vaccinia virus vTF7-3, expressing bacteriophage 
T7 RNA polymerase (Fuerst et al, 1986) was obtained from 
Dr B Moss (National Institutes of Health, USA).
Antiserum
Antiserum to purified Bunyamwera virus was produced by 
intramuscular injection of rabbits with viral protein in 
complete Freund's adjuvant at weekly intervals for three 
weeks, followed by a boost four weeks later and bled two 
weeks after the final inoculation (Watret et al, 1985).
Enzymes
The following endonucleases were used: PstI, Bam HI, 
Hind III, EcoRI, Sail, Smal, PvuII, Ncol, Bglll, Hpal, 
Xbal, Bell, Dral, Haell, Haelll. All were products of
Bethesda Research Laboratories, Boehringer Mannhein, or New 
England Biolabs.
Other enzymes used were T3 RNA polymerase, T7 RNA 
polymerase, T7 DNA polymerase (Pharmacia); DNA
polymerase I, T4 DNA ligase (Bethesda Research Labs); calf
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alkaline intestinal phosphatase (Boehringer Mannhein); 
trypsin (Gibco Ltd); DNase I, RNase A (Promega Corp); 
lysozyme (Sigma).
Plasmids
The cloning and transcription vectors used were 
pTZ18U, pTZ19U, pT7T318U, pT7T319U, and were from Pharmacia 
LKB Biotechnology. Vaccinia virus transfer vector pTF7.5 
was obtained from Dr B Moss. The pUEX vector was obtained 
from Dr D P Leader (Department of Biochemistry, University 
of Glasgow).
The full length M segment cDNA (pBUN205) was cloned in 
pUC9 by Dr R M Elliott (Institute of Virology, Glasgow). 
The recombinant plasmid, pTZBUNS, carrying the S segment 
cDNA in pTZ18R under control of the T7 promoter was 
constructed by A McGregor (Institute of Virology, Glasgow).
Bacterial strains and culture media
The bacterial strains used in transformation 
experiments and in the propagation of vector and
recombinant plasmids were E.coli DH5a (F~08odlacZ M15,
recAl, endAl, gyr A96, thi-1, hsdR17 (r“k, mk+), supE44, 
relAl, deoR, (lacZYA-argF) U169 and DH5 (F,- end A l , 
hsdR17 (r_k, mk+), supE44, thi-1, T", recAl, gyrA96, relAl. 
Ecoli JM83, 4 (F,‘ , ara, (lac-proAB), rpsL, 08odlacZ M15 
was used in the growth of pBUN205. These were products of 
BRL. E.coli HMS174 (recAl hsd R rifr ) and BL21 (F-
hsdS gal) were hosts for the expression of NSm fusion 
proteins using the pUEX3 vector and were obtained from 
Dr F W Studier (Brookhaven National Laboratory, USA).
The bacteria were grown and maintained in either: 
L-broth (LB): lOg NaCl, lOg bactopeptone, 15g yeast extract 
per litre; or 2YT broth: 5g NaCl, 16g bactopeptone, lOg
yeast extract per litre. L-broth agar (for plates) 
consisted of L-broth plus 1.5% (W/V) agar.
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Chemicals and Reagents
Chemicals and reagents were products of BDH, Poole, 
England, except:
Absolute ethanol, Hayman Ltd, formerly James Burroughs.
Dimethyl sulphoxide, Koch-light Labs.
Caesium chloride, Melford Laboratories Ltd.
Ammonium persulphate - electrophoresis purity reagent, 
Biorad Laboratories, Richmond CA, USA.
TEMED (N, N, N', N '-tetramethylethylenediamine), electro­
phoresis purity reagent, Biorad Laboratories, Richmond 
CA, USA.
Agarose (genetic technology grade), FMC Bioproducts, 
Rockland, USA.
Goat anti-rabbit IgG fluorescein isothiocyanate conjugate, 
Sigma Chemicals Ltd.
Tunicamycin, Sigma Chemicals Ltd.
Agarose (low gelling temperature), Miles Labs.
Glacial acetic acid, May and Baker.
EN3 hance, DuPont Ltd.
Coomasie Brilliant Blue
Hindlll digested r DNA, Pharmacia.
Chloroform, May and Baker, Ltd.
Ampicillin (Penbrittin), Beecham Research Labs Ltd.
Methyl mercuric hydroxide, Lancaster Synthesis Ltd, 
Morecambe, England.
ABTS (2, 2'-Azino-bis (3-ethylbenz-thiazoline-6-sulphonic 
acid), Diammonium salt, Sigma Chemical Co Ltd.
Brefeldin A (6-4-dihydroxy-2- [6-hydroxy-l-heptenyl]-4- 
cyclopentanecrotonic acid r-lactone), Sigma Chemical Co 
Ltd.
Glycerol, May and Baker.
Formamide, Fluka Chemicals Ltd.
Staphylococcus aureus (10%W/V), formalin fixed, Bethesda 
Research Laboratories.
Sephadex G-50, Pharmacia LKB Ltd.
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Amberlite MB-1 (mixed bed resin ion exchanger), Sigma 
Chemical Co Ltd.
Ribonucleoside 5 '-triphosphates, dNTPs, 'Universal' and T7 
promoter sequencing primers, methyl diguanosine 
triphosphate sodium salt (m7GpppG), Pharmacia LKB Ltd. 
Wheat germ agglutinin, Sigma Chemical Co Ltd.
Wheat germ agglutinin, Rhodamine isothiocyanate conjugate, 
Sigma Chemical Co Ltd.
RNasin, Promega Corp.
Donkey anti-rabbit IgG peroxidase, Sigma Chemical Co Ltd.
Radiochemicals
Radiochemicals were supplied by Amersham International 
pic, except for Tran38 S-label, which was obtained from ICN 
Biochemicals, Inc.
3 5 S-L-methionine 
Tran3 8 S-label (70% 3 8S-L- 
Methionine, 15% 3 8S-L-Cysteines 
a - 3  2 p-dATP 
a _3 2 p-dCTP 
a - 3  2 p-dGTP 
a -3 2 p-dTTP
Other materials
Rabbit reticulocyte lysates, NEN Research Products. 
Nitrocellulose BA85, Schleicher and Schuell.
Dialysis tubings. Medical International Ltd.
Tissue culture flasks and dishes, Gibco Ltd? Sterilin Ltd. 
Water (sterile, distilled), Media lab, Institute of 
Virology, Glasgow.
Trypsin (0.25%), Media lab, Institute of Virology, Glasgow. 
Photographic films, Kodak Ltd.
Microtitre plates for ELISA, Immulon-2, flat-bottomed, 
Dynatech Inc, Chantilly, Virginia, USA.
Repelcote, BDH.
about 800mCi/mmole 
approximately 1,100/mmole
3.000 Ci/mmole
3.000 Ci/mmole
3.000 Ci/mmole
3.000 Ci/mmole
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Commonly used solutions
DNA preparation solution I (50mM glucose, 25mM TrisHCl pH. 
8.0, lOmM EDTA).
DNA preparation solution II (0.2M NaOH, 1% SDS).
DNA preparation solution III (5M potassium acetate pH. 
4.8), (3M with respect to potassium and 5M with respect
to acetate).
PBS (170mM NaCl, 3.4mM KC1, lOmM K2HP04, 1.8mM KH2P04,
6 .8mM CaCl2 , 4.9mM MgCl2 ), supplied by the Media lab, 
Institute of Virology, Glasgow.
NTE (lOOmM NaCl, lOmM Tris-HCl p.H. 7.5, ImM EDTA).
TE (lOmM Tris HC1, pH 7.5, ImM EDTA).
TBE (90mM Tris HC1, 90mM boric acid, ImM EDTA, pH. 8.0).
20 x SSC (3M NaCl, 3M trisodium citrate).
20 x SSPE (3M NaCl, 0.18M NaH2P04, 20mM EDTA, pH. 7.4).
TAE (40MM Tris-acetate, pH. 8.0, ImM EDTA).
50 x Denhart's solution (1% polyvinylpyrrolidone, 1% BSA 
Pentex fraction V, 1% Ficoll).
10 x EM buffer (0.05M sodium borate, 0.1M sodium sulphate,
0.01M EDTA, 0.15M boric acid).
2 x RNA gel sample buffer (20% glycerol, 0.05% bromophenol 
blue, 2 x EM buffer).
Protein dissociation mix (lOOmM Tris-HCl, pH 6 .8 , 200mM 
6-mercttptoethanol, 4% SDS, 0.2% bromophenol blue, 20% 
glycerol).
Carrier DNA (lOmg/ml salmon sperm DNA).
5% milk (dried skimmed milk (w/v in water).
10 x Tris-glycine (0.25M Tris HC1, 2.5M glycine, 1% SDS, 
pH. 8.3).
RNase A solution (lOmg/ml pancreatic RNase A in lOmM Tris 
HC1, pH. 7.5, 15mM NaCl), prepared by heating to 100°C 
for 15 minutes, aliquots stored at -20°C.
Sequencing gel mix (8% acrylamide/bisacrylamide 57:3, 
1 x TBE).
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Agarose gel loading buffer (0.25% bromophenol blue, 0.25% 
Xylene cyanol, 30% glycerol).
X-gal (20mg/ml 5-bromo-4-chloro-3-indolyl-3-D-galactoside 
in dimethylformamide).
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METHODS
Growth of cells and viruses 
Bunvamwera virus
1x10® BHK-21 cells were seeded in burrlers (850cm2 
growth area) and grown at 37°C in GMEM in a 5% carbon
dioxide atmosphere.
Confluent monolayers of cells were infected with BUN 
at an m.o.i. of 0.01 pfu/cell in 5ml GMEM containing 5% 
NBCS and allowed to absorb for one hour at 31°C. A further 
25ml of medium was added and incubation continued at 31°C 
for up to five days or until the cytopathic effect was 
extensive.
Similar conditions were employed for the growth of BUN 
and Maguari virus temperature sensitive mutants except that 
they were grown in 175cm2 flasks .
The culture fluids from virus infected cells were 
harvested and clarified at 3,000 rpm for 10 min at 4°C in
50ml Falcon tubes. The supernatant was aliquoted and 
stored at -70°C.
Titration of Bunvamwera virus stocks
Growth medium was removed from confluent monolayers of 
BHK-21 cells in 50mm petri dishes and ten-fold serially- 
diluted virus stocks in PBS containing 2% NBCS (200yl) was 
absorbed for one hour at 31°C. Overlay medium (Eagle's 
supplemented with 2% NBCS and containing 0.6% agarose) was 
added to each dish and the dishes were incubated at 31°C 
for four to five days. Cidex, containing 2% 
glutaraldehyde, was equilibrated with an equal volume of
PBS and used to fix the monolayers for two hours or
overnight. Plaques were counted after staining with 
Giemsa.
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Vaccinia virus
Vaccinia viruses (wild type strain WR and recombinant 
vTF7-3) were grown and propagated in CV-1 cells, 
essentially by the method of MacKett et al, 1985. Infected 
cell monolayers, on showing extensive c.p.e., were scraped 
into the medium, pellet ed by centrifugation at 3,000 
r.p.m. for five min at 4°C and the pellet resuspended in 
2ml of lOmM Tris-HCl, pH 9.0, for each 175cm2 flask. The 
cell suspension was subjected to three cycles of freeze- 
thaw or ultrasonication until the cells were completely 
disrupted. The nuclei were removed by centrifugation at 
750g for 5 min. The supernatant was incubated with 1/10 
volume of trypsin (2.5mg/ml) at 37°C for 30 min with 
frequent vortexing. The resultant material was layered 
onto an equal volume of 36% sucrose (W/V) in lOmM Tris-HCl, 
pH 9.0 in a Sorvall AH 627 tube. The virus and some debris 
were pelletted at 14,000 r.p.m. for 80 min at 4°C and 
resuspended in Tris-HCl pH 9.0. These partially purified 
virus preparations were assayed by plaque titration and 
used in all experiments involving vaccinia virus.
Bacterial cell cultures
Seed stocks of bacteria were made from overnight 
cultures which were prepared by inoculating 10ml of 2YT 
medium with a single bacterial colony and grown at 37°C 
with shaking until saturation. An equal volume of 80% 
(V/V) glycerol was added and the aliquots kept at -20°C or 
-70°C.
Large scale preparation of plasmid DNA
The procedure was essentially that described by 
Maniatis et al (1982). 10ml 2YT containing the appropriate 
antibiotic (ampicillin 100yig/ml or tetracycline lOpg/ml) 
were inoculated with lOpl of bacterial seed culture and 
grown, overnight with shaking. 5ml of this was inoculated
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into a 2 litre conical flask containing 400ml of 2YT plus 
antibiotic. This was grown overnight at 37°C with shaking. 
The bacterial cells were pellet ed at 5,000 r.p.m. in a GS3 
Sorvall rotor for 10 min at 4°C. The pellet was vortexed 
briefly to loosen it and then resuspended in 8ml of DNA 
preparation solution I containing 5mg/ml lysozyme. The 
mixture was transferred into an SS34 plastic centrifuge 
tube and left to stand at room temperature for 5 min. 
Eighteen ml of DNA preparation solution II was added, the 
tube covered by parafilm and mixed by gently inverting the 
tube a few times and left to stand on ice for 10 min. 
Twelve ml of ice cold potassium acetate pH 4.8 was added 
and the contents mixed by sharply inverting the tube a few 
times and placed on ice for another 10 min.
The contents were centrifuged at 18.000 r.p.m. for 
20 min in SS34 Sorvall rotor at 4°C. The supernatant was 
transferred to 30ml Corex tubes and DNA was precipitated by 
addition of 0 .6vol of isopropanol and left to stand at room 
temperature for 15 min. The DNA was recovered by 
centrifugation at 10,000g in SS34 Sorvall rotor for 20 min 
at room temperature. The pellet was washed with 70% 
ethanol, repelleted and dried briefly under vacuum.
Purification of plasmid DNA on caesium chloride gradient
The DNA pellet was dissolved in a total volume of 8ml 
of TE (pH 8.0) or water. lg of solid caesium chloride was
added for every ml and gently vortexed until the salt
dissolved. Ethidium bromide 0.8ml (lOmg/ml in H2O) was 
added for every 10ml of caesium chloride solution. The 
solution was transferred to a heat sealable Beckman tube 
for Ti 50 or Ti 65 rotor. The contents were centrifuged at
45,000 r.p.m. for 36 hours at 15°C. Supercoiled DNA was 
harvested by a gauge 18 hypodermic needle inserted in the
side of the tube. Ethidium bromide was removed by
extracting with isoamyl alcohol equilibrated with 5M NaCl,
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until the pink colour disappeared. The DNA solution was 
then dialysed against several changes of TE (pH 8.0) and 
recovered by ethanol precipitation.
Alternative large scale purification of plasmid DNA
A quicker procedure for the purification of plasmid 
DNA did not involve isopycnic centrifugation on caesium 
chloride gradients. After the addition of potassium 
acetate and harvesting of the supernatant, RNase A was 
added to the supernatant to a final concentration of 
20pg/ml. The mixture was incubated at 37°C for 30 minutes 
and extracted twice with an equal volume of 
phenol/chloroform in 50ml Falcon tubes with a 1 minute 
vortex and 5 minute centrifugation between the extractions. 
The aqueous phase was transferred to Corex tubes and two 
volumes of absolute alcohol added. The contents were 
placed on dry ice for 10 min, centrifuged for 15 minutes at
10.000 r.p.m. in an SS34 Sorvall rotor and the pellet 
dissolved in 1.6ml H2O. Then 0.4ml of 4M NaCl and 2ml 20% 
polythene glycol (PEG) was added and incubated on ice for 
one hour. The DNA was collected by centrifugation at
10.000 r.p.m. for 15 minutes and the pellet washed in 70% 
ethanol, recentrifuged for 5 minutes, dried and dissolved 
in 500pl H2O.
Small scale preparation of DNA (minipreps)
Three ml of 2YT medium containing the appropriate 
antibiotic was inoculated with a single bacterial colony 
and incubated overnight with shaking. About half of the 
bacterial suspension was transferred into an Eppendorf tube 
and the rest kept at 4°C. The contents in the Eppendorf 
tube were centrifuged at 13,000 r.p.m. for one minute and 
resuspended in solution I and let to stand at room
temperature for 5 minutes. Freshly prepared solution II
(200pl) was added and the contents mixed by inverting the 
tubes rapidly a few times and placed on ice for 5 minutes.
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Then potassium acetate 150yl pH 4.8 was added, the cap of 
the tube closed and vortexed briefly. The mixture was 
stored on ice for 5 minutes and then centrifuged at
13,000 r.p.m. for 5 minutes. The supernatant was extracted 
once with phenol/chloroform and centrifuged for 2 minutes. 
The aqueous phase was transferred to a fresh tube, the DNA 
ethanol precipitated, washed in 70% ethanol, dried and 
dissolved in 50pl H2O.
Quantitation of DNA
DNA was quantitated spectrophotometrically in quartz 
microcuvettes on a Cecil S95 double beam ultraviolet 
spectrophotometer at the wavelength of 260nm. It was 
assumed that an optical density of one corresponded to a 
DNA concentration of 50pg/ml.
Transformation of bacterial cells with plasmid DNA
Cells were made competent using the method of Dagert 
and Ehrlich (1979). An overnight culture was diluted 1:100 
in 50ml 2YT broth and grown to mid Log phase (about two 
hours) at 37°C. The cells were chilled in an ice bath for 
10 minutes and pelleted by centrifugation at 3,000 r.p.m. 
for seven and a half minutes in sterile 50ml Falcon tubes; 
the cells were resuspended in ice cold (lOOmM) calcium 
chloride. The cells were chilled in an ice bath for at 
least 20 minutes, pelleted as before and suspended in 3ml 
of cold lOOmM calcium chloride.
Plasmid DNA [0.5pg in 50pl of TE or H2O, or lOyl of
ligation reaction] was mixed with 200pl of competent cells
and incubated on ice for one hour. The tranformation
mixture was heat-shocked at 42°C for two minutes and then 
chilled on ice for 5 minutes. 2YT medium (500pl) was added 
to the mixture, incubated at 37°C for one hour and then 
plated out on agar plates containing appropriate
antibiotics. The plates were incubated at 37°C overnight.
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Restriction endonuclease digestion
The optimal conditions for digestion were set up 
according to the manufacturers' data sheets. The amount of 
DNA digested was typically l-2yg in the appropriate buffer 
and for about 2 hours at 37°C. Sometimes double digests,
i.e. using two enzymes on the same DNA sample, were carried 
out.
Electrophoresis of DNA
Electrophoresis of DNA digested fragments was done in 
either non-denaturing or denaturing conditions in 1% or 
0.8% agarose. The agarose was melted in electrophoresis 
buffer in a microwave, cooled and poured in preparative or 
analytical tanks (minigels).
Non-denaturing agarose gels
Electrophoresis was carried out on horizontal slab
gels (minigels or preparative gels) in IX TBE containing 
0.5pg/ml ethidium bromide. DNA samples were mixed with 
l/5th volume loading buffer and applied into preformed 
wells. Electrophoresis was performed at 70V for one hour 
in minigels and 150V for 4 hours or 30V overnight in 
preparative gels.
Denaturing agarose gels
Electrophoresis was carried out on horizontal slab
gels. Agarose was melted in IX EM buffer and cooled to 
about 60°C. 1M stock solution methylmercuric hydroxide was 
added to the melted agarose to a final concentration of
5mM. After the agar had solidified and the comb removed,
the wells were filled with IX EM buffer. An equal volume 
of RNA sample was mixed with 2X sample buffer and to each 
sample lpl of 0.1M methyl mercury solution was added. 
Samples were loaded and run under nonsubmarine conditions / 
at 60V.
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The gel was soaked in 200ml of 0.05M ammonium sulphate 
and 20pl of ethidium bromide solution (lOmg/ml in H2O) 
added. The gel was kept in ethidium bromide solution for
20 minutes and then photographed under UV light.
Recovery of DNA from agarose gels
Two methods for the recovery of DNA from agarose gels 
were employed: electroelution and adsorption on a silica 
matrix.
Electroelution
After electrophoresis the gel was placed on 
"Clingfilm" and visualised by use of a long wavelength 
ultraviolet transilluminator. The agarose containing the 
DNA of interest was excised and transferred into a dialysis 
bag containing 0.5X TBE so that the TBE buffer just covered 
the gel. The ends of the dialysis tubing were sealed, the 
gel slice placed on one side of the tubing and 
electrophoresis carried out in 0.5 x TBE, which just 
covered the tubing, at 150V for 3 hours. The polarity was
reversed for 2 minutes to release DNA from the wall of the 
dialysis tubing, the buffer was saved and the tubing was 
washed with a small quantity of buffer. The buffers were
pooled and the DNA extracted with phenol/chloroform, 
ethanol precipitated, dried under vacuum and dissolved in 
40pl H2O.
Silica Matrix adsorption
The principles of the procedure are based on the data 
of Vogelstein and Gillespie (1979). The materials came in 
a commercial kit known as GENECLEAN II which contained 
silica particles in suspension and referred to by the 
manufacturer as GLASSMILK; sodium iodide, NEW WASH and TBE 
modifier were also supplied in the kit.
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The DNA band was excised from the agarose gel in TBE 
buffer and transferred into an Eppendorf tube. The weight 
of the agarose slice was determined and 3 volumes of Nal 
and half volume of TBE modifier added. The contents were 
incubated at 45-55°C to dissolve the agarose. GLASSMILK 
was added to the solution at concentration of 5pl per 5yg 
of DNA. The mixture was incubated on ice for 5 minutes 
with occasional mixing and pelleted by centrifugation at 
13,500 r.p.m. for 5 seconds. The pellet was washed three 
times with NEW WASH and the DNA eluted into 20pl of H2O by 
incubating at 45-55°C for 5 minutes. The silica particles 
were pelleted, the supernatant containing DNA saved and 
kept at -20°C.
Visualisation and photography of DNA
Ethidium bromide intercalates with DNA enabling it to 
be visualised by fluorescence (Brunk and Simpson, 1977). 
Electrophoresis in agarose gels was performed in 1 x TBE 
containing ethidium bromide. Short wavelength illumination 
at 280nm was used to detect DNA in analytical gels and 
longwave illumination at 365nm was used for preparative 
gels. This was to minimise nicking and dimerization which 
occurs more frequently in the short wave region.
Gels were placed on a transilluminator and 
photographed on a Polaroid camera through a red filter.
DNA cloning
Cohesive end ligations
Plasmid vector DNA (0.01-0.05pg), which had been 
digested by the appropriate endonuclease and 
dephosphorylated with 1U calf alkaline intestinal 
phosphase, was ligated with DNA fragments (O.lpg) cut with 
the same endonucleases in a reaction mixture of 20yl. The 
mixture contained 0.1M Tris-HCl, pH 7.4, 50mM MgCl2 , ImM
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spermidine, ImM ATP, lOOpg/ml BSA. The mixture was 
incubated at room temperature overnight in the presence of 
1U of T4 DNA ligase.
Blunt end ligations
DNA fragments with 5' overlapping cohesive ends were 
converted to blunt ends by using the polymerising activity 
of the Klenow fragment of E.coli DNA polymerase I. One 
microgram of fragments were mixed with 2mM dNTPs in NT 
buffer. Two units of the Klenow fragment of DNA 
polymerase I was added and incubated for 30 min at room 
temperature. The DNA was phenol/chloroform extracted, 
ethanol precipitated and resuspended in 20pl H2O.
Restriction fragments with protruding 3' ends were 
made blunt-ended by using the 3' exonuclease activity of 
bacteriophage T4 DNA polymerase. The reaction included lpg 
of the DNA fragment, 2mM dNTPs, in T4 polymerase buffer 
(33mM Tris-OAc, pH 7.9, 66mM KOAc, lOOmM MgOAC, lOOmg/ml 
BSA, 0.5mM DTT).
Typically 4U of DNA ligase was used in the ligation 
mixes.
Dideoxvnucleotide sequencing of plasmid DNA
The procedure was based on the dideoxynucleotide chain 
termination method described by Sanger et al (1977). The 
sequencing kit was supplied by Pharmacia LKB and contained 
the following components:
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Components
'A ' mix-Short & Long:
'C mix-Short & Long:
'G' mix-Short & Long:
'T* mix-Short & Long:
T7 DNA polymerase: 
Enzyme dilution buffer,
Universal primer:
Annealing buffer: 
Labelling mix:
Stop solution:
ddATP in solution with dATP,
dCTP, dGTP and dTTP.
ddCTP in solution with dATP,
dCTP, dGTP and dTTP.
ddGTP in solution with dATP,
dCTP, dGTP and dTTP.
ddTTP in solution with dATP,
dCTP, dGTP and dTTP.
In buffered glycerol solution. 
A buffered solution containing 
glycerol, BSA and DTT.
5 1-d[GTAAAACGACGGCCAGT]-3’ in 
aqueous solution, 0.80 pM 
(4.44 pg/ml).
A buffered solution containing 
MgCl2 and DTT.
dCTP, dGTP and dTTP in 
solution.
Deionised formamide solution 
containing EDTA, xylene cyanol 
and bromophenol blue.
Preparation of template
Double stranded DNA template (2pg) was denatured by 
incubation with 0.2M NaOH in a volume of lOpl at room 
temperature for 10 minutes. Three pi of 3M NaOAc (pH 4.5) 
and 7pl of distilled H20 were added. Absolute ethanol 
(60pl) was added to the mixture and incubated on dry ice 
for 15 minutes. The precipitated DNA was collected by 
centrifugation at 13,500 r.p.m. for 10 minutes, washed in 
70% ethanol, recentrifuged for 10 minutes and dried briefly 
under vacuum. The pellet was redissolved in lOpl of 
distilled water and kept at -20°C until use.
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The template (lOpl), prepared as described above, was 
annealed to the Universal primer (0.8M) by mixing 2pl of 
primer, 2pl of annealing buffer (200mM Tris-HCl, pH 7.5, 
lOOmM MgCl2 , 250mM NaCl) and incubating the contents at 
37°C for 20 minutes in an Eppendorf tube. The tube and 
contents were then left to stand at room temperature for at 
least 10 minutes.
Labelling reaction
To the tube containing the annealed template were 
added 3pl labelling mix (0.57pM dGTP, dCTP, dTTP), lOpCi 
a-3 2p_dATP and 2pl T7 DNA polymerase (3 units). The 
components were mixed by gentle agitation, collected at the 
bottom of the microfuge tube by a brief centrifugation and 
incubated at room temperature for 5 minutes. Meanwhile, 
2.5pl of sequencing mixes (150pM of the 4 dNTPs, 15pM one 
ddNTP) was dispensed into microfuge tubes pre-labelled 'A',
' C', 'G' and 'T ' . The tubes were prewarmed at 37°C for 
2 minutes. After the labelling reaction had proceeded for 
5 minutes, 4.5pl of this reaction was transferred into each 
of the prewarmed tubes, using a fresh pipette tip for each 
transfer. The contents were mixed by gentle agitation 
collected on the bottom of the tubes and incubated at 37°C 
for 5 minutes. Stop solution (5pl) containing 95% 
formamide, 20mM EDTA, 0.05% bromophenol blue, and 0.05% 
xylene cyanol FF was added to each tube, mixed and the 
samples heated at 80°C on a heating block for 2 minutes 
just before loading.
Sequencing gels
The 8% sequencing mix was made by dissolving 288g 
urea, 45.6g acrylamide, 2.4g bisacrylamide in 500ml 
distilled water. Amberlite (20g) was added and the mixture 
stirred for 30 minutes. The solution was filtered through 
a Whatman 3MM filter, 60ml of 10 x TBE added, the solution 
adjusted to 600ml with deionised water and kept at 4°C.
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The BRL Model S2 electrophoresis apparatus was used. Glass 
plates were silicon treated with 'Repelcote' (2% 
dimethyldichlorosilane in 1,1,1-trichloroethane) and 
assembled with 0.4mm spacers. The sides of the glass 
plates were sealed with Sylglas clear tape. Seventy ml of 
8% sequencing mix were mixed with 800pl ammonium 
persulphate (10%) and lOOpl TEMED and carefully poured 
between the two plates. The flat side of the sharkstooth 
comb was inserted to about 3mm below the shorter plate and 
polymerisation allowed to take place at room temperature. 
The comb was removed after polymerisation (as judged by the 
contents that remained in the beaker) the gel assembly 
secured on the electrophoretic apparatus, the sharkstooth 
comb put into place so that the teeth just made contact 
with the gel. IX TBE was used as the running buffer and 
electrophoresis was carried out at 80 W after loading 2pl 
of each sequence reaction, until the bromophenol blue 
marker was about 1cm from the bottom of the gel. One of 
the glass plates was carefully removed and the gel put on 
Whatman 3mm filter paper as a support by gently pressing 
the paper on the gel and peeling it off the second glass 
plate. The gel was covered with "Clingfilm" and dried at 
80°C under vacuum for about one hour. The "Clingfilm" was 
removed and the gel exposed to X-ray film overnight.
Extraction of total cellular DNA
The procedure used was that described by Mackett et al 
(1985). CV-1 monolayers, infected with putative BUN M 
segment cDNA containing vaccinia virus recombinants, were 
washed once with cold PBS, scraped into 1ml PBS and 
pelleted at 13,500 r.p.m. for one minute. The cells were 
resuspended in lysis buffer (50mM Tris-HCl, pH 7.8, ImM 
EDTA and 30% sucrose, 1% SDS and lOOmM 2-mercaptoethanol). 
After incubation on ice for 30°C, Proteinase K was added to 
a final concentration of 500pg/ml and digestion carried out 
at 37°C. Total nucleic acids were extracted with phenol 
saturated with 1M Tris-HCl pH 7.5. The aqueous phase was
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removed and re-extracted with chloroform: isoamyl alcohol 
(24:1). One tenth volume of 5M NaCl and 2.5 vol ethanol 
were added and left to precipitate at -20°C overnight. The 
contents were centrifuged at 13/500 r.p.m. for 5 minutes, 
and dried under vacuum. The pellet was redissolved in lOmM 
Tris-HCl and digested at 37°C with 0.25yg/ml RNase A for 30 
minutes, phenol/chloroform extracted, ethanol precipitated 
and dissolved in 20^1 H2O.
Southern transfer of DNA
Purified plasmid or total cellular extracted DNAs were 
digested with appropriate restriction enzymes and the 
fragments separated by electrophoresis in agarose gels in 
TBE. The gel was transferred to a baking tray and the DNA 
denatured by soaking the gel in several volumes of 1.5M 
NaCl and 0.5M NaOH for one hour at room temperature with 
constant shaking. The gel was neutralized by soaking in 
several volumes of 1M Tris-HCl (pH 8.0) and 1.5M NaCl for 
one hour at room temperature, again with constant shaking. 
A piece of Whatman 3MM paper was wrapped around a glass 
plate and placed in a large baking dish on a support. The 
dish was filled with 10 x SSC to almost one third, with 
wetting of the Whatman paper. Air bubbles in the 3MM paper 
were removed by smoothing out with a 10ml pipette.
The gel was placed on the damp 3MM paper such that the 
original underside was now uppermost. Nitrocellulose 
filter paper was cut using a scapel to about l-2mm larger 
than the gel in both dimensions. The nitrocellulose paper 
was wetted by floating it on the surface of 2 x SSC until 
wet completely and then immersed in the same solution for 
3 minutes. The wet nitrocellulose paper was placed on top 
of the gel, air bubbles removed between the gel and filter 
and two wet pieces of Whatman 3MM paper placed on top of 
the nitrocellulose paper. A stack of blotting paper (BRL)
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was placed on the 3MM filter paper and a weight of 500g. 
Transfer of the DNA from the gel onto the nitrocellulose 
paper was allowed to proceed overnight.
The nitrocellulose paper was peeled off the gel and 
soaked in 6 x SSC at room temperature for 5 minutes. 
Excess fluid was allowed to drain off and the gel dried at 
room temperature on 3MM paper and then baked for two hours 
between two 3MM sheets at 80°C under vacuum.
Nick translation labelling of DNA probes
Plasmid DNA (200ng) in a reaction volume of 50yl made 
up of nick translation buffer (lOOmM Tris-HCl, pH 7.5, lOmM 
MgS04, ImM DDT, 50yg/ml BSA), lOyCi each a-32P-dATP, 
a-3 2p_dCTP, a-32P-dGTP and a-32P-dTTP, 2mM of each of the 
four unlabelled dNTPs, one unit of DNA polymerase I, and 
two units DNase I was incubated for one hour at room 
temperature. The nick-translated DNA was separated from 
the unincorporated dNTPs by gel filteration chromatography 
in a Sephadex G-50 column made in a 1-ml syringe plugged 
with siliconised glass wool.
Orange G dye was added to the reaction mixture, which 
was applied to the column and eluted with distilled water. 
The eluted DNA was collected in a microfuge tube and 
collection was stopped just before the orange G marker 
reached the bottom of the column. The probes were heated 
at 100°C for 2 minutes before hybridization.
Hybridization of radiolabelled probes to DNA immobilised on 
nitrocellular filters
The baked nitrocellulose filter was placed in a heat- 
sealable plastic bag to which a pre-hybridization mixture 
(5 x SSPE, 50% formamide, 0.5% skimmed milk, 0.2mg/ml
carrier DNA [salmon sperm DNA]) in a 20ml volume was added. 
The bag was heat-sealed and the contents prehybridized at
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42°C for 4 hours in a flat bottomed plastic box. The 
nitrocellulose paper was transferred to a fresh heat- 
sealable bag and a reaction mixture similar in composition 
to the pre-hybridization mixture was added. The nick- 
translation-labelled plasmid DNA probe was added, the bag 
sealed and hybridized at 42°C with shaking overnight.
After removal of the filter from the hybridization 
bag, it was submerged in 2 x SSC and 0.5% SDS, and washed 
with agitation for 30 minutes at room temperature. The 
filter was then transferred to another tray containing 0.1% 
SSC and 0.1% SDS and washed for a further 30 minutes. The 
filter was dried on a sheet of Whatman 3MM filter, placed 
on a support, wrapped in "Clingfilm" and exposed to X-ray 
film at -70°C.
DNA dot blot hybridization
Cells from a 24 well Limbro plate were lysed with 
lOOpl lysis solution (0.5M NaOH, 1% SDS) at room
temperature for 20 minutes. To the lysed cells, 50yl of 
neutralization buffer (1M NaCl, 0.3M Na citrate, 0.5M Tris-
HCl pH 8.0, 1M HC1) was added and the mixture was further
diluted with the addition of lOOpl of distilled water. One 
hundred and twenty microlitres of each sample was applied 
onto nitrocellulose filter paper (Schleicher and Schuell, 
0.2pm pore size) using a Schleicher and Schuell Minifold II 
and vacuum. The nitrocellulose filter was baked at 80°C 
for 2 hours under vacuum and then hybridized with
nick-translated DNA probes.
Radiolabelling of intracellular proteins
Virus infected or uninfected cell monolayers in 35mm 
dishes were radiolabelled with 3BS-methionine or 
35S-methionine/cysteine (lOOpCi/ml) in 1ml PBS for two 
hours, or in Eagle's medium minus methionine for 4 hours at 
37°C or at 31°C. The fluid containing the radioactive
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material was removed and the monolayers washed with ice 
cold PBS. The cells were dissociated in a protein 
dissociation mix (0.125M Tris-HCl, pH 6.8, 4% SDS, 10%
2-merceptoethanol, 20% glycerol, 0.1% bromophenol blue). 
The contents on the plate were scraped with the plunger of 
a 1ml syringe and transferred into microfuge tubes, boiled 
for 5 minutes and kept at -20°C.
Radioimmunoprecipitation
Infected or uninfected cells were labelled as 
described above and after washing with cold PBS, the cells 
were scraped into PBS. One tenth was used to prepare total 
cell lysates as described above and the remaining nine 
tenths were processed for immunoprecipitation by pelleting 
the cells for 1 minute at 13,500 r.p.m. and lysing the 
cells in 800pl of lysis buffer (0.05M Tris-HCl pH 8.0, 
0.15M NaCl, 0.5% Nonidet-P40). The contents were vortexed 
briefly and incubated on ice for 30 minutes with occasional 
vortexing. The nuclei and other debris were removed by 
centrifugation at 13,500 r.p.m. for 5 minutes. The 
supernatant was transferred to a fresh tube, incubated with 
pre-immune sera for 4 hours at 4°C on a turning wheel mixer 
and precleared by incubation with 50yl of 10% formalin- 
fixed Staphylococcus aureus for 30 minutes on the wheel 
mixer at 4°C. The bacteria were removed by centrifugation 
in a microfuge for 1 minute and aliquots of immune sera 
added and incubated at 4°C overnight. One hundred 
microlitres of Staphylococcus aureus suspension was added 
to each sample and incubation continued for another 
30 minutes. The immune complexes were collected by 
centrifugation for one minute and washed alternately with 
TBS, TBS with 2.5M KC1, and two final washes of TBS + 0.1% 
SDS; and then resuspended in protein dissociation mix, 
boiled for 5 minutes and stored at -20°C.
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SDS-polvacrvlamide gel electrophoresis of proteins
Fractionation of proteins was carried out on 
polyacrylamide gels in the presence of 0.1% SDS using the 
discontinous buffer system described by Laemmli (1970). 
Resolving gels contained 10, 12 or 15% acrylamide
crosslinked with N ’, N'-methylene bisacrylamide in the 
ratio of 75:1 in resolving gel buffer (0.375M Tris-HCl, pH 
8.8, 0.1% SDS). For polymerisation ammonium persulphate 
was added to a final concentration of 0.1% (V/V), and TEMED 
was added to a final concentration of 0.01% (V/V). After 
pouring the gel between the sealed glass plates, it was 
overlaid with butanol to form a flat surface and exclude 
air. When the gel had polymerized the butanol was removed 
and the gel top was washed with deionised water. The 
stacking gel solution containing 3.8% polyacrylamide, 
62.5mM Tris-HCl, pH 6.8 and 0.1% SDS was layered on the 
resolving gel after addition of ammonium persulphate and 
TEMED, and a well-former comb put into place. After 
polymerisation of the stacking gel, wells were washed out 
with deionised water to remove any unpolymerised 
acrylamide. The gel-glass plate assembly was secured on 
the electrophoretic tank, running buffer (53mM Tris-HCl 
53mM glycine, 0.1% SDS) was put in the tank reservoirs and 
electrophoresis performed at 35mA for the small tanks or 
60mA for the large tanks until the bromophenol blue 
tracking dye was a few milimetres from the bottom of the 
gel.
Gels were removed from the glass plates, immersed in 
fixer (7% acetic acid, 20% methanol in water) for 30-60 
minutes, stained with 0.2% Coomassie brilliant blue for 
30 minutes and destained in gel fixer or processed for 
fluorography. For the latter the gel was soaked in 
En3Hance (Dupont) for 30-60 minutes and washed for 
30 minutes against several changes of water. The gels were
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dried down under vacuum using Bio-Rad gel driers and 
exposed to Kodak-X-Omat film at -70°C overnight or until 
the protein bands were satisfactorily intense.
Western blotting
Infected and uninfected cell proteins were dissociated 
in protein dissociation mix, boiled and fractionated on an 
SDS-polyacrylamide gel and transferred to a 0.45pm 
nitrocellulose filter by electroblotting using an LKB 
2117-250 NovaBlot electrophoretic transfer system. 
Electroblotting was carried out at a current of 0.8mA/cm2 
of gel in a continuous buffer system (39mM glycine, 48mM 
Tris-HCl, 0.0375% SDS (W/V) 20% methanol (V/V) in H20).
This solution was used both for the anode and the cathode. 
The assembly of the unit and filter stacks was done as 
described by the manufacturer.
After electroblotting the filter was air dried, cut 
into strips and excess protein sites blocked by submerging 
the membrane into TBST buffer (lOmM Tris-HCl, pH 8.0, 
containing 150mM NaCl, 0.05% Tween 20, 1% BSA) for 30
minutes at room temperature with shaking. The blocking 
solution was replaced with TBST containing the appropriate 
dilution of primary antibody and incubated for 30 minutes. 
The unbound antibody was removed by washing three times in 
TBST, 5 minutes per wash. The TBST was replaced with anti- 
IgG horseradish peroxidase conjugate (1:2,500 dilution in 
the same buffer) for 30 minutes and the membrane washed 3 
times again in the same buffer. The membrane was dried on 
filter paper and transferred to a solution containing the 
peroxidase substrate (4-chloro-l-naphthol). This was 
prepared by diluting stock solution (lOOmg/ml in methanol): 
50pl of the stock was added to 2ml of methanol and brought 
to 10ml with TBS (lOmM Tris-HCl pH 8.0, 150mM NaCl). To 
this was added 35pl of a 30% solution hydrogen peroxide.
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The colour reaction was stopped by rinsing the filter with 
deionised water for several minutes. The membrane was air 
dried on filter paper and photographed.
In vitro transcription and translation of recombinant 
plasmids.
Transcription
The transcription vectors pTZ18U or 19U and pT7T318U 
or 19U or pTF7-5 were employed for transcription under the 
control of either the T3 or T7 RNA promoters. Run-off 
transcripts were synthesized using T3 RNA polymerase or T7 
RNA polymerase in the presence or absence of cap analogues 
after linearizing with an appropriate restriction 
endonuclease.
The transcription reaction was carried out in a volume 
of 50ul containing transcription buffer (40mM Tris-HCl 
pH 7.5, 6mM MgCl2 , 2mM spermidine, lOmM NaCl), lOmM DTT, 
0.5mM rNTPs (ATP, CTP, GTP, UTP), 40U RNasin, 20U T7 RNA
polymerase. To make capped RNAs 0.5mM m7GpppG was also 
added. The reaction was incubated for one hour and 45 
minutes at 37°C. 1U of DNase I was then added and the 
reaction continued for another 15 minutes. RNA transcripts 
were extracted with phenol/chloroform, ethanol
precipitated, dissolved in lOpl H2O, and stored at -70°C 
until used.
Translation in vitro
In vitro translation was performed using the New 
England Nuclear (Dupont) rabbit reticulocyte system. A 
premix was made containing 5pl 33S-methionine, 5.5yl
translation cocktail, 2ul 1M potassium acetate and 0.5pl 
32.5mM magnesium acetate. One microgram RNA in 2pl H20 and 
10yl lysate were added to the premix and incubated at 37°C 
for 90 minutes. Twenty five microlitres of protein
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dissociation mix was added and the mixture boiled for five 
minutes and loaded on gels for SDS-polyacrylamide 
electrophoresis.
Construction of recombinant vaccinia viruses
The vaccinia virus transfer vector pTF7-5 (Fuerst 
et al, 1987) was used to make recombinant viruses. The 
plasmid contains the T7 (0IO) promoter and terminator which 
are flanked by thymidine kinase (TK) sequences of vaccinia 
virus to enable homologous recombination. The promoter and 
terminator are joined by a synthetic linker (CGGGATCCGG) 
which generates a unique BamHI site in the plasmid. The 
cDNAs of interest were cloned into the plasmid using this 
unique BamHI site.
The protocol used for generation of recombinant 
viruses was that described by Mackett et al (1985). 
Monolayers of CV-1 cells in 35mm dishes were infected with 
vaccinia virus (WR strain) at a m.o.i. of 0.05 pfu/cell and 
absorbed at 37°C for one hour. The virus inoculum was 
removed and the monolayer washed twice with serum free 
medium. One microgram of plasmid DNA was mixed with 200pl 
of HEPES buffered saline (140mM NaCl, 5mM KC1, 0.75mM 
NaHP40, 6mM dextrose, 25mM Hepes pH 7.05). The DNA was 
precipitated by the addition of calcium chloride to a final 
concentration of 125mM and incubated at room temperature 
for 30 minutes. The DNA precipitate was added to the 
infected monolayers and incubation continued for another 
30 minutes at room temperature. Two mililitres DMEM 
containing 5% FCS was added to the dishes and incubated at 
37°C for 3& hours. The medium was changed and incubation 
continued for 48 hours at which time cells were scraped 
into the medium and the virus released by freeze-thawing 
three times.
The selection of TK" recombinants was done by growing 
the progeny virus from the transfection in TK"143 cells
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overlaid with 1% low gelling temperature agarose containing 
25pg/ml BUdR at 37°C until plaques were visible when 
stained with neutral red. The plaques were picked using a 
pasteur pipette and put in 200ul of DMEM containing 5% FCS. 
The mixture was freeze-thawed a few times on dry ice/37°C 
with some vortexing and half the material used to infect 
TK*143 in 24 well Limbro plates and incubated at 37°C for
2-3 days. The medium was removed and cells processed for 
dot blot or Southern blot analysis. Positive samples were 
amplified by growing the remaining half of the transfection 
progeny in 25cm2 flasks, virus was released by freeze 
thawing and grown in 175cm2 flasks. Eight infected flasks 
were used to prepare virus stocks in CV-1 cells and 
purified as described above.
Transient expression of transfected plasmid DNAs in vTF7-3 
infected cells
The procedure used is essentially that described by 
Rose et al (1991). CV-1 cells, grown to near confluency in 
35mm dishes, were infected with vTF7-3, a recombinant 
vaccinia virus that encodes T7 RNA polymerase, at a m.o.i. 
of 10 pfu per cell at 37°C for 30 minutes in 0.5ml OptiMEM. 
Cationic liposomes were prepared (by Dr R M Elliott) by 
mixing one milligram of PtdEtn (dioleoylL-a- 
phosphatidylethanolamine) and 0.4mg DDAB
(dimethyldioctadecyl ammonium bromide). The solution was 
evaporated to dryness in a SpeedVac concentrator, 
resuspended in 10ml sterile deionized water, sonicated 
until the solution became almost clear and kept at 4°C. 
Fifteen microlitres of liposomes were added to 1ml of 
OptiMEM followed by addition of 2.5ug of plasmid DNA. The 
mixture was added to infected cells and incubated at 37°C 
for 3 hours in a CO2 incubator. At 3 hours post­
transfection, 1ml of DMEM containing 5% FCS was added to 
the transfection mixture. At 4 hours post-transfection 
cells were processed for immunofluorescence or radioimmuno- 
precipitation analyses.
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Indirect immunofluorescence
BHK-21 cells, CV-1 or HeLaT4+ cells were seeded and 
grown to subconfluency on 18 x 18mm sterile coverslips in 
35mm dishes at 37°C. The cells were infected with 5 pfu 
per cell in the case of BUN for one hour at 31°C or 10 pfu 
per cell with recombinant vaccinia viruses for 30 minutes 
at 37°C. The inocula were removed and growth medium added 
to the dishes. Cells were fixed at 8 hours post infection 
for vaccinia virus transient and dual expression systems 
and the following day for BUN infected cells.
The growth medium was removed from the dishes by 
aspiration using a pasteur pipette and the cells were 
washed once in PBS. The PBS was removed and the cells were 
fixed in 3.7% formaldehyde for 30 minutes at room 
temperature for the detection of surface antigens and in 
3.7% formaldehyde followed by treatment for 30 min at room 
temperature with 0.5% NP40 for detection of internal
antigens. The fixative was removed by washing twice in PBS 
(5 minutes per wash with shaking).
The primary antibody was diluted 1:100 in PBS and 
adsorbed on methanol-fixed cells overnight at 37°C (the 
same cells as those to be used in the experiments). The 
adsorbed antiserum was clarified by centrifugation at 
10,000 rpm for 5 minutes. 50pl was layered onto the
coverslips and incubated for 30 minutes at room
temperature. The cells were washed in PBS four times, 
5 min per wash with shaking. Goat antirabbit IgG
fluorescein isothiocyanate conjugate diluted 1:100 in PBS, 
was spun at 13,500 rpm for 5 min and 50pl layered onto the 
coverslips. After incubation at room temperature for 
30 min, the cells were washed four times as before. To 
stain the Golgi complex, wheat germ agglutinin rhodamine 
isothiocyanate conjugate, diluted 1:100 and spun at
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13,500 rpm, was layered on the coverslips and incubated for 
another 30 minutes at room temperature, followed by washing 
four times in PBS.
The coverslips were immersed a few times in de-ionised 
water to remove as much PBS as possible and then mounted on 
microscope slides in CITIFLOR, an anti-fading agent (City 
University, London). The coverslips were sealed with nail 
varnish and the cells were examined and photographed on a 
Nikon Microphot-SA fluorescence microscope using the blue 
filter at a wavelength of 480nm for fluorescein and green 
filter at the wavelength of 546nm for rhodamine. 
Photographs were taken on Kodak Ektachrome 400 day film for 
colour slides and Kodak Plus-X Pan film for black and white 
prints.
Production of antiserum to the NSm protein
Two approaches were used to raise antibodies to the 
NSm protein. One was by synthesis of 3-galactosidase 
fusion proteins and the other was by synthesis of branched 
peptides to be used as antigens.
0-aalactosidase-NSm fusion proteins
The pUEX3 plasmid vector (Bressan and Stanley, 1987) 
was used in the cloning and expression of LacZ gene fusion 
proteins. This vector contains the bacteriophage r cro 
sequences, E.coli LacZ sequences and a CI857 thermolabile 
repressor gene.
The NSm protein is encoded from nucleotide 963 to 
1485. A DNA fragment containing NSm sequences was obtained 
by digesting the BUN M segment cDNA with Dral which cuts at 
nucleotide 941 and Haelll which cuts at nucleotide 1535. 
Both enzymes generate blunt end fragments. The NSm 
fragment was cloned into the Smal site of pUEX3, as shown 
in Fig 3.1. Recombinant plasmids were analysed for
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orientation of the insert by restriction enzyme digestion 
and plasmid DNA sequencing. Cultures of the correct 
recombinants were grown overnight at 30°C, then diluted 
1:20 in 2YT containing ampicillin lOOpg/ml and incubated at 
30°C until the O.D.aso was about 0.2 (about 4 hours). The 
culture was then taken to a 42°C waterbath for 20 minutes 
and then incubated at 42°C for 2 hours on a shaker.
The bacterial cells were pelleted at 3,000 rpm in a 
bench centrifuge for 10 minutes and the pellet resuspended 
in 4ml lysozyme solution (50mM Tris-HCl, pH 8.0, 50mM EDTA, 
15% sucrose, O.lmg/ml lysozyme) and incubated on ice for 
30 minutes. Six millilitres of detergent mix (1% Triton 
X-100, 0.5% deoxycholate, 0.1M NaCl, lOmM Tris-HCl pH 7.5, 
ImM EDTA) and kept on ice for 5 minutes. The mixture was 
pelleted by centrifugation at 10,000 rpm in SS34 rotor for 
10 minutes, the pellet resuspended in 1.5ml 8M urea, 2% 
3-mercaptoethanol and an equal volume of protein 
dissociation mix added. The mixture was boiled for 
10 minutes and the proteins were fractionated on 10% 
SDS-polyacrylamide gels, with commercially available
3-galactosidase run on the same gels as a marker. The 
protein bands were stained with 0.05% Coomassie brilliant 
blue in de-ionised water for 10 minutes and destained in 
water for 30 minutes. The fusion band, which was larger 
than 3~galactosidase, was excised from the gel with a clean 
scapel and the gel slice macerated.
The gel pieces containing the fusion protein was 
passed through a 10ml syringe a few times. A 18 gauge 
needle was attached to the syringe and the gel pieces were 
forced through the needle until they could pass through 
easily. An equal volume of sterile water was added and a 
mixture which contained about 100ug of protein injected 
subcutaneously into New Zealand white rabbits. The rabbits 
were boosted three times at 10 day intervals with the same
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dose of protein and bled 10 days after the last boost. 
Sera we*£ tested by radioimmunoprecipitation and enzyme- 
linked immunosorbent assays to branched particles.
Branched peptides
Two branched peptides, M245 and M246, spanning codons 
349 to 364 and 417 to 430 respectively, were synthesised by 
A Owsianka, Institute of Virology, using continuous flow 
Fmoc chemistry (Atheron et al, 1979; Sheppard, 1983) using 
a Novabiochem peptide synthesizer. Peptides were 
synthesized directly onto a branched lysine core (Peptide 
and Protein Research, Reading, UK) to generate a peptide 
with eight identical branches (Possnett et al, 1988; Tam, 
1988). The lysine core was synthesized onto an alanine 
residue coupled via an acid-labile bond to the resin using 
Fmoc-Lys (Fmoc) pentafluorophenyl ester.
After synthesis, side chain protecting groups were 
removed by treatment with 95% trifluoroacetic acid (5%) in 
water for peptide M245, and 95% trifluoroacetic acid (5%) 
in ethylmethylsulphide for peptide M246, which contained a 
methionine, using standard procedures. The amino acid 
compositions of the branched peptides were determined by 
amino acid analysis (Cambridge Research Biochemicals, 
Cambridge, UK) and were of the expected composition. The 
branched peptides are schematically illustrated in Fig 3.4.
Generation of ________antipeptide sera
The branched peptides were dissolved in water and 
emulsified in an equal volume of Freund's complete adjuvant 
(Gibco) for the first injection and in Freund's incomplete 
adjuvant for subsequent injections. New Zealand white 
rabbits were immunised on days 0, 10, 30 and 40 with lOOpg
or 300pg of peptides 245 and 246. There was a preterminal 
bleed on day 35 and final bleed on day 50.
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Enzyme-linked immunosorbent assay
To determine the titres of antipeptide sera
from immunized rabbits an ELISA was carried out in
microtitre plates. The branched peptides were diluted in 
PBS to a concentration of 50pg per ml. Wells were 
precoated with lOOpl of the peptide solution using 
Immunolon 2 (Dynatech) plates, overnight at 4°C. The 
peptide solution was removed and the unbound sites blocked 
with 1% BSA in PBS for one hour at 37°C. The plates were 
washed three times in PBS containing 0.02% Tween 20 (PBST) 
and incubated with lOOyl in PBST for one hour at 37°C. The 
plates were washed 5 times in PBST and incubated with lOOyl 
of donkey antirabbit IgG horseradish peroxidase diluted 
1:4,000. The plates were washed another 5 times in PBST 
and reacted with a 0.5mg/ml solution of the substrate ABTS 
(2', 2-azino-bis (3-ethylbenzthazoline-6-sulphonic acid) in 
0.1M citrate phosphate buffer, pH 4.0, containing 0.01% 
hydrogen peroxidase. The plates were incubated at room 
temperature for 30 minutes and read on a Titertek Multiscan 
plate reader at 405nm.
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RESULTS
SECTION ONE
PRODUCTION OF ANTI SERA TO THE NON-STRUCTURAL PROTEIN NSm
In addition to the two structural glycoproteins, G1 and 
G2, the middle RNA segment of BUN also encodes a non- 
structural protein termed NSm. The cellular residence and 
function of this protein are unknown. There was a need 
therefore to raise antisera specific for NSm, with the view 
of using these to uncover the intracellular localisation of 
NSm in BUN infected cells and in cells expressing NSm via 
recombinant vaccinia viruses. If NSm were identifiable in a 
given cell organelle/s this may help to delineate the role 
of NSm in viral morphogenesis. Another question to be 
looked into was whether NSm translocates by itself to these 
organelle/s or whether the presence of other BUN proteins is 
required.
Two approaches were designed: one involved synthesis of 
fusion proteins of NSm with 3-galactosidase using the pUEX3 
vectors, and the second was to synthesize branched peptides 
to selected sequences of the NSm protein. Rabbits would 
then be immunized with these in order to obtain antisera 
that reacted with NSm in a specific manner.
Construction of pUEX3/NSm plasmid
The sequences encompassing BUN NSm were predicted by 
extrapolation from those of SSH (Fazakerley et al, 1989; 
Elliott, 1990). The amino terminus is predicted to be at 
codon 300 (nucleotide 963) and the carboxy terminus at 
codon 477 (nucleotide 1485) .
The pUEX3 vector, which contains the lacZ gene under 
control of the cro promoter, was linearised with Smal and 
ligated with the NSm fragment such that the NSm gene was in
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frame with the 3-galactosidase coding sequence, as shown in 
Fig 3.1. E.coli strain DH5a cells were transformed with the 
ligation mixture and recombinant plasmids were analysed by 
restriction enzyme digestion with Hpal: this would yield
three fragments if the insert was present and two fragments 
if there was only vector DNA. Out of 24 colonies picked, 
ten yielded plasmids containing the insert. Of these three 
had the insert in the correct orientation with respect to 
the LacZ gene as demonstrated by plasmid dideoxy DNA 
sequencing (fig 3.2) using a primer (GATTGGTGGCGACGACTCCT) 
complementary to nucleotides 4101-4121 of the pUEX3 vector 
(obtained from Dr Hong Jin, Institute of Virology).
Expression of the 3-galactosidase-NSm fusion protein
Overnight cultures of E.coli cells carrying pUEX3/NSm 
recombinants were diluted 1:20 in 2YT medium and grown for 
four hours at 30°C. The cultures were then transferred to a 
42°C shaker and incubated for two hours to induce synthesis 
of the fusion protein. As can be seen in Fig 3.3, lanes 1 
to 3, no 3~galactosidase or fS-galactosidase-NSm fusion 
protein expression was detected when cells carrying pUEX3, 
or pUEX3/NSm fusion 1 and 2 were grown at 30°C. When the 
same cells were grown at 42°C, (S-galactosidase was 
expressed, as shown in lane 4. In lanes 5 and 6 two new 
proteins, which were absent in the uninduced cultures, were 
seen: one of similar size to 3-galactosidase and one larger, 
which had the expected size for the p-galactosidase/NSm 
fusion protein. The level of expression of 3-galactosidase 
was much higher than that of the fusion protein. A 
commercial preparation of 3~galactosidase protein was 
included as a marker in lane 7. The induced 3~9alactosidase 
was slightly larger than native 3~9 alactosidase because 
pUEX3 makes a cro LacZ fusion protein.
Figure 3.1 Construction of pUEX3/NSm.
A BUN M cDNA fragment encoding all of NSm sequences was 
cleaved from pTF7-5M by digesting with Dral which cuts at 
nucleotide 941 and Haelll which cuts at nucleotide 1535. 
The blunt ended fragment was ligated into the Smal site of 
the 3-galactosidase fusion protein vector pUEX3.
G2 iNSM G1
Dral Haelll
Dral
Haelll
Eco R1 SmalBamHI Sail Pst1
L acZ
pUEX3
c1857
Smal
T4 DNA Llgase
L acZ
cro
pUEX3
Blal
C1857
Figure 3.1
Figure 3.2 Determination of orientation of the NSm coding 
region in pUEX3/NSm.
Putative pUEX recombinants containing NSm sequences were 
sequenced using a primer complementary to nucleotide 
4101-4121 of the pUEX3 vector. The sequence was determined 
by use of the T7 DNA polymerase, as described in the Methods 
section. Tracks are GATC from left to right. The Smal/Dral 
fusion and BUN M gene nucleotides from position 942 are 
indicated.
^ _____  AGCCTGAGAGTA.. .from nt 945
Smal/Dral ( CCC/AAA )
Figure 3.2
Figure 3.3 Expression of (J-galactosidase/NSm fusion 
proteins.
E. coli DH5a cells were transformed with pUEX3 and pUEX3/NSm 
recombinant plasmids. Transformed cultures were maintained 
at 30°C and shifted to 42°C for 2 hr to induce synthesis of 
fusion proteins (see Methods). Controls were kept at 30°C. 
The cells from both the induced and the uninduced cultures 
were pelleted, dissolved in protein dissociation buffer and 
electrophoresed on a 10% polyacrylamide gel. The gel was 
then stained with Cooma^Le brilliant blue. Lane 1 
represents DH5a cells transformed with pUEX3 and grown at 
30°C. Lanes 2 and 3 represent cultures of recombinant 
pUEX3/NSm plasmids 1 and 2 at 30°C. Lane 4 is the induced 
pUEX3 transformed culture and expression of
cro-p-galactosidase is evident. In lanes 5 and 6, which
represent cultures transformed by recombinant pUEX3/NSm 
plasmids 1 and 2, after induction at 42°C respectively, two 
extra bands which are absent in uninduced cultures can be 
seen. The lower band is most likely cro-p-galactosidase; it 
is slightly larger than the commercial 3-galactosidase 
marker shown in lane 7, because it is a cro-3-galactosidase 
fusion protein. The upper band is of the size expected for 
a fusion of cro-3~galactosidase and NSm.
F
I I
Figure 3.3
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Synthesis of branched peptides to NSm
Two branched peptides, M245 and M246, were synthesised 
as described in the Methods Section. Branched peptide M245 
and M246 corresponded to amino acids 349 to 364 and 417 to 
430, respectively, and are shown schematically in Fig 3.4A.
The amino acid sequence for branched peptide M245 is:
(TDQKYTLDEIADVLQA)eKA
and for M246:
(NMYHSKKSIKYVGD)8KA
The branching tree of the peptides is shown in 
Fig 3.4B.
After synthesis, the branched peptides were analysed 
for their amino acid content and the results for branched 
peptide M245 is shown in Table 3.1A and peptide M246 in 
Table 3.IB.
Characterisation of antisera to fusion proteins
Two New Zealand white rabbits codenamed 1/2 and 2/2 
were immunized subcutaneously with macerated polyacrylamide 
gel slices containing the fusion proteins, as described in 
the Methods Section. After the final bleed, sera were 
characterized by radioimmunoprecipitation assay of BUN 
infected cell lysates and by an enzyme linked immunosorbent 
assay to the branched peptides from the NSm coding region. 
In radioimmunoprecipitation experiments the sera from 
rabbits inoculated with the fusion proteins of
3-galactosidase/NSm failed to react with NSm in BUN infected 
cell lysates or in lysates of cells infected with 
recombinant vaccinia viruses containing the M segment cDNA 
(data not shown).
Figure 3.4 Branched peptides M245 and M246.
Branched peptides M245 and M246, spanning codons 349 to 364 
and 417 to 430 of the BUN M segment ORF, respectively, and 
of amino acid sequences shown in Fig 3.4A were synthesised 
by the flow Fmoc chemistry. The peptides were synthesised 
onto a branched lysine core which was coupled onto an 
alanine residue generating eight identical branches, as 
shown in Fig 3.4B. X indicates the position of either 
peptide M245 or M246.
B ranched  P ep tide  A n tisera  to  NShi
G2 NSM
245
T
246
TDQKYTLDEIADVLQA NMYHSKKSIKYVGD
Branched Peptide Tree
x
Figure 3.4
Table 3.1 Analysis of amino acid composition for branched 
peptide M245 (Table 3.1A) and M246 (Table 3.IB).
The analysis was carried out to determine the concentration 
of amino acids and also the ratio of the theoretical 
composition and the obtained composition.
Table 3.1A
AMINO ACID ANALYSIS OF PEPTIDE M245 
(TDQKYTLDEIADVLQA)s KiA
conc. nmoles/ml ratio expected ratio
ASX N 292.290 2.84 3
THR T 156.238 1.52 2
GLX Q 334.731 3.26 3
ALA A 249.068 2.42 2.13
VAL V 95.567 0.93 1
ILE I 97.492 0.95 1
TYR Y 98.016 0.95 1
LYS K 204.241 1.99 1.8
LEU L 220.126 2.14 2
Table 3.IB
AMINO ACID ANALYSIS OF PEPTIDE M246 
(NMYHSKKSIKYVGD)8K? A
conc. nmoles/ml ratio expected ratio
ASY N 146.770 2.05 2
SER S 121.805 1.70 2
GLY G 90.261 1.26 1
VAL V 84.981 1.19 1
MET M 69.226 0.97 1
ILE I 83.686 1.17 1
TYR Y 143.262 2.00 2
HIS H 72.865 1.01 1
LYS K 301.620 4.26 3
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The two antisera were tested for their ability to 
recognise branched peptide M245 in an enzyme-linked
immunosorbent assay. Antiserum 1/2 showed distinct 
difference between the pre-bleed and the terminal bleed sera 
(Fig 3.5A). Although the optical density values for
antiserum 2/2 were high compared to those of 1/2, there was 
no difference between the pre-bleed and the terminal bleed 
(Fig 3.5B). The sera raised from fusion proteins were
inferior in terms of specificity compared to those raised 
from branched peptides, as will be shown in the next
section. The sera were not used for detection of NSm in
cells.
Characterization of antisera to branched peptides
Branched peptide M245 was used to immunize three
rabbits, designated 1/8, 2/8 and 3/8, at quantities of
lOOpg, 300pg and l,000yg per inoculation, respectively. 
Branched peptide M246 was used to immunize rabbits 
designated 4/8 and 5/8 at lOOpg and 300yg per inoculation, 
respectively. In all cases immunization was via the 
intramuscular route on the hind legs. The advantage of 
using branched peptides is that it is not necessary to 
couple the peptide to a carrier protein or other surface. 
The amounts of peptide were varied since the effective dose 
to generate antisera of good avidity and specificity was
unknown.
After the terminal bleed blood was incubated at 37°C 
for 30 min and then at 4°C overnight. The serum was
separated from the clot and aliquots were kept at 4°C for 
immediate use or at -20°C for long-term storage.
The antisera were characterized by their ability to 
react with NSm in BUN-infected cell lysates or in
recombinant vaccinia virus (expressing the full length M
Figure 3.5 Enzyme-linked immunosorbent assay using 
antiserum to the 3-gal/NSm fusion protein from rabbits 1/2 
and 2/2.
Microtitre plates were coated with branched peptide M245, as 
described in the Methods section. The vertical axis 
represents the optical density values at 405 nm and the 
horizontal axis represents the Ln 2 dilution of double 
antiserum. The open and full-boxed graphs show the readings 
of pre-bleed and terminal bleed, respectively. Fig 3.5A 
represents readings of sera from rabbit 1/2 and Fig 3.5B 
represents readings of sera from rabbit 2/2.
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Figure 3.6 Enzyme-linked immunosorbent assay of antisera 
from rabbits 1/8 and 2/8 to branched peptides.
Microtitre plates were coated with branched peptide M245, as 
described in the Methods section. Rabbit 1/8 was immunized 
with lOOyg of branched peptide M245, whereas rabbit 2/8 was 
immunized with 300pg of branched peptide M245. The curves 
with a dot in the box represent the prebleed sera, the 
curves with the full diamond respresent the pre-terminal 
bleed and the other curves represent the terminal bleed. 
Fig 3.6A represents data of sera from rabbit 1/8 and 
Fig 3.6B data of sera from rabbit 2/8.
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segment) infected cell lysates by radioimmunoprecipitation 
reactions, and some antisera were characterized by enzyme- 
linked immunosorbent assays.
Antisera 1/8 and 2/8 were characterised by ELISA. 
Microtitre plates coated with 5pg of branched peptide 245 
per well were incubated with appropriate dilutions of sera, 
as described in the Methods section (Fig 3.6)
In radioimmunoprecipitations for detection of NSm in 
BUN infected cell lysates, 20pl preiramune serum were 
incubated with lysates in a 800pl reaction for 4 hr at 4°C 
and precleared by incubation with 50pl of Protein A bearing 
Staphylococcus aureus (10%) for 30 min at 4°C followed by 
centrifugation at 13,500 rpm for 1 min. The supernatant was 
transferred to a fresh tube, 5pl of the terminal bleed were 
added and incubated at 4°C overnight on a rotary mixer. The 
mixture was reacted with lOOyl of S. aureus for 30 min at 
4°C and prepared for polyacrylamide gel electrophoresis, as 
described in the Methods section.
As can be seen in Fig 3.7, immune sera from rabbits 
1/8, 2/8, 3/8 and 4/8 immunoprecipitated NSm, but the
preimmune sera did not react. The G1 and other host bands 
can also be seen but these are present in both preimmune and 
immune sera. The 2/8 antiserum appeared to recognise NSm 
more strongly than the other three and this antiserum was 
used in further experiments.
Infected cells were processed for indirect 
immunofluorescence, as described in the Methods Section. 
After the last wash, goat anti-rabbit IgG fluorescein 
isothiocyanate 50pl (diluted 1:100 in PBS and microfuged at 
13,500 rpm for 5 min) was overlaid on the coverslips and 
incubated for 30 min at room temperature. The coverslips 
were washed four times in PBS and overlaid with 50pl of 
wheat germ agglutinin rhodamine isothiocyanate conjugate 
(diluted 1:100 in PBS) and incubated at room temperature for
Figure 3.7 Characterisation of antipeptide sera to NSm.
BHK-21 cells infected with BUN were labelled at 24 hrs for 
4 hrs with 39S-methionine. After removal of nuclei and 
other debris by centrifugation at 13,500 rpm for 5 min, cell 
lysates were pre-cleared by incubation with pre-bleed sera 
for 4 hrs followed by incubation with Staphylococcus aureus 
Protein A for 30 min and centrifuged at 13,500 rpm for 
1 min. The pre-cleared lysates were incubated with antisera 
to branched peptide, M245 represented by 1/8, 2/8 and 3/8 
and to branched peptide 246 represented by 4/8 and 5/8. P 
indicates pre-bleed and T indicates terminal bleed sera. 
The dissociated proteins were fractionated on 15% 
polyacrylamide gels.
Lane 1 is 39S-methionine labelled mock infected whole cell 
lysate; lane 2 is BUN infected whole cell lysate, L, G 1 , N 
and NSm can be observed as indicated. Lane 3 is BUN 
infected cell lysate precipitated with pre-immune serum 
1/8P. Lane 4 is BUN infected cell lysate precipitated with 
immune serum 1/8T. Lanes 5, 7, 9 and 11 are BUN infected
cell lysates precipitated with 2/8P, 3/8P, 4/8P and 5/8P,
respectively. Lanes 6, 8, 10 and 12 represent BUN cell
lysates precipitated with 2/8T, 3/8T, 4/8T and 5/8T,
respectively. It can be observed that except for branched 
peptide 5/8T, all immune branched peptide antisera 
recognised NSm. Other proteins were also precipitated but 
they are present in both the pre-immune and immune 
precipitations.
Figure 
3.7
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30 min then washe four times in PBS. The coverslips were 
immersed in de-ionised water for a few times and then 
mounted on microscope slides in CITIFLOR and examined on 
Nikon Microphat-SA fluorescence microscope, as described in 
the Materials section.
Fig 3.8A shows BUN infected cells labelled with 
rhodamine conjugated wheatgerm agglutinin. The pattern of 
staining is perinuclear and characteristic of the Golgi 
complex. Fig 3.8B shows the same cells as in Fig 3.8A 
processed for indirect immunofluorescence with branched 
antipeptide 2/8 and IgG conjugated fluorescein 
isothiocyanate. The NSm is clearly detectable and there is 
a striking co-localisation of NSm with the rhodamine stained 
Golgi complex. Figure 3.8C are BUN-infected BHK-21 cells 
processed for indirect immunofluorescence using branched 
antipeptide serum 2/8.
In summary, 3-galactosidase-NSm fusion proteins were 
made and used to immunize rabbits to produce antisera to 
NSm. However, the sera produced from fusion proteins were 
not good enough for detection of NSm. On the other hand, 
sera produced using branched peptides to selected sequences 
in the NSm coding region recognised NSm in 
radioimmunoprecipitation and immunofluorescence. The 
branched antipeptide sera helped to demonstrate by immuno­
fluorescence that NSm in BUN-infected cells localises in the 
Golgi complex.
Figure 3.8 Detection of NSm in BUN infected BHK-21 cells.
Cells were infected with BUN and were fixed with 3.7%
formaldehyde and permeabilized with 0.5% NP40 at 24 hrs post 
infection. The cells were processed for indirect immuno­
fluorescence using branched antipeptide antiserum 2/8 and 
fluorescein isothiocyanate conjugated antirabbit IgG. The
cells were also treated with wheat germ agglutinin
conjugated to rhodamine isothiocyanate. Fig 3.8A shows
cells treated with rhodamine wheat germ agglutinin as viewed 
through the red filter at 546nm and shows the cellular 
distribution of the Golgi complex. Fig 3.8B shows the same 
BUN infected cells treated with branched antipeptide
antiserum 2/8 and fluorescein isothiocyanate and viewed at 
480nm. The pattern of distribution of NSm in Fig 3.8B
coincides with the pattern of distribution of NSm in
Fig 3.8A. Fig 3.8C is mock infected cells treated with 
branched antipeptide antiserum.
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Restriction maps and BUN M sequence ttHin back of thesis.
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SECTION TWO
EXPRESSION OF THE BUN MIDDLE RNA SEGMENT
The BUN middle RNA segment encodes two glycoproteins G1 
and G2 and a non-structural protein referred to as NSm. 
These proteins are thought to be derived from a polypeptide 
precursor which is probably processed co-translationally to 
give rise to the mature products. The polypeptide precursor 
has not been detected in virus infected cells, which 
suggests that cleavage is a cotranslational event 
(Pennington et al, 1977; Lees et al, 1986). Attempts to 
translate BUN M RNA specific mRNA in vitro were unsuccessful 
(Abraham and Pattnaik, 1983; Elliott, 1985) though the 
reasons for this are unclear. However, it has been possible 
to translate in vitro M segment mRNA of UUK isolated from 
infected cells (Ulmanen et al, 1981) and mRNA of RVF 
transcribed from recombinant plasmid DNA (Suzich and 
Collett, 1988).
One of the aims of this project was to express the 
middle RNA segment gene products from a cloned complementary 
DNA (cDNA). The cDNA had been made by J. F. Lees 
(Lees et al, 1986) and cloned in to pUC9, and referred to as 
PBUN205. The full length cDNA is 4458 base pairs long with 
56 non-coding base pairs at the 5' end and 103 non-coding 
base pairs at the 3' end. It has an ATG initiation codon at 
position 57-59 and a TGA termination codon at position 
4356-4358.
Two expression strategies were employed; in vitro 
translation in rabbit reticulocyte or wheatgerm cell free 
systems, and expression in mammalian cells using recombinant 
vaccinia virus.
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Attempts to translate in vitro BUN M segment mRNA
Translation of M segment mRNA in cell free systems in 
the presence or absence of canine pancreatic microsomal 
membranes would give an indication as to whether the primary 
translation product was cleaved cotranslationally or post- 
translationally. This would be revealed by the presence of 
a precursor uncleaved polypeptide or mature processed 
products in polyacrylamide gels.
Since the failure to translate BUN M mRNA isolated from 
infected cells (Lees et al, 1986) may have been due to the 
low amounts synthesised in cells, an attempt was made to 
translate BUN M mRNA produced from a cloned BUN M cDNA. The 
full length M cDNA was cloned under control of bacteriophage 
T3 or T7 promoters in plasmid vectors, in order to 
synthesise BUN M mRNA in vitro by run-off transcription.
Construction of pTZ BUN M
The pTZ18U and pTZ19U transcription vectors have a T7 
RNA promoter and are represented in Fig 4.1.
The pBUN205 plasmid DNA was obtained from 
Dr R. M. Elliott. The BUN M cDNA insert was removed from 
pBUN205 by digestion with Pstl. pTZ18U or pTZ19U DNA^as 
linearised with Pstl and dephosphorylated with calf alkaline 
intestinal phosphatase at 37°C for 30 min. The insert was 
ligated with the vector overnight at room temperature using 
T4 DNA ligase. E.coli JM101 or DH5a were transformed with 
the ligation mixture, plated out on agar plates and 
incubated at 37°C overnight. The colonies were analysed by 
miniprep, as described in the Methods Section. It was 
apparent that there was contaminating intact pBUN205 in the 
ligation mixtures. This problem was overcome by digesting 
pBUN205 with both Pstl and Haell to prepare the M cDNA 
insert. Haell cuts three times in the pUC9 backbone but
Figure 4.1 Schematic representation of the pTZ18U, pTZ19U, 
pT7T318U and pT7T319U transcription vectors.
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there are no sites in the BUN M cDNA. The insert was 
ligated with vector and 21 out of 70 colonies analysed (30%) 
contained recombinant plasmids, as demonstrated by digestion 
with Pstl which gave two fragments of ~4.5kb and 2.7kb. The 
orientation of insert was determined by digesting with 
Hindlll which would yield fragments of 6.7kb and 0.3kb if 
the M cDNA had been inserted in the wrong orientation 
relative to the T7 RNA promoter or about 4. 3kb and 2.9kb if 
the cDNA had been inserted correctly. All recombinant 
plasmids obtained had inserts in the wrong orientation to 
the T7 RNA promoter. The experiment was repeated several 
times and similar results were obtained.
It was decided to use a dual promoter transcription 
vector, pT7T3, which has T7 and a T3 RNA promoters on either 
side of the polylinker (Fig 4.2). This was an attractive 
vector because the actual orientation did not matter as 
either the T7 or T3 RNA polymerase could be utilized to 
synthesise the message-sense RNA transcripts.
Construction of pT7T3 BUN M  and in vitro transcription and 
translation of M  segment mRNA
The insert and vector were prepared essentially in the 
same way as described for the pTZ vectors using Haell and 
Pstl digestion. After ligation, 45 minipreps were analysed. 
Six had inserts, as revealed by digestion with Pstl and all 
were inserted such that message-sense RNA would be 
transcribed from the T3 RNA promoter (orientation determined 
by digestion with Hindlll) . The orientation was further 
confirmed by plasmid dideoxy nucleotide sequencing, as shown 
in Fig 4. 3.
RNA transcripts were made by run-off transcription 
using T3 RNA polymerase. The plasmid was cut either with 
Hindlll at nucleotide 4326, or Ncol at nucleotide 3608, or 
Bglll at nucleotide 2800, or PvuII at nucleotide 2467, or 
Hpal at nucleotide 1211. Transcripts were analysed in
Figure 4.2 Construction of pT7T3 BUN M.
The full length BUN M cDNA was cleaved from plasmid pBUN 205 
by digestion with Pstl. The vector sequences in pBUN205 
were cleaved with Haell to facilitate purification of the M 
cDNA fragment. The insert was cloned into the Pstl site of 
the pT7T3 vector.
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Hae II
Pstl
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Figure 4.3 Plasmid dideoxy sequence of pT7T3 BUN M.
Single stranded DNA template was generated by incubation 
with 0.2M NaOH. The template was annealed with the 
Universal primer and labelling reactions carried out by 
T7 DNA polymerase, as described in the Methods section. 
Track are GATC from left to right. The Pst I site and start 
(AGTAGT) of the BUN M segment cDNA are indicated.
|  BUN M ATG
C/GGG I 
derived
from
cloning
R.M.E.
personal
comm.
AGTAGTGTACTACCGATACATCACAA
'  | Pstl(CTGCAG)
| BamH1 (GGATCC) 
Sma1 (CCCGGG)
Plasmid DNA dideoxy sequence  of pT7T3BUNM
Figure 4.3
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denaturing methyl mercuric hydroxide agarose gels, stained 
with ethidium bromide, and were of the expected sizes 
(Fig 4.4).
With the possibility that structures in the non-coding 
region at the 5' end of the mRNA might affect translation, 
another construct of pT7T3 BUN M was made from pBUN 204 
which has a deletion from nucleotide 1 to 32 in the 5' end. 
The M cDNA of pBUN 204 also inserted such that mRNA was 
transcribed from the T3 promoter. Run-off transcripts were 
made with truncations at the 3' end similar to those of 
pT7T3 BUN M of the pBUN 205 origin. The transcripts were 
analysed on the same gel as that for pT7T3 BUN M 205, as 
shown in Fig 4.4.
The transcripts were translated in vitro in rabbit 
reticulocyte and wheatgerm systems under various conditions. 
Plasmid DNAs were linearised with Hindlll and either capped 
or uncapped transcripts were synthesised (see Methods). The 
transcripts were used to programme wheat germ or rabbit 
reticulocyte lysates in the presence or absence of 
microsomal membranes (Fig 4.5). A MAG S RNA message, which 
was known to translate efficiently, was included as a 
positive control (Elliott and McGregor, 1989) . The MAG N 
protein was synthesised in rabbit reticulocyte lysate 
system, lane 2, and in wheatgerm system, lane 8. Capped 
transcripts derived from pT7T3 BUN M 205 and 204 in lanes 3 
and 4, respectively, failed to translate. When membranes 
were added to capped transcripts, no translation products 
were observed (lanes 5 and 6). Attempts to translate the 
transcripts in wheatgerm was also unsuccessful (lanes 9 and 
10) .
Truncated transcripts from plasmids cut with Hindlll, 
Ncol, Bglll, PvuII and Hpal were also not translated in the 
rabbit reticulocyte system, as shown in Fig 4.6. MAG and 
BUN S messages were translated under the same conditions to 
yield N protein. This suggested that the inability to
Figure 4.4 In vitro transcription of pT7T3 BUN 205 and
pT7T3 BUN 204.
Run-off transcripts were made using T3 RNA polymerase after 
truncations were made on the cDNA with Hindlll at nucleotide 
4326, Ncol at nucleotide 3608, Bglll at nucleotide 2800, 
PvuII at nucleotide 2467 and Hpal at nucleotide 1211. 
Transcripts were analysed in denaturing methyl mercuric 
hydroxide agarose gels and stained with ethidium bromide. 
The MAG S cDNA was included as a positive transcription 
control (last lane). The restriction map showing sites used 
to make truncations are shown in this Figure.
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Figure 4.5 In vitro translation of pT7T3BUNM derived RNA.
Plasmids pT7T3BUN205 and pT7T3BUN204 were linearised with 
Hind III and run-off transcripts made using T7 RNA 
polymerase. Transcripts were translated in rabbit 
reticuloycte lysate and wheat germ in the presence (lanes 5 
and 6) or absence (lanes 3 and 4) of microsomal membranes 
and labelled with 33S-methionine. Lane 1 is mock-infected 
BHK cell proteins; lane 2 is rabbit reticulocyte lysates 
programmed with MAG S RNA. Lanes 3 and 4 are lysates 
programmed with capped RNAs derived from pT7T3BUN205 and 
pT7T3BUN204, respectively. Lanes 5 and 6 are lysates 
programmed with capped RNAs derived from pT7T3BUN205 and 
pT7T3BUN204, respectively, in the presence of microsomal 
membranes. Lane 7 is lysates to which only water was added. 
Lane 8 is wheat germ programmed with MAG S RNA. Lanes 9 and 
10 are wheat germ programmed with RNAs derived from 
pT7T3BUN205 and pT7T3BUN204, respectively.
Figure 4.5
Figure 4.6 In vitro translation of mRNAs transcribed from
PT7T3BUN205 and pT7T3BUN204.
Plasmids pT7T3BUN205 and pT7T3BUN204 were linearised with 
Hind III at nucleotide 4326, Ncol at nucleotide 3608, Bglll 
at nucleotide 2800, PvuII at nucleotide 2467 or Hpal at 
nucleotide 1211. Run-off transcripts were made as
illustrated in Fig 4.4 and translated in rabbit reticulocyte 
lysates. Track 1 is mock-infected BHK-21 cell proteins; 
tracks 2 and 3 are rabbit reticulocyte lysates programmed 
with MAG and BUN S RNAs, respectively. Tracks 4, 5, 6, 7 
and 8 are rabbit lysates programmed with RNAs derived from 
PT7T3BUN205 linearised with Hindlll, Ncol, Bglll, PvuII and 
Hpal, respectively. Tracks 9, 10, 11, 12 and 13 are lysates 
programmed with RNAs derived from pT7T3BUN204 linearised 
with Hindlll, Ncol, Bglll, PvuII and Hpal, respectively.
Figure 4.6
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translate BUN M transcripts was caused by intrinsic factors 
in the M RNA segment. The addition of cap analogues did not 
improve translatability in the rabbit reticulocyte system.
Construction of pT7T3 BUN M  BamHI and in vitro expression
An attempt was made to translate in vitro M segment RNA 
derived from the internal BamHI fragment, i.e. bases
1352-4001. This was to test the suspicion that the failure 
to translate full length mRNA may have been due to the 
sequences at the 5' end especially in the G2 region.
The BUN M cDNA fragment from nucleotide 1352 to 4001 
has an in frame ATG at nucleotides 1430-1432. The fragment 
was inserted into the BamHI site of the pT7T319U vector. 
Determination of orientation of insertion indicated that all 
recombinants would make message-sense RNA from the T3 RNA 
promoter.
Run-off transcripts were synthesized, after linearising
the plasmid with Hindlll, or Pstl using T3 RNA polymerase.
Transcripts were translated in a rabbit reticulocyte system
in the presence or absence of dog pancreatic microsomal
membranes, as described in the Methods section. As can be
seen in Fig 4.7, a protein of about 90K was made in the
^^rf.ions Droarammed with the synthetic RNAs and this 
which was of the size expected
protein^was nor seen m  the control in which water had been 
added instead of RNA.
Half of the material was subjected to 
radioimmunoprecipitation using a polyclonal antiserum to 
BUN. As can be seen in Fig 4.8, the 90K protein was 
specifically recognised by the antiserum showing that the 
protein was related to the BUN M RNA segment gene products.
In vitro translation of BUN M RNA was not satisfactory 
for the study of the biogenesis of the G1 and G2 
glycoproteins and NSm. Full length RNAs were not translated
Figure 4.7 In vitro translation of the BUN M BamHI internal 
fragment.
Transcripts were made from Hindlll and Pstl linearised 
plasmid containing the internal BUN M BamHI fragment and 
translated in a rabbit reticulocyte lysate system. Lane 1 
represents rabbit reticulocyte lysates to which only water 
was added. Lanes 2 and 3 are lysates programmed with RNA 
derived from plasmid pT7T3 containing the internal BUN M 
BamHI cDNA linearised with Hindlll in the absence or 
presence of microsomal membranes, respectively. Lanes 4 and 
5 are lysates programmed with RNA derived from a plasmid 
pT7T3 containing the BamHI cDNA linearised with Pstl in the 
absence or presence of microsomal membranes, respectively.
1
T7
Hind III
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Figure 4.7
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whereas an internal RNA sequence yielded a protein which was 
recognised by a BUN antiserum. This suggests that sequences 
at the 5' end of the full length mRNA may inhibit 
translation in vitro, but this has not been investigated 
further. It was therefore decided to attempt to express
BUN M RNA gene products in vivo using the vaccinia virus
expression system.
Expression of the BUN M RNA gene products by recombinant 
vaccinia viruses
The system used was that described by Fuerst et al 
(1987). This involved the construction of a recombinant
vaccinia virus containing the BUN M gene flanked by
bacteriophage T7 promoter and terminator sequences. 
Expression of the target gene would occur when cells were 
co-infected with a second recombinant vaccinia virus which 
contains the bacteriophage T7 RNA polymerase gene under the 
control of a vaccinia virus promoter.
Construction of d TF7-5 BUN M
pTF7-5 is a vaccinia virus transfer vector which has 
bacteriophage T7 RNA promoter and terminator sequences 
flanked by vaccinia virus TK sequences for recombination in 
the TK locus of the vaccinia virus genome. The vector was 
prepared by cutting with BamHI and filling in the 5' 
overhangs using the Klenow fragment of DNA polymerase I.
The BUN M insert was obtained by digesting pBUN205 with 
Pst I and Hae II. The Pstl 3' overhanging ends were filled
in using T4 DNA polymerase. The blunt-ended vector and 
insert DNAs were ligated using T4 DNA ligase at room 
temperature overnight. E.coli DH5a cells were transformed 
with the ligation mixture, as described in Methods, and 
miniprep analyses performed on overnight cultures. The 
presence of the insert was tested for by digestion with 
Hind III. One hundred and ninety minipreps were performed
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and none of the colonies picked carried a recombinant 
plasmid. Repeated efforts of ligations, refilling and 
religating failed to give rise to recombinant molecules.
An alternative approach was therefore attempted, 
starting with an internally deleted fragment of the BUN M 
cDNA derived from pT7T3pMlldl3. This construct contains M 
segment sequences from position 32 to the BamHI site at 1352 
and from the BamHI site at position 4001 to the end of the M 
segment cDNA (Fig 4.9)
The insert from pT7T3pmlldl3 was removed by Pstl 
digestion, blunt-ended using T4 DNA polymerase and ligated 
with BamHI cut and Klenow filled in pTF7-5 DNA (Fig 4.9). 
DH5a cells were transformed with the ligation mixtures and 
plated on agar plates. Twenty four colonies were picked and 
one had the insert with the correct orientation relative to 
the T7 promoter, as shown by digestion with Hindlll. The 
orientation of the insert was confirmed by plasmid dideoxy 
DNA sequencing, as shown in Fig 4.10. The construct was 
further digested with BamHI which showed the presence of 
only one BamHI site, i.e. in the BUN M cDNA.
This clone, pTF7-5/dl3M, was digested with BamHI so 
that the 2.7kb missing fragment of BUN M cDNA (bases
1353-4000) could be inserted. Forty eight colonies were 
picked after ligation of pTF7-5/dl3M with the 2.7kb BamHI 
fragment. All had the 2.7kb fragment insert but in opposite 
orientation to the promoter. This apparent persistence of 
the M segment fragments against the bacteriophage T7 RNA 
promoter could not be explained and was at best frustrating.
However, careful reexamination of the plates revealed 
some tiny colonies that were less than one third of a 
millimetre in diameter. Twenty four of these were picked 
and prepared for miniprep analyses. Twenty one of them had 
inserts and fifteen had the M cDNA correctly assembled. One
Figure 4,8 Immunoprecipitation of the translation products 
of the internal BamHl fragment of BUN M.
The translation products were immunoprecipitated with anti- 
BUN sera, as described in the Methods section. Lanes 1 and 
3 are lysates programmed with RNA derived from plasmid pT7T3 
containing the internal BUN M BamHI cDNA fragment linearised 
with Hindlll in the absence or presence of microsomal 
membranes, respectively. Lanes 5 and 7 are lysates 
programmed with RNA derived from the plasmid linearised with 
PstI in the absence or presence of microsomal membranes. 
Lanes 2, 4, 6 and 8 are immunoprecipitates of translation 
products in lanes 1, 3, 5 and 7, respectively. Lane 9 is
the immunoprecipitate of protein from lysates to which only 
water was added.
Figure 4.8
Figure 4.9 Construction of pTF7-5 BUN M.
A BUN M cDNA with a deletion from nucleotide 1352 to 
nucleotide 4001 was obtained by digesting pT7T3pmlldl3 with 
Pstl. The PstI 3' overhang ends were filled in with T4 DNA 
polymerase. The fragment was cloned into Klenow filled-in 
BamHI site of the pTF7-5 vector. The construct was
linearised with BamHI and ligated with the missing BamHI 
2.7kb BUN M fragment.
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Figure 4.10 Plasmid DNA dideoxy sequence of pTF7-5/pmlldl3.
The sequence was determined by the T7 DNA polymerase, as 
described in the Methods section. This showed that the 5' 
end of BUN M cDNA had been placed under the control of the 
bacteriophage T7 RNA promoter. Tracks are GATC from left to 
right.
•  i
*r-
i
lATG for BUN M gene product
AGACACCATCTTTATTT e.t.c.
Filled-in BamHI site
Plasmid DNA dideoxy sequence  of pTF7-5/d13
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clone was designated pTF7-5 BUN M, and grown in bulk for 
recombination experiments with vaccinia virus.
Generation and characterisation of vaccinia virus BUN M
recombinants
Recombinant viruses were prepared by infecting CV-1 
cells with vaccinia virus strain WR and transfecting the 
infected cells with calcium phosphate precipitated 
pTF7-5 BUN M plasmid DNA. Selection of recombinants was 
made by plaque assay on TK~ cells in the presence of BUdR, 
as described in the Methods Section. Plaques were picked 
and grown in TK- cells in 24 well Limbro plates in the 
presence of BUdR. Plaques which exhibited c.p.e. were
regrown in TK- cells in the presence of BUdR and total 
cellular DNA was isolated for dot blot analysis on
nitrocellulose filters. Replicate filters were hybridised 
with 32P-labelled pBUN205 DNA or with 32P-labelled pTF7-5 
DNA, as shown in Fig 4.11. Out of the three isolates which 
appeared to be recombinants, numbers 4 and 6 were subjected 
to Southern analysis by digesting with BamHI and EcoRI, then 
running the samples on agarose gels and transferring the DNA 
to nitrocellulose filters. The filters were hybridised with 
32P-labelled pT7T3 BUN M DNA and the result is shown in 
Fig 4.12. The 2.7kb BamHI and 2.16kb EcoRI internal 
fragments could clearly be seen, indicating that 
recombination had occurred. Recombinant viruses referred to 
as recBUN M were grown in bulk and semi-purified, as 
described in the Methods Section.
Characterization of proteins synthesised by recombinant 
vaccinia virus
In order to investigate whether the positive 
recombinant viruses, as demonstrated by dot blot and 
Southern blot analyses:, synthesised the gene products of the 
M segment of BUN, CV-1 cells were infected with both 
recBUN M and vTF7-3 (dual vaccinia virus). Infected cells
Figure 4.11 Characterization of vaccinia virus BUN M
recombinants by dot blot hybridization.
Putative recombinant vaccinia viruses that exhibited c.p.e. 
in TK‘143 cells in the presence of BUdR were further grown 
in TK"143 cells. Total cellular DNA was isolated and 
transferred onto nitrocellulose filters. The filters were 
hybridized either with 32P-labelled pBUN205, as shown in 
Fig 4.11A, or with 32P-labelled pTF7-5, as shown in
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Figure 4.12 Southern blot analysis of recombinant vaccinia 
virus recBUNM.
Putative vaccinia virus recombinants containing BUN M cDNA, 
designated 2, 4, 5, 6 and 9, which exhibited c.p.e. in
TK-143 cells in the presence of BudR were analysed by 
Southern blotting of DNA extracted from infected CV1 cells. 
The DNA was digested with BamHI or EcoRI, separated in a 
0.8% agarose gel and transferred to a nitrocellulose filter. 
The filter was hybridized with 32P-labelled pT7T3BUNM DNA. 
Lanes 1 and 7 are pBUN205 digested with BamHI and ECoRI, 
respectively, as markers. Lanes 3 and 5 represent samples 4 
and 6 cut with BamHI and lanes 9 and 11 are the same samples 
digested with EcoRI. These two samples are the ones that 
gave a positive signal in the dot blot experiments 
(Fig 4.11). The difference in migration between the 2.7kb 
BamHI fragment and the ECoRI 2.149kb of BUN M can clearly be 
seen in both samples. This result confirms the dot blot 
result that samples 4 and 6 contained recombinant vaccinia 
virus.
BamHI EcoRI
2 3 4 5  6 7  ,8 SL 1Q 1,1 1?
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were labelled with 3sS-methionine from 14 to 18h post
infection and cell extracts analysed by SDS-polyacrylamide 
gel electrophoresis.
The optimum multiplicity of infection was determined by 
infecting monolayers at multiplicities of 1, 5 and
10 pfu/cell of each vaccinia virus. It was observed that
infecting cells at multiplicities of 10 for each recombinant 
vaccinia virus was ideal because at this level of infection, 
most of the host protein synthesis was shut off and a sharp 
protein band that co-migrated with authentic G1 protein 
could be seen, as in Fig 4.13. This protein band was absent 
in cell lysates separately infected with recBUN M or VTF7-3 
viruses. Better separation was observed when 10% gels were 
used, as shown in Fig 4.14. Note that in this experiment G2 
was not detected (G2 has previously been reported to be 
variably detected in BUN-infected cells; Elliott, 1985) and 
NSm would have travelled with the dye front on this gel. It
was also observed that the intensity of the T7 polymerase
band diminished in the dually infected cells while other 
vaccinia virus proteins remained relatively the same.
To determine the authenticity of the proteins 
synthesized, fractionated proteins in a polyacrylamide gel 
were electrotransferred onto nitrocellulose filters and 
analysed by Western blotting. The anti-BUN serum recognised 
the G1 and N proteins in the BUN-infected cell lysates 
(Fig 4.15, lane 2) and a protein that co-migrated with the 
authentic G1 protein in the dual vaccinia infected virus 
cell lysates (lane 3). A similar protein was absent in 
cells individually infected with recBUN M and VTF7-3 
recombinant vaccinia viruses (lanes 4 and 5, respectively).
To further confirm the authenticity of G1 and to detect 
NSm, radiolabelled cytoplasmic extracts were prepared from 
dual vaccinia virus, BUN, or mock-infected cells and reacted 
with anti-BUN, anti-peptide or preimmune sera, and analysed 
in a 15% polyacrylamide gel (Fig 4.16). G1 was precipitated
5
Figure 4.14^ Determination of optimal multiplicity of 
infection for the dual recombinant vaccinia viruses 
expressing the M segment.
CV-1 cells were mock infected, infected with BUN at pfu of 
5/cell and variously infected with 1, 5, 10 pfu/cell of each 
recBUN M and vTF7-3. Cells were labelled with
33S-methionine and fractionated on a 12% polyacrylamide gel. 
Lane 1 represents mock infected cells, lane 2 is BUN 
infected cells, lanes 4 and 7 are vTF7-3 and recBUN M 
recombinant vaccinia viruses, respectively. Lanes 5, 6 and 
3 are dually infected cells with vaccinia viruses at 1, 5 
and 10 pfu/cell, respectively. The level of expression of 
G1 at 1 and 5 pfu/cell looked similar. Expression of G1 was 
reduced at 10 pfu/cell but the host background was also 
reduced.
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Figure 4 . 1 ^  Expression of M gene in recombinant vaccinia 
virus.
CV-1 cells were infected with recBUN M and vTF7-3 at 
multiplicities of 10 pfu/cell, dually or individually. The 
cells were also mock infected or infected with BUN at 
5 pfu/cell. The infected cells were labelled with 
33S-methionine in 35 mm dishes with 100pCi/dish at 24 hr 
post infection for 4 hrs. The cells were dissociated in 
protein dissociation mix, boiled and run in a 10% 
polyacrylamide gel. Lane 1 is the mock infected cell 
lysate. Lane 2 is the BUN infected, cell lysates, G1 and N 
proteins can clearly be identified. Lane 3 is the dual 
recBUN M/vTF7-3 vaccinia virus infected cell lysate and a 
protein that co-migrates with authentic BUN G1 can be seen. 
This protein is absent from the individually recBUN M and 
vTF7-3 infected cells, which are represented in lanes 4 and 
5, respectively.
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Figure 4.15 Western blot analysis of proteins synthesised 
in recBUN M and vTF7-3 recombinant dual expression system.
CV-1 cells were infected with BUN at 5 pfu/cell, with 
recBUN M and vTF7-3 at 10 pfu of each per cell and with 
recBUN M and vTF7-3 individually at 10 pfu/cell. Infected 
cells were harvested at 24 hrs post infection, lysates run 
in a 12% polyacrylamide gel and electrotransferred on a 
0.45pm nitrocellulose filter. The filter was reacted with 
rabbit anti-BUN serum at a dilution of 1:100 for 30 min. 
The proteins were visualised by incubating the filter with 
anti-IgG horseradish peroxidase diluted 1:2,500 and reacted 
with 4-chloro-l-naphthol substrate. Lane 1 is mock infected 
cell lysate. Lane 2 is BUN infected cell lysate and G1 and 
N can clearly be seen. Lane 3 is the dual recombinant 
recBUN M and vTF7-3 infected cell lysate, and a protein that 
co-migrates with authentic BUN G1 can be seen. This protein 
is absent in lanes 4 and 5 which are recM BUN M and vTF7-3 
infected cell lysates, respectively.
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Figure 4.16 Radioimmunoprecipitation of recombinant 
vaccinia virus infected cells.
CV-1 cells were infected with BUN or dual recombinant
vaccinia viruses recBUNM and vTF7-3. Cell lysates were 
precipitated with polyclonal anti-BUN serum or branched
antipeptide sera M245 or M246. Lane 1 is mock infected
whole cell lysate, lane 2 is mock infected cell lysate
reacted with anti-BUN serum. Lane 3 is the whole cell 
lysate of BUN infected cells, G 1 , N and NSm can be
identified. Lane 4 is the BUN infected cell lysate 
immunoprecipitated with anti-virion serum; G1 and N are 
recognised by the antiserum. Lane 5 is BUN infected cell 
lysate reacted with branched antipeptide serum M245; NSm is 
clearly precipitated by the antipeptide serum. Lane 6 is 
dual vaccinia virus lysates precipitated by anti-BUN serum, 
G1 is identifiable. Lane 7 is the dual vaccinia virus
infected cell lysate. Lanes 8 and 10 are dual vaccinia 
virus infected cell lysates reacted with pre-bleed of M245 
and M246, respectively. Lanes 9 and 11 are dual vaccinia 
virus infected cell lysates with the immune sera of M245 and
M246, respectively; NSm is precipitated with the immune sera
and not the non-immune.
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from dual vaccinia virus infected cells by antt'BUN serui1 
(lane 6) but G2 was not detected in either ^©'combinan^ 
vaccinia virus or BUN-infected cells (lanes 4 a^ dl 6). Th? 
anti-peptide sera precipitated NSm from dual vac-inia viru? 
infected cell extracts (peptide M245, lane 9 and M246-
lane 11). There was a marked background precipitation o:: 
mainly vaccinia virus proteins. However, comp*rif3on wit? 
the pattern given by the preimmune serum (lane* 8 and 10* 
suggests that the precipitation of NSm is specif ic: to th? 
immune serum. Some G1 was also precipitated fbom th£
recombinant vaccinia virus infected cells by the NSm serum’ 
this was not observed using the BUN infected zell lysate
(lane 5) . This result demonstrated that the polyproteii1 
precursor was made and properly processed.
Transient expression of M, G 1 , G2 and NSm ‘CQnes of
Bunvamwera virus
An alternative expression system, which opviates th£ 
need to make a recombinant vaccinia virus, is that 'described 
by Fuerst et al (1986; 1987) which involves transfection of 
cells with T7 promoter plasmid DNA and infection with th£ 
recombinant vaccinia virus which synthesises ba£teriophag#
T7 RNA polymerase. Constructs of the full lengtP M  segment
cDNA and its truncations representing G 1 , G2 afld NSm werS 
made by placing the genes under the control of the
bacteriophage T7 promoter.
Plasmid DNA containing a particular BUN CDNA was
introduced into the cytoplasm of cells infected with
vaccinia virus VTF7-3 which synthesises T7 RNA polymerase,* 
as described in the Methods Section. cells were
radiolabelled at 4 hr post-transfection with 3 8 S-'Hiethlonind
for 4 hr or processed for indirect immunofluofescence at:
8 hr post-transfection.
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Construction and transient expression of the full length M  
cDNA under control of T7 RNA promoter
The M segment cDNA, under the control of the T3 
promoter in the pT7T319U transcription vector, was removed 
by restriction enzmye digestion with Smal and Pstl. The 
fragments were separated in preparative 1% agarose gel. The 
gel slice with the fragment of interest was excised and the 
DNA purified by the silica matrix adsorption and elution 
method as described in the Methods Section. A pT7T318U 
Smal/PstI vector was prepared and the fragments ligated 
using T4 DNA ligase (Fig 4.17). This "forced cloning" 
placed the M cDNA under control of the T7 promoter.
A construct with insert in the correct orientation was 
transiently expressed in CV-1 cells and proteins synthesised 
were characterised by radioimmunoprecipitation. As can be 
seen in Fig 4.18, the G1 glycoprotein transiently expressed 
from the full length M cDNA was recognised by anti BUN serum 
(lane 6). The transiently expressed G1 also co-migrated 
with authentic G1 immunoprecipitated in BUN infected cell 
extracts (lane 4). The G2 glycoprotein could not be seen 
for reasons already mentioned above. The NSm protein would 
have come off the gel and cannot, of course, be recognised 
by the anti BUN serum in immunoprecipitation reactions.
Construction of PT7T3/G1 and transient expression of G1
The predicted sequence of the G1 gene has the amino 
terminal end at nucleotide 1485 and carboxy end at 
nucleotide 4358. A fragment containing all G1 coding 
sequences would have been obtained by digesting the BUN M 
cDNA with BamHI and Pstl which cut at nucleotides 1352 and 
4458, but there is another BamHI site at nucleotide 4001. 
Hence, pT7T319U was digested with BamHI and Sail and ligated 
with BamHI/Sall BUN M cDNA fragment from bases 1352 to 1641. 
This construct was then used to insert the rest of the cDNA
Figure 4.17 Construction of BUN M cDNA under the control of 
the T7 RNA promoter.
The BUN M cDNA which previously was under the control of the 
T3 promoter in the pT7T319U vector was removed by digestion 
with Smal and Pstl and ligated into the Smal/PstI site of 
pT7T318U vector.
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Figure 4.18 Transient expression of the full length BUN M 
cDNA.
The full length BUN M cDNA under the control of the 
bacteriophage T7 RNA promoter was transfected into CV-1 
cells infected with the vTF7-3 vaccinia virus. Cells were 
labelled 4 hr post transfection with 35S-methionine for 4 hr 
and analysed by immunoprecipitation using anti-BUN serum. 
Lane 1 is mock infected whole cell lysate/ lane 2 is mock 
infected cell lysate reacted with anti-BUN serum. Lane 3 is 
BUN infected whole cell lysate, lane 4 is BUN-infected cell 
lysate precipitated with anti-BUN serum; G1 and N can be 
clearly identified. Lane 5 is the whole cell lysate of 
transfected cells and lane 6 is the immunoprecipitate of 
material from lane 5; the G1 glycoprotein is identifiable.
Figure 4.18
108
which encodes G 1 f i.e. from Sail (1641) to PstI (4458) with 
an in-frame ATG at bases 1430-1432 (Fig 4.19).
pT7T318U DNA was cut with Smal and PstI and a Smal/PstI 
G1 fragment (bases 1352-4001) from pT7T319U BUN M was 
obtained and ligated with the vector. This enabled the G1 
fragment to be placed under the control of the T7 RNA 
promote in pT7T318U (Fig 4.19). The G1 protein was
efficiently expressed, as shown in Fig 4.20, lane 8. The
protein was precipitated by the anti-virion serum and 
co-migrated with G1 made by the virus (lane 4) and by 
recombinant dual vaccinia virus (lane 6).
A time course of the transient expression of G1 was 
carried out and samples prepared for radioimmuno- 
precipitation at 4, 6, 9 and 12 hrs post infection. The
highest amounts of G1 were observed ^  4 and
decreased thereafter (Fig 4.21).
The pT7T318U/Gl construct with a deletion from 
nucleotide 4326 (made by digestion with Hind III and 
religating) was transiently expressed, as described above 
(Fig 4.23, lane 8). The protein is slightly smaller than G1 
made by BUN (lane 4) transiently expressed (Gl, lane 6).
Effect of tunicamvcin on glvcosvlation of Gl
CV-1 cells in 33mm dishes were infected in duplicate 
with BUN at 5pfu/cell or with dual vaccinia viruses at 
lOpfu/cell each. The Gl glycoprotein was also transiently 
expressed via vTF7-3 plasmid transfection, as described 
above. After absorption of BUN and dual vaccinia viruses .
and after transfection with the Gl construct under control
of T7 RNA promoter, Eagle's medium containing 5pg/ml of 
tunicamycin (a glycosylation inhibitor) was added to one set
of dishes. The dishes were incubated at 31°C for BUN and
37°C for vaccinia viruses. The medium was removed the 
following day and cell lysates processed for radio-
Figure 4.19 Construction of Gl under the control of T7 RNA 
promoter in pT7T318U.
A BamHI/Sall fragment of BUN M cDNA (nt 1352-1641) was 
ligated into BamHI/Sall linearised pT7T3 19U. This 
construct was linearised with Sall/PstI and ligated with the 
Sall/PstI (nt 1642-4656) fragment of BUN M cDNA. The BUN M 
insert was removed by digestion with Smal/PstI and cloned 
into the Smal/PstI site of pT7T318U, so that Gl mRNA would 
be transcribed from the T7 promoter.
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pT7T318U
Figure 4.20 Transient expression of Gl.
CV-1 cells in 35 mm dishes were infected with recombinant 
vaccinia virus vTF7-3 at MOI of 10 pfu/cell. The infected 
cells were transfected with plasmid pT7T318UBUNGl and 
labelled with 38S-methionine at 4 hr post transfection for 
4 hr. One tenth of the cells were dissociated in protein 
dissociation mix and the remainder was processed for 
immunoprecipitation with anti-BUN serum. Samples were 
analysed in a 10% polyacrylamide gel. Whole cell lysates 
are shown of mock (lane 1), BUN (lane 3), dual vaccinia 
virus infected (lane 5), vTF7-3 infected and transfected 
(lane 7), and vTF7-3 infected (lane 9) cells. Immuno- 
precipitates are shown of of mock (lane 2), BUN (lane 4), 
dual vaccinia virus infected (lane 6), vTF7-3 infected and 
transfected (lane 8), and vTF7-3 infected (lane 10) cell 
lysates. It can be seen that a protein which co-migrated 
with Gl protein in BUN infected and dual vaccinia virus 
infected cells was also synthesised in the transiently 
expressed system for Gl and this protein was recognised by 
BUN antiserum (lane 8).
Figure 4.20
Figure 4.21 Time course of transiently expressed Gl.
Near confluent CV-1 cells in 35 mm dishes were infected with 
vaccinia virus VTF7-3 for 30 mins in OptiMEM and transfected 
with 2.5pg of the plasmid construct pT7T318UBUNGl. Cells 
were labelled with 38S-methionine at 4, 6 and 12 hrs for
4 hrs. One tenth of the cells were dissociated in protein 
dissociation mix and the remainder was processed for 
radioimmunoprecipitation reactions, as described in the 
Methods section. Labelled and immunoprecipitated cell 
lysates were run in 10% polyacrylamide gel and the gel 
processed for autoradiography. Lanes 1, 3 and 5 are whole 
cell extracts labelled at 4, 6 and 12 hrs, respectively. 
Lanes 2, 4 and 6 are the corresponding immunoprecipitated 
cell lysates using the anti-BUN polyclonal serum. The Gl 
glycoprotein was detected at 4 hrs post transfection and the 
rate of synthesis decreased after that. Lane 7 is the 
vaccinia virus vTF7-3 infected cell lysate and lane 8 is the 
immunoprecipitate of vTF7-3 infected cells with anti-BUN 
serum.
Figure 4
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immunoprecipitation using the anti-BUN serum (Fig 4.22). 
The Gl glycoprotein synthesized by dual vaccinia virus 
(lane 4), or transiently expressed (lane 5), co-migrated 
with the BUN synthesized Gl (lane ^ ) . There was no similar 
protein synthesized in mock-infected cell lysates (lane 2).
In the presence of tunicamycin a faster migrating form 
of G l , Glo, was immunoprecipitated from BUN infected 
(lane 7), dual vaccinia virus infected (lane 8) and 
transfected (lane 9) cell lysates. This result shows that 
Gl expressed by dual recombinant vaccinia viruses or by the 
transient expression system was properly glycosylated, as 
demonstrated by the identical size with BUN synthesised G l .
Construction of PTF7-5/G2 and transient expression G2
The first attempt to clone an M cDNA fragment
representing G2 was by digesting pT7T3pmlldll with BamHI 
which cuts at a site at the 5* end of the M cDNA in the 
polylinker and with Bell which cuts at nucleotide 9§1 in the 
M cDNA. This fragment would then be cloned into the BamHI
site of pTF7-5 by sticky-end ligations as the Bell site will
ligate into a BamHI site, although neither site would be 
recreated after ligation. Problems were encountered when I 
tried to cut the cDNA with Bell. This was explained by the 
possible effect of dam methylase which introduces methyl 
groups at the N6 position of adenine in the sequence
5’GATC3’ (Hattman et al, 1978). This renders the enzyme 
Bell unable to cut its recognition site TGATCA 
(Maniatis et al, 1982). Attempts were made to digest 
pT7T3/pmlldll grown in E,Coli GM48 cells, which are dam", 
but only partial digestion could be obtained even with 
prolonged incubation.
The strategy to obtain a G2 M cDNA fragment to clone in 
pTF7-5 was changed and involved cutting pT7T3/plldll with 
Smal which is at the 5' end of G2 in the polylinker and Dral 
which cuts at nucleotide 941 and eight amino acids short of
Figure 4.22 Glycosylation of the Gl protein.
CV-1 cells in 35 mm dishes were mock-infected, infected with 
BUN at 5 pfu/cell, or infected with dual vaccinia viruses at 
10 pfu/cell each. The Gl glycoprotein was also transiently 
expressed via the vTF7-3 vaccinia system. Two dishes were 
prepared for each infection. After absorption Eagles medium 
without methionine was added to one set of dishes and 
contained 5pg/ml of tunicamycin with lOOyCi per dish of 
39S-methionine. The other set contained 33S-methionine but 
no tunicamycin. The dishes were incubated at 31°C for BUN 
infected cells and at 37°C for vaccinia viruses. The medium 
was removed the following day and 10% of the cells were 
dissociated in protein dissociation mix and the remainder 
was prepared for radioimmunoprecipitations using anti-BUN 
serum. Samples were analysed in 10% polyacrylamide gel. 
Track 1 is whole mock-infected cell lysate with tunicamycin. 
Tracks 2 and 6 are immunoprecipitates (IPs) of mock infected 
lysates and mock infected lysates with tunicamycin, 
respectively. Tracks 3 and 7 are BUN infected lysates and 
BUN infected lysates with tunicamycin, respectively. 
Tracks 4 and 8 are dual vaccinia virus infected and dual 
vaccinia virus infected with tunicamycin, respectively. 
Tracks 5 and 9 are transiently expressed Gl and transiently 
expressed Gl in the presence of tunicamycin, respectively. 
The BUN antiserum recognised the Gl glycoprotein in both 
tunicamycin and tunicamycin untreated samples. The Gl 
protein was the same size whether expressed by BUN, dual 
vaccinia virus, or transiently expressed. The Gl protein in 
tunicamycin treated samples (Gl©) migrated faster than in 
untreated samples.
Figure 4.22
Figure 4.23 Transient expression of Gl with a deletion at 
the carboxy-terminus.
The pT7T318U plasmid containing Gl specific sequences under 
control of T7 RNA promoter was digested with Hindlll which 
cuts at nucleotide 4326 in the Gl gene and in the vector 
polylinker, and religated. The deleted Gl was transiently 
expressed and labelled with 38S-methionine, as described in 
the Methods section. Lane 1 is whole mock infected CV-1
cell lysate. Lanes 2, 4, 6, 8 and 10 are immunoprecipitates 
using anti-BUN serum of mock infected, BUN infected, 
transiently expressed G l , transiently expressed truncated Gl 
and vTF7-3 infected cell lysates, respectively. Lanes 3, 5, 
7 and 9 represent whole cell lysates of BUN infected, Gl 
expressed, truncated Gl expressed and vTF7-3 infected, 
respectively. The truncated Gl in lanes 7 and 8 is slightly 
smaller than the full length Gl in lanes 3, 4, 5 and 6.
Figure 4.23
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the predicted boundary of G2 and NSm. This fragment was 
purified by electrophoresis and electroelution in agarose 
gel followed by phenol/chloroform extraction and ethanol 
precipitation. The G2 fragment was ligated into filled-in 
BamHI site of pTF7-5 (Fig 4.24). Miniprep analyses were 
performed to demonostrate presence of insert by restriction 
digestion with EcoRI which would give a pattern of two bands 
(116 and 5115 base pairs) in agarose gels. Candidates with 
inserts were further digested with Hindlll and EcoRI in 
order to determine the orientation of insertion. The 
correct orientation would give fragments of 3.464, 0.861 and 
0.116 kb and the wrong orientation would give 1.554, 
2.771 and 0.116 kb fragments. Out of 36 colonies picked, 
nine had inserts but only one had inserted in the right
orientation as demonstrated by Hindlll digestion and plasmid 
dideoxy DNA seqencing (Fig 4.25).
Recombinant vaccinia viruses were made with G2 as shown 
by DNA dot blots (Fig 4.26) but it was difficult to
demonstrate its expression as radioimmunoprecipitations 
consistently failed to show G2 even in BUN infected cell
lysates. The G2 fragment in pTF7.5 under the control of the 
T7 RNA promoter was transiently expressed using the vaccinia 
vTF7-3 system and expressed products analysed by indirect 
immunofluorescence, using the BUN polyclonal antiserum.
Fluorescence was observed in transfected cells (Fig 4.27A) 
and not in mock-infected (Fig 4.27B)^
showing that G2 was actually 
synthesised. This was interesting as the same antiserum 
failed to detect G2 in radioimmunoprecipitations of BUN 
infected cell lysates and in recombinant dual vaccinia 
viruses expression systems.
The construct containing NSm with its own ATG was made 
by PCR and obtained from Dr Richard Elliott. Details of 
construction and expression of NSm under the control of the 
T7 RNA promoter are included in the next chapter.
Figure 4.24 Construction of pTF7-5/G2.
The fragment containing most of the sequences of G2 was 
obtained by digesting pT7T3pmlldll with Smal which cuts to 
the 5' end of G2 in the vector polylinker and Dral which 
cuts at nucleotide 941 in BUN M cDNA. The fragment was 
ligated into the Klenow filled-in BamHI site of pTF7-5.
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Figure 4.25 Determination of orientation of insertion of G2 
in pTF7-5.
The orientation of G2 under the control of the bacteriophage 
T7 RNA promoter in the pTF7-5 vaccinia virus transfer vector 
was determined by plasmid dideoxy sequencing using T7 DNA 
polymerase, as described in the Methods section. Tracks are 
GATC from left to right.
start of M: AGTAGTGTA
P stI  GACGTC 
from polylinker
Figure 4.25
Figure 4.26 Characterisation of vaccinia virus recombinants 
containing G2 by dot blot hybridization.
Total cellular DNA was extracted from cells infected with 
putative recombinants (which had exhibited c.p.e. in TK-143 
cells in the presence of BUdR) and analysed by dot blot 
hybridization. Fig 4.26A shows DNA transferred onto 
nitrocellulose paper and probed by 32P-labelled pT7T3BUNM 
DNA. Fig 4.26B shows the same samples probed by 
32P-labelled pTF7-5 DNA. Plaques 3 and 10 gave a positive 
signal.
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Figure 4.27 Detection of transiently expressed G2.
HeLa T4+ cells infected with vTF7-3 were transfected with 
PTF7-5/G2 plasmid DNA and processed for immunofluorescence 
using anti-BUN serum, as described in the Methods section. 
Fig 4.27A shows staining of cells transfected with 
PTF7-5/G2, and Fig 4.27B are cells infected with vTF7-3 
alone.
Figure 4.27
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Results from this £ec-Ken show that the BUN M RNA can 
be translated in vitro if some sequences at the 5' end are 
deleted. It was possible to express full length M segment 
RNA in dual vaccinia virus and in transient expression 
systems. The G l , G2 and NSm proteins could also be
expressed individually in transient expression systems.
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SECTION THREE
INTRACELLULAR LOCALIZATION OF PROTEINS ENCODED BY BUN M RNA 
SEGMENT
In order to study the intracellular transport and 
targetting of the Gl and G2 glycoproteins and NSm to the 
Golgi complex, permeabilized infected cells were stained 
with specific antisera and fluorescein isothiocyanate 
conjugated sheep anti-rabbit IgG, counterstained with 
rhodamine-conjugated wheat germ agglutinin (WGA) which 
predominantly stains the Golgi complex. Fluorescence 
studies were done on cells infected with vTF7-3 and 
recBUN M, which express the full length BUN M cDNA, and on 
cells expressing G l , G2 and NSm individually in the 
transient system, described by Fuerst et al (1986).
Localisation of proteins in dual vaccinia virus expression 
system
Subconfluent monolayers of HeLa T4+ cells were 
co-infected with the recombinant vaccinia virus containing 
the full length M cDNA and vTF7-3, the vaccinia virus which 
expresses T7 RNA polymerase, as detailed in Materials and 
xMethods. Cells were fixed with 3.7% formaldehyde and 
processed for indirect immunofluorescence using the anti-BUN 
serum which recognises both Gl and G2. Cells were also 
stained with the antipeptide serum to NSm. Controls 
included BUN, vTF7-3 and mock infected monolayers. The 
pattern of immunofluorescent staining of BUN-infected HeLa 
T4+ cells (Fig 5.1A) was cytoplasmic but not localised 
particularly to the Golgi region of the cells. This was 
probably because at this relatively late time after 
infection (8 hpi) the cytoplasm contained mature virions in 
the Golgi-derived membrane vesicles en route to being 
released. Similar observations have been made on HeLa T4+ 
cells infected with PT (Matsuoka et al, 1988). Fig 5.IB 
shows the pattern of staining by WGA in uninfected HeLa T4+
Figure 5.1
Fig 5.1A shows fluorescence of HeLa T4+ cells infected with 
BUN. HeLa T4+ cells were processed for indirect 
fluorescence with anti-BUN serum and fluorescein 
isothiocyanate conjugated anti-rabbit IgG, as already 
described. The fluorescence is generally cytoplasmic.
Fig 5.IB shows the fluorescence pattern of HeLa T4+ cells 
after direct labelling with rhodamine conjugated wheat germ 
agglutinin. The cells were viewed and photographed using 
the red filter at wavelength 546nm. The fluorescence 
pattern is perinuclear and localises in the Golgi complex.
Figure 5.1
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cells, and is typical for the perinuclear pattern associated 
with the Golgi complex. In the dual vaccinia virus infected 
cells (Fig 5.2A) there was strong perinuclear fluorescence 
indicating the localisation of the expressed proteins to the 
Golgi complex. No fluorescence was detected in MI cells or 
in cells infected with recombinant vaccinia virus vTF7-3 
alone (Figs 5.2B and 5.2C, respectively).
The branched antipeptide sera to NSm recognised NSm in 
recombinant dual infected cells. The pattern of staining 
was perinuclear (Fig 5.3A) and coincided with the staining 
pattern given by rhodamine conjugated WGA (Fig 5.3B).
Localisation of G1
PT7T318U containing the G1 coding sequences under the 
control of the T7 promoter (Fig 4.19) was used to express G1 
transiently, as described above. Transfected cells were 
processed for indirect immunofluorescence using anti-BUN 
serum as the primary antibody. The G1 glycoprotein was 
efficiently expressed, as can be seen in Fig 5.4A. The 
distribution of fluorescence was generally cytoplasmic and 
not particularly localized to the Golgi. This pattern of 
staining is similar to that reported for the ER (Lippincott- 
Schwartz et al, 1989).
Localisation of G2
The G2 coding sequences were cloned in the vaccinia 
virus transfer vector pTF7-5 under the control of the 
bacteriophage 010 promoter and 0TO terminator (Fig 4.24). I 
was not confident that I would actually observe G2 specific 
immunofluorescence, since previous reports indicated that G2 
was difficult to detect by immunoprecipitation in cell 
lysates (Elliott, 1985; Watret, 1985). However, the result 
shown in Fig 5.4B indicated that G2 was synthesised, as 
cells were stained by anti-BUN serum. The distribution of 
G2 in cells was perinuclear similar to that of NSm in BUN
Figure 5.2 Localisation of proteins in cells infected with
recBUN M and vTF7-3 recombinant vaccinia viruses.
HeLa T4+ cells grown on coverslips were infected with 
recBUN M and vTF7-3 viruses at 10 pfu/cell each. Cells were 
fixed at 8 hr post infection and processed for indirect 
immunofluorescence using anti-BUN serum, as described in the 
Methods section. Fig 5.2A shows the fluorescence pattern in 
dual vaccinia virus infected cells. Fig 5.2B shows mock 
infected cells processed for indirect fluorescence using the 
same materials as cells in fig 5.2A. Fig 5.2C are cells 
which were infected with recBUN M alone and processed for 
indirect fluorescence, as above.
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Figure 5.3 Intracellular localisation of NSm expressed from
dual recBUNM and vTF7-3 recombinant vaccinia viruses.
Cells were dually infected with recBUNM and vTF7-3 vaccinia 
viruses at a MOI of 10 each and processed for indirect 
immunofluorescence with antipeptide serum to NSm and 
fluorescein conjugated anti-rabbit IgG (Fig 5.2A). The same 
cells as in Fig 5.2A were directly labelled with rhodamine 
conjugated wheatgerm agglutinin (Fig 5.2B). There is 
striking co-localization of NSm in Fig 5.2A and the Golgi 
complex in Fig 5.2B. Fig 5.2C is mock infected cells 
treated with antipeptide serum and fluorescein conjugate.
Figure 5.3
Figure 5.4 Intracellular localisation of the G1 and G2 
glycoproteins.
HeLa T4+ cells grown to subconfluency on coverslips were 
infected with the vT7-3 recombinant vaccinia virus at 
10 pfu/cell for 30 min. The infected cells were transfected 
with pT7T318U containing G1 and pTF7-5 containing G2, both 
under the control of the T7 RNA promoter. At 8 hr post
transfection cells were fixed in 3.7% formaldehyde and
processed for indirect fluorescence using the BUN antiserum, 
as described in the Materials section. Fig 5.4A shows the 
fluorescence pattern in the pT7T3 18U/G1 transfected cells. 
Fig 5.4B are cells transfected with pTF7-5/G2 and Fig 5.4C
are cells infected with vTF7-3 only.
Figure 5.4
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and vaccinia dual recombinant infected cells, and distinct 
from the pattern given by G1 alone (Fig 5.4A) . This is a 
Golgi pattern staining and this suggested that G2 
glycoprotein was competent to transport from the ER to the 
Golgi complex. No staining was observed in cells infected 
with vTF7-3 alone (Fig 5.4C). This result also demonstrates 
that G1 and G2 glycoproteins can be expressed independently.
Translocation of NSm
From results described in Section One regarding the 
localisation of NSm in BUN-infected cells and results on the 
localisation of NSm in dual vaccinia virus infected cells, 
it became apparent that NSm localises in the Golgi complex. 
I wanted to test whether NSm by itself, i.e. in the absence 
of other virus coded proteins, had the ability to 
translocate from the ER to the Golgi complex. This was made 
possible by transient expression of an NSm specific plasmid 
pTZNSm.
pTZNSm contains the NSm coding region cloned under
control of the T7 promoter in pTZ18U and was provided by 
Dr Richard Elliott. The NSm coding sequence was obtained 
using the polymerase chain reaction to amplify the 
appropriate region of pBUN204 DNA, using the synthetic 
oligonucleotide primers (NSml) 5'GCTGCCCGGGCATGAGGCTTTGCAAAT 
and (NSm2) 5' CGATCCCGGGTCATGCGACCATTATAATTGTAT. NSml is 
complementary to BUN M gene bases 963-982 (plus strand) and 
introduces an in-frame ATG to initiate translation as well 
as a Smal restriction site. NSm2 is complementary to BUN M
gene bases 1485-1466 (minus strand) and introduces a TGA 
stop codon and Smal restriction site. pTZNSm produces a. T7
RNA polymerase driven transcript which encodes amino acids 
303-476 of the BUN M gene polyprotein.
HeLa T44 cells were infected with vTF7-3 and
transfected with pTZ18NSm, as described above. Cells were
fixed with formaldehyde and permeabilised with NP40. The
Figure 5,5 Intracellular location of NSm and N.
HeLa T4* cells infected with VTF7-3 were transfected with 
pTZ18NSm, containing NSm sequences under control of the T7 
RNA promoter. The construct was transiently expressed, as 
described in the Methods section, and processed for indirect 
immunofluorescence using antiserum to the branched peptide. 
Fig 5.5A shows fluorescein staining of transfected cells and 
Fig 5.5B are the same cells directly stained with rhodamine 
wheat germ agglutinin. The staining pattern in 
Fig 5.5A and B is perinuclear and consistent with the Golgi 
complex. The cellular distribution of N is shown in 
Fig 5.5. The pattern is generalised cytoplasmic, suggestive 
of ER localisation.
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Figure 5,6 Intracellular localisation of co-expressed G1 
and G2.
The G1 and G2 glycoproteins were transiently expressed in 
cells infected by vTF7-3 by transfecting plasmid DNAs 
pT7T3Gl and pTF7-5G2. The cells were treated with medium 
containing 50pg/ml cycloheximide at 6 hr post transfection 
and fixed 6 hr thereafter in 3.7% formaldehyde. The cells 
were processed for indirect immunofluorescence using anti- 
BUN serum, as already described. Fig 5.9A shows cells in 
which G1 and G2 were co-expressed and treated with 
cycloheximide. Figs 5.9B and C are mock infected and vTF7-3 
infected cells, respectively.
Figure 5.6
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location of NSm was assessed with the antipeptide sera to 
NSm. The same cells were treated with rhodamine conjugated 
WGA. Fig 5.5A represents cells transiently expressing NSm 
stained with the antipeptide serum and Fig 5.5B shows the 
same cells directly stained with rhodamine conjugated WGA. 
There is a striking co-localisation of the fluorescence 
patterns. Since wheatgerm agglutinin stains the Golgi 
complex, this result shows that NSm expressed by itself is 
capable of translocating to the Golgi in the absence of 
other BUN proteins. Because of the availability of a 
plasmid containing the S RNA, which expresses the N protein, 
the cellular localisation of N was investigated using anti­
virion serum. The N protein exhibited a generalised 
cytoplasmic pattern like G1 (Fig 5.4A).
Co-expression of G1 and G2
It has been reported that co-expression of the G1 and 
G2 glycoproteins of HTN is necessary for targetting of both 
glycoproteins to the Golgi complex (Ruusala et al, 1992). 
Since my results shown above suggested that G2 expressed on 
its own had the ability to translocate to the Golgi complex 
whereas G1 remained in the ER, I sought to determine whether 
co-expression of G2 and G1 would enable G1 to shift into the 
Golgi from the ER.
Subconfluent monolayers of HeLa T4+ cells were infected 
with vTF7-3 and transfected with equal amounts of G1 and G2 
containing plasmids, and then processed for indirect immuno­
fluorescence. BUN antiserum was used as the primary 
antibody. As can be observed in Fig 5.6A, the pattern of 
staining was characteristically that of the Golgi, and 
distinct from pattern observed when G1 was expressed alone 
(Fig 5.4A). It could be argued that since the pattern of 
staining is G2 characteristic and since the primary antibody 
recognises both G1 and G 2 , the cells may be expressing only 
G2 and not Gl. This is improbable since, in my experience, 
G1 is the more efficiently expressed than G2. The relative
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intensity of fluorescence in G2 expressed alone was usually 
lower than G 1 . The way to solve this problem is by use of 
monoclonal antibodies that specifically identify either G1 
or G2. However, there have been no reports about making 
monoclonal antibodies specific to G2 for any member of the 
Bunyavirus genus.
Effect of cycloheximide
The transport of proteins from the ER to the Golgi 
complex was investigated in the presence of cycloheximide (a 
protein synthesis inhibitor). Cells infected with the full 
length BUN M, vaccinia virus recBUN M and vTF7-3 or cells 
expressing Gl, G2 and NSm separately by the transient system 
were treated with cycloheximide for 3 hrs before fixation 
for immunofluorescence. Since the half-life for 
translocation of the Bunyaviridae glycoproteins is about 
45 mins (Kuismanen, 1984; Gahmberg et al, 1986a) these 
conditions would ensure that no newly synthesised protein 
would be detected by immunofluorescence in the ER and also 
determine if previously synthesised proteins were 
transported out of the Golgi complex.
Effect of cycloheximide on dual vaccinia virus infected 
cells
Cells were infected with recBUN M and vTF7-3 at m.o.i. 
of ten. The medium was replaced with warm medium containing 
50pg/ml cycloheximide at 12 hrs post infection for 3 hrs, 
and then the cells were processed for indirect immuno­
fluorescence. As can be seen from Fig 5.7A, the pattern of 
staining of the Golgi complex was sharper compared to that 
of the untreated dual infected cells in Fig 5.2A. This is 
because all the proteins had translocated from the ER giving 
a better definition of the Golgi complex.
IFigure 5.7 Intracellular localisation and effect of 
cycloheximide and Brefeldin A on proteins expressed by dual 
infection with recBUN M and vT7-3 vaccinia viruses.
HeLa T4* cells on coverslips were dually infected with 
recBUN M and vT7-3 at 10 pfu/cell. At 8 hr cycloheximide 
(50yg/ml) or Brefeldin A (lOpg/ml) was added to the medium 
and incubation continued for a further 3 hr. The cells were 
fixed in 3.7% fomaldehyde and processed for indirect 
immunofluorescence, as described in the Methods section. 
Fig 5.6A shows the dual infected cells treated with 
cycloheximide. The pattern is perinuclear. Fig 5.6B are 
cells treated with Brefeldin A. Fig 5C are mock infected 
cells. The pattern in Fig 5.6B is generalised cytoplasmic 
and consistent with the ER pattern.
mB
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Effect of cycloheximide on Gl, G2
Cells were transfected with respective plasmids 
expressing Gl and G2 individually and Gl and G2 together. 
At 4 hrs post transfection the medium was replaced with one 
containing cycloheximide at 50yg/ml and incubation continued 
for 3 hrs. In Fig 5.8A, it can be observed that the pattern 
for Gl after cycloheximide treatment remained generally 
cytoplasmic and similar to that of untreated cells 
(Fig 5.4A). This means that the Gl glycoprotein continued 
to reside in the ER during 3 hr of protein synthesis 
inhibition, i.e. no transport out of the ER to the Golgi. 
The pattern of staining for G2 remained the same as prior to 
treatment with cycloheximide, i.e. still remained 
perinuclear, as shown in Fig 5.8B. Fig 5.8C shows mock- 
infected cells treated with cycloheximide.
Effects of brefeldin A
Brefeldin A (BFA) is a 13-membered macrocyclic lactone
isolated from fungi with antibacterial activity which has
also been reported to inhibit transport of proteins out of 
the ER (Fujiwara et al, 1988; Misumi et al, 1986; Dorns
et al, 1989; Chon et al, 1991; Lippincott-Schwartz et al, 
1988; 1990). In addition to retention of proteins in the 
ER, BFA also causes disassembly of the Golgi apparatus and, 
on prolonged treatment, dilation of the ER (Fujiwara et al, 
1988). The drug's action is most dramatic on resident and 
itinerant proteins in the cis and medial Golgi cisternae 
(Dorns et al, 1989; Lippincott-Schwartz et al, 1989).
In this section of my study on the transport of
proteins encoded by the M segment of BUN from the ER to the
Golgi apparatus, I sought to determine whether the BUN 
glycoproteins Gl and G2 are recyclable back to the Golgi 
apparatus or are unaffected by treatment with BFA. If the
Figure 5.8 Intracellular localisation and effect of 
cycloheximide on transiently expressed Gl and G2.
HeLa T4* cells were infected with vT7-3 recombinant vaccinia 
virus for 30 min and then transfected with plasmid pT7T3 18U 
containing the Gl coding sequences or plasmid pTF7-5 
containing the G2 coding sequences under control of the T7 
RNA promoter. The medium was replaced with that containing 
50yg/ml of cycloheximide at 6 hr post transfection and 
incubation continued for another 3 hr. Cells were processed 
for indirect immunofluorescence using anti-BUN serum, as 
already described. Fig 5.8A shows the fluorescence pattern 
of Gl after treatment with cycloheximide. Figs 5.8B shows 
the fluorescence pattern of G2 after treatment with 
cycloheximide. Fig 5.8C are mock infected cells treated 
with cycloheximide.
Figure 5.8
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glycoproteins are not returned to the ER, this would suggest 
that they translocate into the trans-cisternae of the Golgi 
complex.
E f f e c t  o f  BFA i n  d u a l  v a c c i n i a  v i r u s  i n f e c t e d  c e l l s
Cells were infected with recBUN M and vTF7-3, as 
described above. The medium was replaced 12 hrs post 
infection with one containing 10pg/ml BFA and incubation 
continued for a further 3 hrs, before the cells were 
processed for immunofluorescent staining. The pattern of 
staining (Fig 5.7B) was very different from that observed in 
untreated dually infected cells in Fig 5.2A or those treated 
with cycloheximide in Fig 5.7A. The fluorescence was 
observable throughout the cytoplasm, suggestive of the ER 
staining, and that the glycoproteins Gl and G2 which are 
recognised by the antiserum translocated into the cis or 
medial cisternae and not the trans cisternae of the Golgi.
E f f e c t  o f  BFA on G l , G2 a nd  G1/G2
Cells transfected with respective plasmids, as 
described above, were treated with lOyg/ml BFA at 4 hrs post 
transfection for 3 hrs. Cells were processed for indirect 
immunofluorescence, as described in Materials and Methods. 
The pattern of fluorescence for Gl remained the same 
(generally cytoplasmic) as in untreated cells (Fig 5.9A). 
The G2 pattern changed from perinuclear to cytoplasmic 
(Fig 5.9B). The co-expressed Gl and G2 pattern which 
previously was perinuclear, as in Fig 5.6A, became 
cytoplasmic (Fig 5.9C). It was noted that the intensity of 
fluorescence was higher in cells where Gl and G2 were 
co-expressed than where Gl and G2 were expressed 
individually. The reasons for this are not known.
Figure 5.9 Intracellular localization and the effect of BFA 
on transiently expressed G l , G2 and co-expressed G1/G2.
HeLa T4+ cells were transfected with plasmid pT7T318U 
containing Gl coding sequences, plasmid pTF7-5 containing G2 
coding sequences or co-transfected with the Gl and G2 
containing plasmids. The cells were treated with lOyg/ml 
BFA at 6 hr post transfection and incubation continued for a 
further 3 hr. Cells were fixed in formaldehyde and 
processed for indirect immunofluorescence, as described in 
the Materials section. Fig 5.9A shows the staining pattern 
of transiently expressed Gl in cells treated with BFA. 
Fig 5.9B shows the fluorescent pattern of G2 after treatment 
with BFA. Fig 5.9C is the distribution of co-expressed Gl 
and G2 after treatment with BFA.
V
Figure 5.9
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Surface expression of G l , G2 and proteins
Cells dually infected with recBUN M/vTF7-3, infected 
with BUN or transfected with plasmids carrying Gl, Gl with a 
deletion from nucleotide 4326 to 4458, G2 and N genes in 
cells infected with vTF7-3 were prepared. Two sets of cells 
were prepared for each expression. One set was 
permeabilized with NP-40 after fixation with formaldehyde, 
while the other set remained unpermeabilized. All 
preparations were processed for indirect immunofluorescence 
using anti-BUN serum and IgG fluorescein isothiocyanate 
conjugate.
In BUN infected cells (Fig 5.10A) the internal 
distribution of fluorescence was observed all over the 
cytoplasm and also on the surface of unpermeabilised cells 
(Fig 5.10B). This indicated that the virion particles were
present both inside the cell and on the surface. In dual
vaccinia virus infected cells, internal fluorescence was 
seen mainly in the Golgi region (Fig 5.11A) and some surface 
expression was also detected (Fig 5.11B).
The Gl glycoprotein exhibited a generalised cytoplasmic 
pattern indicative of the ER (Fig 5.12A), but there was no 
appreciable fluorescence on the surface (Fig 5.12B).
The truncated form of Gl, lacking ten amino acids at 
the carboxy terminus, had an internal ER pattern of
fluorescence (Fig 5.13A) and a marked and sharp surface 
staining (Fig 5.13B). This result suggests that the carboxy 
terminal end of Gl may have a membrane anchoring function
and may also have ER retention capacity.
The G2 glycoprotein internal pattern was perinuclear 
(Fig 5.14A) and there was no surface fluorescence 
(Fig 5.14B).
Figure 5.10 Surface and internal distribution of 
fluorescence in BUN-infected HeLa T44 cells.
HeLa T44 cells on coverslips were infected with BUN at 
5 pfu/cell and fixed in 3.7% formaldehyde at 12 hr. One set 
of infected cells were permeabilized with 0.5% NP40 and the 
other left intact. Both sets of cells were processed for 
indirect fluorescence using anti-BUN serum. Fig 5.14A shows 
the pattern of fluorescence in permeabilised HeLa T4+ cells. 
Fig 5.14B is the pattern of unpermeabilized cells,
indicating surface distribution.
Figure 5.10
Figure 5.11 Surface and internal distribution of proteins 
in cells dually infected with recBUN M and vT7-3 vaccinia 
viruses.
HeLa T44 cells were infected with recBUN M and vT7-3, as 
described in the legend of Fig 5.2. Cells were fixed in 
3.7% fomaldehyde at 8 hr post infection. One set of cells 
were permeabilized with 0.5% NP40 and both sets of cells 
were processed for immunofluorescence using anti-BUN serum. 
Fig 5.15A shows the staining pattern of the permeabilized 
HeLa T44 cells. Fig 5.15B is the pattern of unpermeabilized 
cells.
Figure 5.11
Figure 5.12 Internal and surface distribution of Gl.
HeLa T44 cells transiently expressing Gl, as described in 
the Methods section, were fixed in 3.7% formaldehyde. One 
set was permeabilized with 0.5% NP40 and both sets were 
processed for indirect immunofluorescence using anti-BUN 
serum. Fig 5.12A shows the internal fluorescence while 
Fig 5.12B shows the surface fluorescence.
Figure 5.12
Figure 5.13 Internal and surface distribution of G1 with 
C-terminal deletion.
The cells were fixed in formaldehyde and one set 
permeabilized. The cells were processed of indirect 
immunofluorescence with anti-BUN serum. Fig 5.13A shows the 
fluorescence pattern in permeabilized cells. Fig 5.13B is 
the pattern in unpermeabilized cells, indicating surface 
fluorescence.
AFigure 5.13
Figure 5.14 Internal and surface distribution of G2.
HeLa T44 cells transiently expressing G2 were fixed in 3,7% 
formaldehyde. One set was permeabilized with 0.5% NP40 and 
both sets were processed for indirect immunofluorescence 
using the anti-BUN serum. Fig 5.14A shows G2 with its 
characteristic Golgi complex staining pattern. Fig 5.14B 
shows the fluorescence distribution of G2.
Figure 5.14
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Conclusions drawn from results in this o* are:
1 G2 and NSm are competent to transport independently from 
the ER to the Golgi complex.
2 The G1 glycoprotein becomes competent to transport into 
the Golgi from the ER when co-expressed with G2 from 
different plasmids and from the full-length cDNA.
3 The internal staining pattern of G1 and the N protein 
are similar, and generally cytoplasmic
4 BUN-infected cells showed fluorescence both internally 
and on the surface.
5 G1 and G2 hardly showed expression on the cell surface 
but some fluorescence was observed in dual vaccinia 
virus infected cells.
6 Deletion of the carboxy end of G1 led to internal 
fluorescence to show on the surface.
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DISCUSSION
The aims of this project were to: express the BUN M RNA 
segment from a cloned cDNA; clone and express individual 
gene products of BUN M RNA; characterise the translocation 
of the G1 and G2 glycoproteins and NSm from the ER; and 
determine the cellular localization of NSm. These have 
largely been achieved by demonstrating the success of: 
(1) expression of a BUN M RNA fragment from nucleotide 1452 
to 4001 in vitro and expression of the full length BUN M RNA 
from cloned cDNAs; (2) expression of the G1 and G2 
glycoproteins and NSm individually; (3) production of 
antisera using branched peptides to NSm and using these to 
demonstrate the cellular localisation of NSm to be the Golgi 
complex; (4) demonstration that both G2 and NSm are capable 
of translation to, and retention in, the Golgi complex in 
the absence of other viral proteins; and (5) co-expression 
of G1 and G2, resulting in G1 (which alone was retained in 
the ER) being transported to the Golgi complex.
The results will be discussed under the following 
subtititles: Production of antiserum to NSm; Expression of 
BUN M RNA gene products; Intracellular transport and 
localization of BUN M gene products.
Raising site specific antisera to NSm
All members of the Bunyavirus genus encode a 
nonstructural protein, NSm, which was mapped to the M RNA 
segment (Elliott, 1985; Fuller and Bishop, 1982). The fact 
that NSm is encoded by the BUN M RNA segment was further 
demonstrated from nucleotide sequence analysis of BUN M RNA 
which revealed that in addition to the G1 and G2 
glycoproteins, the M segment had the capacity to encode a 
further protein of 16K which corresponded to NSm (Lees 
et al, 1986).
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The function of NSm is unknown and before this work was 
accomplished its cellular residence was also unknown. 
Demonstrating the cellular residence of NSm would serve as 
an important step towards delineating the role of NSm in 
virus replication and morphogenesis. To facilitate this 
aim, an antiserum that would react specifically to NSm was 
required. One possibility to produce an antiserum to NSm 
was to fractionate virus infected cell lysates in 
polyacrylamide gels and use those as immunogens. There 
would be a technical problem of efficiently isolating NSm 
from the background of host proteins and also the fact that 
NSm is present in relatively small amounts.
I employed two approaches to raise antisera to NSm. 
One involved the use of (S-galactosidase/NSm fusion proteins 
and the other involved raising antisera to synthetic 
peptides to pre-determined sequences in the NSm coding 
region. Fusion proteins are becoming increasingly common as 
sources of immunogens for producing antibodies to proteins 
that were previously non-immunogenic and to proteins whose 
amino acid sequences have been deduced from existing 
nucleotide sequences. 3~galactosidase (3~gal) has been 
utilized as a carrier protein more than other proteins 
because of the establishment of its amino acid sequence 
(Fowler and Zabin, 1978) and the fact that its antigenic 
sites recognised by T cell repertoires have been worked out 
(Krzych et al, 1982). 3~gal fusion proteins have been shown 
to elicit production of antibodies to foreign proteins which 
are located at both the amino and carboxy termini of the 
3~gal moiety (Shunau et al, 1980; Broekhuijsen et al, 1986, 
1987; Winther et al, 1986; Spindler et al, 1984). The 
system has advantages which include the relative ease of 
constructing appropriate vectors and the large amounts of 
protein that can be produced. A further advantage of using 
fusion proteins with 3-gal is that the 3~gal moiety can be 
used as a means of identifying the protein either 
immunologically by use of antibodies to 3~gal or
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biochemically by use of substrates such as 
0-nitrophenyl-3-D-galactosid<£ (ONPG) , as described by Miller, 
1972.
A potential disadvantage of fusion proteins is that 
they are predominantly present in an insoluble form of the 
cell lysate (Ausubel et al, 1990). However, insolubility of 
the protein may be advantageous if the purification step 
uses SDS-PAGE (Rio et al, 1986; Spindler et al, 1984). The 
insolubility of fusion proteins may have an added advantage 
in protecting them from degradation by host cell proteases.
Construction of the cro-3-gal-NSm gene was facilitated 
by inserting the Dral (nucleotide 941) and Hae III 
(nucleotide 1541) fragment of the BUN M cDNA. The CI857 
thermolabile repressor gene was functional and allowed 
control of expression of the 0-gal/NSm fusion proteins. 
E.coli DH5a cells tranformed with pUEX3/NSm and pUEX3 
plasmids did not synthesise fusion proteins nor 3~gal at 
30°C (Fig 3.3, lanes 1-3) but a 30°C to 42°C temperature 
shift resulted in 3-gal (lane 4) and 3-gal/NSm fusion 
proteins (lanes 5 and 6, uppermost band) being synthesised. 
The lower band observed in lane 5 and 6 is most likely 
cro-3-gal; it does not quite correspond with the induced 
cro-3-gal in lane 4 which appears slightly larger because of 
the greater expression and overloading on the gel. The 
lower band does not exactly co-migrate with the commercial 
3~gal marker because it is a cro-3~gal fusion protein.
The upper band which was of the expected size for 
cro-3-gal/NSm fusion protein was synthesised in much less 
amounts than cro-3_gal. This may be attributed to poor 
r ( v a v \ j » toxicity to the cells, or protein instability 
introduced by the presence of NSm sequences. Proteolysis 
may be another factor leading to reduction in observed 
amounts, but this was ruled out as no new smaller bands 
which would suggest degradation could be observed in the 
induced samples.
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The fusion protein band was excised from the 
polyacrylamide gel, macerated and used as the immunogen. 
The polyacrylamide which is non-toxic to animals confers a 
'slow-release' effect of the cro-p-gal/NSm into the lymphoid 
system of rabbits, thus providing an adjuvant effect. The 
antiserum raised using fusion proteins failed to recognise 
NSm in BUN-infected cell lysates by radioimmuno- 
precipitation. This may be a result of the heavily 
hydrophobic nature of NSm which made the NSm protein 
inaccessible to the rabbit immune system. In an ELISA
system fusion antiserum 1/2 recognised peptide M245 weakly, 
as shown by differences in the OD values at 405 nm of 
preserum and terminal sera (Fig 3.5A). There was no 
difference between preserum and terminal serum for fusion 
antiserum 2/2 (Fig 3.5B). This may be attributed to the 
rabbit having been exposed to cross-reacting antigens to NSm 
or defective blocking of unoccupied sites on the microtitre 
plates. The latter was ruled out because the plates come 
from the same batch as for antiserum 1/2 and repeated assays 
gave similar results. This could also be as a result of 
individual variation among rabbits leading to production of 
non-specific immunocomplexes.
Since good fusion antisera to NSm could not be made 
with 3-galr attention was switched to producing antipeptide 
sera to NSm. Studies since 1980 have shown that synthetic 
peptides can induce antibodies reactive with their cognate 
sequences in the native protein (Sela and Arnon, 1981; 
Lerner, 1982). Site specific antipeptide antibodies have 
been shown to be useful laboratory reagents for confirming 
de novo proteins from recombinant DNA, exploring 
biosynthetic pathways and precursors, probing structural 
functions and to orient proteins in cellular compartments 
and subcellular organelles. They are also useful in the 
study of the chemistry and structure of the antigen-antibody 
union, e.g. chemistry of virus neutralisation, and for 
production of passive immunoprophylaxis (Lerner, 1984).
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Unlike antibodies to native proteins which are 
dependent on secondary structure, Green et al (1983), using 
influenza virus haemagglutinin as a model, demonstrated that 
reactivity of antipeptide antibodies is independent of 
secondary structure or location in the molecule. In cases 
involving peptides for eliciting antipeptide antibodies, it 
was necessary to couple the peptide to a carrier protein 
such as keyhole limpet haemocyanin. This resulted in a 
number of problems including immune response to the carrier 
(Posnett et al, 1988; Tam, 1988). These authors synthesised 
peptides by the multiple antigen peptide system which 
resulted in branched peptides. McLean et al (1991) 
demonstrated that branched peptides were superior to single 
peptides coupled to a carrier when it came to antigen 
presentation to the immune system.
In my study branched peptides to two predetermined 
amino acid sequences in the NSm coding region, as shown in 
Fig 3.4B, were utilised. Two regions were chosen because of 
the possibility that one peptide might miss intermediates in 
a processing cascade when the part of the protein to which 
the antibody is directed is removed and also because if 
antisera to more than one region of a protein detect the 
same products in cells, the certainty of a reaction of 
immunological specificity will be ensured (Lerner, 1984). 
Regions containing hydrophilic amino acids were chosen in 
the peptides to increase the likelihood of solubility and 
enable the peptides to be antibody accessible.
The antibodies to both branched peptides M245 and M246 
recognised NSm in radioimmunoprecipitations, as shown in 
Fig 3.7. There is recognition of other proteins but this 
was nonspecific as both pre- and immune sera recognised 
these proteins. The G1 glycoprotein was also recognised by 
the immune sera but not preimmune sera in dual vaccinia 
virus expressed cell lysates. This probably I is due to the
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j presence of vaccinia vims proteins because immune branched
antipeptide M245 precipitated only NSm in BUN infected cell 
lysates (Fig 4.16, lane 5).
In an ELISA assay for branched antipeptide sera 1/8 and 
2/8 reacting with peptide M245, there was good specificity 
and a high ELISA titre (Fig 3.6). It was also revealed that
immunising rabbits with 300pg of branched peptide l^ad to a 
better immune response than with lOOyg per inoculum. This
was shown by the OD values at 405nm of preterminal sera 2/8 
(300pg) exhibiting a profile similar to the terminal sera 
1/8 (lOOpg), i.e. higher antibody levels were achieved in a
shorter time (35 days) with 300pg compared with 50 days for
lOOpg.
Using branched peptide serum M245 in immunofluorescence 
studies, the usefulness of branched anti-peptide sera to NSm 
was demonstrated when the residence of NSm in virus infected 
cells was determined to be the Golgi complex. This was
shown by co-localisation of NSm using fluorescein
isothiocyanate and rhodamine conjugated wheat germ 
agglutinin which predominantly stains the Golgi complex 
(Fig 3.8). This is the first demonstration of the residence 
of NSm for any member of the family Bunyaviridae. Since 
maturation of members of the Bunyaviridae family takes place 
in the Golgi complex, NSm is most likely to have an 
important role in viral morphogenesis. The heavily 
hydrophobic NSm probably provides the surface over which 
virion assembly occurs, but the exact role of NSm is an 
aspect for future research.
Expression of BUN M RNA segment
Previous attempts to translate mRNA derived from the 
M RNA segment of BUN in vitro were unsuccessful (Abraham and 
Pattnaik, 1983; Elliott, 1985). Yet, similar approaches by 
Ulmanen et al (1981) resulted in the translation of UUK M 
mRNA which yielded a polyprotein precursor to the G1 and G2
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glycoproteins. The reasons for this difference are not 
known and one of the aims of my project was to express the 
BUN M RNA segment from a cloned cDNA. This is because the 
levels of mRNA made in vitro are higher than the levels 
isolated from BUN infected cells. This was also a challenge 
because no reports of expression of the M RNA segment from a 
cloned cDNA had been made for any member of the Bunyavirus 
genus, although the first sequence in the genus was reported 
for SSH in 1984 (Eshita and Bishop, 1984).
The initial approach was to clone the BUN M cDNA in a 
suitable transcription vector and translate the mRNA in 
rabbit reticulocyte lysate or wheat germ in vitro 
translation systems. Whether the processing (cleavage) of 
the putative polyprotein precursor was a co-translational or 
post-translational event would be demonstrated by the 
presence or absence of mature proteins when canine 
pancreatic microsomal membranes were added to the 
translation reaction.
The transcription vectors used were those of the pTZ 
series which have a T7 RNA promoter. It was expected to be 
a straightforward cloning exercise as the BUN M cDNA insert 
would easily be obtained by digestion of pBUN205 with PstI 
and cloning the fragment into the PstI site of the pTZ 
vectors. Repeated efforts however failed to place the BUN M 
cDNA under the control of the T7 RNA promoter in order to 
make message-sense transcripts - as revealed by 
determination of orientation using restriction enzyme 
digestion. The cDNA was inserted the wrong way in all cases 
analysed. This observation suggested that inserts under the 
T7 promoter were being selected against by the bacteria, 
causing deletions in the plasmids or that the BUN M cDNA 
under the T7 promoter was toxic to bacteria. The strategy 
was then changed to employ the pT7T3 transcription vector 
which has both the T7 and T3 RNA promoters on either side of 
the polylinker. Analysis of recombinant plasmids again 
showed that the BUN M cDNA inserted against the T7 promoter
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in all cases but was under the control of the T3 promoter. 
This observation confirmed the one made above that 
transformed bacteria selected against the BUN M cDNA under 
T7 promoter control and apparently the bacteria were
tolerant to BUN M cDNA under T3 RNA promoter control. The 
reason for toxicity could be
due to the presence of the lacZ promoter in the pUEX3 vector.
When
attempts were made to express full length cystic fibrosis
transmembrane conductase regulator (CFTR) cDNA in E.coli, 
deleterious effects were observed (Gregory et al, 1990). 
The problem was circumvented by assembling the full-length 
CFTA open reading frame in a vector containing a low copy
number of DNA replication.
Run-off transcripts of full length and truncated cDNA 
made using T3 RNA polymerase revealed that mRNAs of expected 
sizes were made, as shown in Fig 4.4. These transcripts
were made in roughly the same amounts as the control MAG S 
mRNA which is known to be translatable in vitro (Elliott and 
McGregor, 1989). Attempts to translate the BUN M mRNAs
alongside the MAG S transcripts in vitro were unsuccessful 
in both rabbit reticulocyte lysate and wheat germ systems.
Failure to translate could be as a result of poor initiation 
of translation. However, production of capped transcripts 
did not result in translation. It was thought that elements 
at the 5' end may be responsible for inhibiting translation. 
To test this theory, a BamHI fragment from nucleotide 1352 
to 4001 with an ATG at nucleotides 1430-1432 was cloned into 
the pT7T3 vector and run-off transcripts made using the T3 
RNA polymerase. These transcripts represent some carboxy 
aa459-1315 terminal sequences of NSm and most of G1. 
Interestingly, a translational product of about 90K which 
was recognised by the BUN antiserum in radio-
immunoprecipitation was made, as shown in Figs 4.7 and 4.8. 
This result suggests that sequences in the 5' 1350
nucleotides of the middle RNA segment do affect initiation 
of translation.
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The use of in vitro translation of BUN M mRNA 
transcripts made from cDNA was therefore unsuitable for the 
study of the biogenesis of the BUN M RNA gene products. The 
strategy was shifted to the use of vaccinia virus which has 
become widely used as an expression vector. Vaccinia virus 
as an expression vector has many advantages because it 
encodes an entire transcription system including capping, 
methylating and polyadenylating enzymes. Also, as a member 
of the poxvirus family, replication occurs within the 
cytoplasm rather than the nucleus making nuclear transport 
and processing unnecessary (Moss, 1990). Many proteins have 
been expressed using this system, including BUN polymerase 
gene (Jin and Elliott, 1991) in this laboratory.
Attempts to clone the full length BUN M cDNA in the 
vaccinia virus transfer vector vTF7-5 were unsuccessful. 
This could have been due to the usually more difficult blunt 
end ligations or some intrinsic properties within the BUN M 
gene. Li et al (1988) reported difficulties in obtaining a 
recombinant M cDNA gene of VSV that could be expressed in 
vaccinia. They also observed that plaques that formed had 
the M gene inserted in the reverse non-expressible 
orientation. In my case, the strategy for cloning BUN M in 
vTF7-5 involved starting with a truncated BUN M cDNA with a 
large deletion from nucleotide 1352-4001. The full length 
BUN M segment was then reconstructed by ligating in the 
BamHI fragment from nucleotide 1352-4001 at the BamHI site 
at position 1352. However, this turned out to be a more 
difficult exercise than expected. All the colonies that 
were picked and analysed had the internal BamHI fragment 
inserted against the bacteriophage 010 promoter. 
Re-examination of plates revealed the presence of tiny 
colonies of about one third of a milimetre in diameter. 
These tiny colonies carried plasmids in which the internal 
fragment inserted in the correct orientation. This 
suggested that some sequences in the insert, which have some 
sequences of NSm and most of G 1 , were toxic to bacteria. The
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small colony size was a useful phenotype for identifying 
plasmids that had inserts in the correct orientation.
Recombination of pTF7-5 BUN M with vaccinia virus was 
achieved by use of calcium phosphate precipitation. Among 
the first 12 plaques picked, three recombined correctly, as 
demonstrated by dot blot hybridisation (Fig 4.11) and as 
shown by Southern analysis (Fig 4.12). Recombinant vaccinia 
virus with BUN M expressed authentic G1 when co-infected 
with recombinant vaccinia virus vTF7-5 which expresses the 
T7 RNA polymerase (Fig 4.14), and also in
radioimmunoprecipitation analysis, as shown in Fig 4.16, 
lane 6. Dual vaccinia virus expression also synthesised NSm 
and this was confirmed in a radioimmunoprecipitation 
experiment using branched antipeptide serum to NSm, as shown 
in Fig 4.16, lanes 9 and 11. Because G2 is not reliably 
seen even in virus infected cells (Elliott, 1985; Watret, 
1985), this result showed that the polyprotein precursor of 
the M segment RNA was synthesised and properly processed. 
This is the first report about the expression of the middle 
RNA gene which encodes the G1 , G2 glycoproteins and NSm for 
a member of the Bunyavirus genus of which BUN is the 
prototype. The dual vaccinia virus system designed by 
Fuerst et al (1985) efficiently expressed the BUN M gene.
To facilitate expression of individual BUN M proteins, 
the transient expression system described by Fuerst (1986) 
using the T7 RNA polymerase^utilized. The system has an 
advantage over the dual vaccinia virus system in that 
isolation of recombinant vaccinia viruses is not necessary. 
Constructs were made by placing full length M, Gl, G2 and 
NSm genes under the control of the T7 promoter. 
Introduction of plasmids into cells was achieved by 
lipofection, using cationic liposomes to transfect the DNA.
Construction of the full length BUN M under the T7 
promoter involved excising it from pT7T319UBUNM by Smal and 
PstI digestion and cloning it into the pT7T318U Smal-PstI
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site (Fig 4.17). The full length BUN M cDNA under the 
control of the T7 promoter was expressed in CV-1 cells and 
the G1 glycoprotein, which co-migrated with authentic G1 in 
BUN infected cells, was immunoprecipitated by anti-BUN 
serum, as shown in Fig 4.18. The G2 glycoprotein could 
still not be detected for the reasons described above.
The construction of G1 involved several steps dictated 
mainly by the availability of restriction enzymes. These 
included ligating a BamHI-Sall fragment in a BamHI/Sall cut 
pT7T319U vector and then filling in with a Sail and PstI 
BUN M fragment (Fig 4.19). Ideally the BamHI site at 1352
and the PstI site at 4458 would have been the fragment to
use but there is another BamHI site at nucleotide 4001. The 
fragment contains an in-frame ATG at position 1430-1432 in 
the C-terminal end of NSm (Fig 4.19) and as this was the 5' 
most ATG, it was hoped that this would be used to initiate 
translation. The G1 glycoprotein was efficiently expressed 
in CV-1 cells and in similar amounts to G1 expressed by the 
dual vaccinia virus system, as shown in Fig 4.20. There is 
another inframe ATG just six base pairs downstream of the 
first ATG and it remains to be determined which one is 
actually involved in initiation. The G1 glycoprotein was 
also transiently expressed in a time course experiment, as
shown in Fig 4.21. Maximal level of expression occurred at
4-6 hr post tranfection. Expression of G1 from this 
internal AUG concurred with the result observed in the 
in vitro expression, and raised the possibility of internal 
initiation in vivo. However, whether this occurs in nature 
is unknown, but may explain inpart why apparently more G1 
than G2 is seen in BUN infected cells. Similar observations 
and suggestions have been made for the expression of HTN 
glycoproteins (Pensiero and Hay, 1992). Jackson (1988) 
described how picornaviruses broke the rules by not 
conforming to the scanning ribosome model developed by Kozak 
(1986). The model suggested that ribosomes initiate only by 
binding to the 5' end followed by linear scanning of the 
mRNA. This was as a result of work by Pelletier and
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Sonenberg (1988), which demonstrated that poliovirus which 
is not naturally capped is translated by internal 
initiation.
Work was also done to determine whether the G1 protein 
synthesised by dual vaccinia viruses and in transiently 
expressed systems was properly glycosylated. This was done 
by use of tunicamycin which prevents glycosylation of the 
lipid bound sugar intermediates needed for protein 
glycosylation (Rothman and Lodish, 1977) . Cells infected
with BUN, dual vaccinia viruses recBUN M and vTF7-3 and 
transfected with pT7T318U/Gl were either treated or not 
treated with tunicamycin. The cell lysates were immuno- 
precipitated with anti-virion serum and proteins analysed by 
electrophoresis in polyacrylamide gel (Fig 4.22). The G1 
protein in treated cells migrated faster than G1 in 
untreated cells. This result indicated that the G1 
glycoprotein was properly glycosylated in both dual vaccinia 
virus and transient expression systems.
As a step towards functional studies of the G1 
glycoprotein, a deletion at the C-terminal end was made by 
digestion with Hind III which cuts at nucleotide 4326 and in 
the polylinker of pT7T3. The deleted plasmid was then
religated to itself. The translational terminator signal is 
present in the pT7T3 sequences. The deleted region 
(aa 1424-1434) in the G1 glycoprotein contains properties of 
a membrane anchoring sequences (Lees et al, 1986). After 
expression the deleted form was slightly smaller than the 
full length G1 (Fig 4.23).
The construct containing the G2 coding sequences was 
made by excising the fragment from pT7T3 BUN M with Smal and 
Dral and ligating it into the Klenow filled-in BamHI site of 
vTF7-5 vector (Fig 4.24). The ideal combination of 
restriction enzymes would have been Smal and Bell because 
Dral cuts the M gene eight amino acids short of the full 
length G2. Bell however failed to cut efficiently due to
Figure 6.1 Effect of sample preparation on detection of G2.
Mock-infected or BUN infected BHK cells were labelled with 
33S-methionine at 24 hpi and cell lysates prepared in 
protein dissociation buffer (see Methods). The samples were 
either not heated (lanes 1 and 5), heated at 37°C for 5 min 
(lanes 2 and 6), heated at 100°C for 1 min (lanes 3 and 7), 
or heated at 100°C for 5 min (lanes 4 and 8)# before 
electrophoresis on a 12% gel. Lanes 1 to 4 are mock- 
infected cell lysates, and 5 to 8 BUN infected cell lysates. 
The positions of BUN proteins L, G1 , G2 and N are indicated. 
This figure was provided by Dr Richard Elliott.
Figure 6.1
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the dam methylase effect. Propagation of the plasmid in 
JM 48 bacteria which are dam" resulted in only partial 
digestion. Recombinant vaccinia virus with G2 was made but
its expression could not be demonstrated. Difficulties in
observing G2 were reported by Elliott (1985) and Watret 
et al (1985).
However, when I transiently expressed G2 and 
immunofluorescence for detection using anti-BUN serum, a 
positive signal indicating synthesis of G2, as shown in 
Fig 4.27, was observed. This observation was interesting
and puzzling. It was then probable that the problem with 
detecting G2 labelled with 35S-methionine was a technical 
one. Among the aspects tested was the method of preparing 
samples for polyacrylamide gel electrophoresis (experiment 
done by Dr Richard Elliott). BHK cells were infected with 
BUN at 10 pfu/cell, radiolabelled for 2 hr at 24 hr post 
infection (a time when inhibition of host protein synthesis 
would be marked; Scallan and Elliott, 1992), and lysed in 
the protein dissociation mix defined in the Methods section. 
The lysate was divided into four aliquots which were either 
left at room temperature, heated at 37°C for 5 min, boiled 
for 1 min or boiled for 5 min before loading samples on the 
gel. As can be seen from Fig 6.1, the sample boiled for 
1 min (lane 7) clearly shows less G2 than the unheated 
(lane 5), or heated at 37°C (lane 6). G2 could not be 
detected in the samples boiled for 5 min, but virion 
specific proteins at the top of lane 8 indicate that G2 
aggregates on heating and probably stays at the top of the 
gel, and that is a plausible reason why G2 could not be 
detected in cells previously boiled for 5 min. Another 
possibility would be degradation, but this could not be 
demonstrated as some smaller bands would be expected but ! 
were not seen. This result makes safe my observation that 
G2 was actually made and detectable by immunofluorescence 
when transiently expressed. This is because all 
immunofluorescence manipulations were carried out at room 
temperature.
Figure 6.2 Detection of G2 expressed in recombinant 
vaccinia virus infected cells.
HeLa T4+ cells were mock-infected (lane 1), infected with 
BUN (lane 2) , recBUN M and vTF7~3 (lanes 3 and 4), recBUN M 
alone (lane 5), or vTF7-3 alone (lane 6). Cells were 
labelled with 35S-methionine at 18-20 hr post infection and 
cell lysates reacted with anti-BUN serum. The immune 
precipitated proteins were dissolved in protein dissociation 
buffer, but were not heated before electrophoresis on 12% 
polyacrylamide gel. Positions of BUN proteins L, G1 , G2 and 
N are indicated. This figure was provided by 
Dr Richard Elliott.
Figure 6.2
The detection of G2 strengthens the work I perfomed using 
recombinant vaccinia viruses in that (a) the precursor is 
properly translated and processed, and (b) the immunofluorescence 
detected by transient expression of a plasmid containing only G2 
sequences appears valid.
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Further experiments by Dr Richard Elliott showed that 
G2 was made and detectable by immunoprecipitation in dual 
vaccinia virus infected cells (Fig 6.2). Lane 1 is immuno- 
precipitation of MI, lane 2 immunoprecipitation of BUN 
infected cells, lanes 3 and 4 are dual vaccinia infected 
cells and lanes 5 and 6 are BUN recM AND vTF7-3 infected 
cell lysates, respectively. This result, coupled with the 
result in Fig 4.16, in which G1 was recognised by anti­
virion sera and NSm by branched antipeptide sera, confirms 
that the polypeptide precursor of the middle RNA segment was 
made and properly processed.
Intracellular localisation of BUN M RNA gene products
Apart from their similarity in general structure which 
characterizes the members of the Bunyaviridae, the site of 
virion maturation in the Golgi cisternae is another 
distinctive feature of the family. The site of virion 
maturation was originally used as a criterion for the 
creation of the family (Murphy et al, 1973). It is now 
known however that other groups of viruses, including the 
corona and pox, also mature and bud at the Golgi complex 
(Pettersson et al, 1991).
The maturation and budding at the Golgi complex is 
thought to be determined by targetting of one or several of 
the glycoproteins to the compartment. This view was 
supported by the observation by Kuismanen et al (1984, 1985, 
1988) that both the glycoproteins of UUK accumulated in the 
Golgi complex. Further work by Matsuoka et al (1988) for PT 
and Wasmoen et al (1988) for RVF also showed that the 
glycoproteins translocated to the Golgi complex in virus 
infected cells when expressed by recombinant vaccinia
viruses. The same reports were made for HTN glycoproteins 
where G1 and G2 expressed from a vaccinia virus vector 
accumulated in the Golgi complex (Pensiero et al, 1988).
135
I was interested to understand how the proteins encoded 
by the BUN M RNA segment translocate from the ER to the 
Golgi complex. This was made possible by transiently 
expressing truncated BUN M genes that represented G 1 , G2 and 
NSm. The fate of translated products was tracked by 
indirect immunofluorescence using anti-BUN polyclonal 
antibodies for G1 and G2 and the anti-peptide antisera to 
NSm. Immunofluorescence was also performed on proteins 
expressed from the full length cDNA. The fluorescence 
pattern was compared with that of wheat germ agglutinin 
conjugated to rhodamine which predominantly stains the Golgi 
complex, as shown in Fig 5.IB. The pattern is distinctively 
perinuclear.
In cells expressing proteins in the dual vaccinia virus 
system, the pattern of staining using the anti-virion sera 
was similar to that of wheat germ agglutinin. When the 
cells were treated with cycloheximide, the pattern was 
similar but a sharper and better defined perinuclear 
staining, as shown in Figs 5.2A, 5.7A. This better
resolution was caused by inhibition of protein synthesis, 
thus allowing the proteins already synthesised to transport 
to their destination. Treatment of cells with BFA for 3 hr 
before fixation resulted in redistribution of fluorescence 
from the Golgi pattern to the generalised cytoplasmic 
pattern which is characteristic of the ER (Fig 5.7B). This 
result suggested that the G1 and G2 glycoproteins which are 
recognised by anti-BUN sera reside in either the cis or 
medial cisternae and not the trans cisternae, which is not 
affected by BFA treatment (Lippincott-Schwartz et al, 1989).
When G1 was expressed alone, it failed to translocate 
to the Golgi complex even in the presence of cycloheximide 
(Figs 5.4A, 5.8A). Treatment of BFA had no effect on the 
intracellular distribution of G1 (Fig 5.9A). G1 by itself 
then is incompetent to transport out of the ER to the Golgi 
complex. On the other hand, the distribution of G2 was 
perinuclear and similar to that of full length dual vaccinia
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expressed proteins (Fig 5.4B). Treatment of cells 
expressing G2 with cycloheximide improved the perinuclear 
definition whereas BFA had a dramatic effect of changing
perinuclear Golgi pattern to the ER pattern, as shown in 
Fig 5.9B. This result suggested that the G2 glycoprotein 
has intrinsic information to translocate to the Golgi
complex from the ER, and the observation is in agreement
with the postulation made by Lees et al (1986) from the
deduced amino acid sequence of BUN M RNA. The first 17 
amino acids which are hydrophobic overall and which are at 
the amino terminal end of G2 have characteristics of a
signal sequence. When the sequences of BUN, SSH, LAC and 
L74 a LAC variant were aligned some conservation of amino 
acids was observed especially at amino acid 17 for BUN and 
14 for the others, where a serine is conserved. The
predicted cleavage site was just before the conserved
serine, as shown in Fig 6.3.
Pensiero and Hay (1992) reported that co-expression of 
G1 and G2 of HTN was necessary for G2 to translocate to the 
Golgi complex. A similar report has been made for UUK by 
Ronnholm (1992) where G1 expressed alone transported to the 
Golgi complex. However, when G1 and G2 were co-expressed, 
both glycoproteins translocated to the Golgi complex. It
should be mentioned at this point that G1 of HTN and UUK are 
at the amino terminal half of their respective precursors, 
whereas G2 occupies this position in the BUN precursor.
It was therefore of interest to see if G2 of BUN would 
rescue G1 and transport it out of the ER. The G1 and G2
glycoproteins were co-expressed, as described above. The 
pattern of fluorescence was perinuclear in cells
co-transfected with G1 and G2 cDNAs, suggesting that both G1 
and G2 had translocated to the Golgi (Fig 5.6A). BFA
reversed the Golgi pattern to the ER pattern, as shown in
Fig 5.9C. It can be argued that the perinuclear pattern 
observed in the co-transfected cells is due to the
expression of G2 alone but this is discounted, because in my
Figure 6.3 Putative signal peptide cleavage sites and 
conserved tripeptides in the M gene proteins of BUN, SSH, 
LAC and LAC L74 variant virus.
Sequence data from (a) Lees et al (1986); (b) Eshita and
Bishop (1984); and (c) Clerx van-Haaster et al (1982).
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experience G1 is the more efficiently expressed protein than 
G2 and the intensity of fluorescence in co-transfected cells 
is higher, as can be seen in Fig 5.9C, than in individually 
transfected cells. The best way to resolve this problem is 
to utilise monoclonal antibodies. Although no reports have 
been made about the synthesis of monoclonal antibodies to G2 
for any member of the Bunyavirus genus, monoclonal 
antibodies to G1 alone will suffice to show that G1 has been 
rescued by G2 to transport into the Golgi when both are 
co-expressed. Alternatively, specific peptide antisera
could be produced. Another way would be to carry out 
subcellular fractionation after radiolabelling and then 
analyse fractions in polyacrylamide gels.
Transient expression of NSm and detection by branched 
antipeptide sera in immunofluorescence studies revealed that 
NSm by itself is competent to translocate to the Golgi 
complex. It remains to be seen what effect co-expression of 
G1 with NSm will have on the transport competency of G1 to 
the Golgi complex. It was reported for PT, however, that 
deletion of NSm had no effect on the transport of G1 and G2 
to the Golgi (Chen et al, 1991). If NSm has no role in the 
translocation process then the dual vaccinia virus
expression result also confirms that G2 is necessary to 
enable G1 to translocate to the Golgi complex. The 
mechanism by which G1 and G2 interact in order to
translocate from the ER to the Golgi complex needs to be 
worked out.
Work was also done to determine whether the G1 and G2
o
glycoproteins and the nuclq[capsid protein N expressed on the 
cell surface in HeLa T44 cells. Controls included cells 
infected with BUN. BUN infected cells showed the presence 
of the virus both internally (Fig 5.10A) and on the surface 
(Fig 5.10B). Internal fluorescence would be the total of G1 
and G2 packaged into virions and G1 and G2 unpackaged and
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present in the ER and the Golgi complex. The surface 
fluorescence presumably represents virus particles which are 
exiting from the plasma membrane.
There was some surface fluorescence for the
glycoproteins expressed from recombinant dual vaccinia 
virus. Although the cells in Fig 5.11B do not show
extensive vaccinia virus cpe, the fluorescence may actually 
be due to early vaccinia virus cpe presenting the G1 and G2 
synthesising factories to the surface, enabling their 
detection by the anti-BUN serum. G1 transiently expressed
showed its characteristic ER pattern when detected
internally (Fig 5.12A). There was very little, although 
detectable amount, of G1 on the surface of cells. Madoff 
and Lenard (1982) demonstrated that LAC G1 accumulated 
inside infected cells, although some was detectable on the 
cell surface by pulse-chase experiments. They also 
demonstrated that the population of LAC G1 on the cell 
surface resembled that in extracellular virions in being 
fully endo-H resistant, a property that is generally 
considered to represent complete processing through the 
Golgi apparatus. It remains to be seen if BUN G1 detected 
on the surface when expressed individually is endo-H 
resistant, as results in Section Three of this thesis 
indicated that G1 expressed on its own could not transport 
to the Golgi.
A candidate to study the endo-H resistance of G1 found 
on the cell surface exists in the form of BUN G1 with a 
deletion of 10 amino acids at the carboxy end. When 
transiently expressed in cells the truncated G1 showed 
internal fluorescence pattern of the ER, as shown in 
Fig 5.13A, which is similar to the full length G 1 . Surface 
fluorescence was however better defined and prominent 
(Fig 5.13B) than in the full length G 1 . This result 
supports the predicted structure of G1 from nucleotide 
sequence which indicated presence of a terminal anchor 
sequence at the carboxy terminal end (Lees et al, 1986).
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Unlike G1, the G2 glycoprotein showed perinuclear 
staining as in Fig 5.14A and no detectable surface 
expression. This suggests that the G2 has the signal to 
transport from the ER to the Golgi and also information to 
retain into the Golgi, and retention of G1 in the Golgi is 
the function of G2.
The internal fluorescence of the N protein was 
cytoplasmic and similar to that of G1 . It is suggested that 
the N protein also needs the G2 glycoprotein to enable it to 
reach the station of virus maturation, which is the Golgi 
apparatus, but work needs to be done to demonstrate this.
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FUTURE PROSPECTS
Expression of the middle RNA genome segment of 
Bunyamwera virus provides an important basis for detailed 
analysis of functions of G1 and G2 glycoproteins and NSm. 
This is especially so when the individual proteins have been 
cloned and expressed. Areas of immediate interest are:
1 Assigning the membrane fusion function to either G1 or 
G2 by independently expressing them at the pH of fusion.
2 Using site-directed mutagenesis and gene deletions to 
determine domains in the glycoproteins responsible for 
membrane anchorage.
3 Determining the amino acid sequences on G2 and NSm that 
are necessary for translocation from the ER to the 
Golgi. This would be done by use of mutagenesis and 
construction of chimaeric proteins, e.g. with plasma 
targetted glycoprotein like VStf G.
4 In the longer term, determining the function of NSm, by 
introducing changes in the virus by site-directed 
mutagenesis and gene deletions. This, however, presents 
a problem, because the RNAs of negative stranded viruses 
are non-infectious, compared with the positive stranded 
viruses whose RNAs are infectious.
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